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 Abstract 
Introduction: Where access to sanitation is incomplete and environmental 
water contact high, water-borne diseases such as schistosomiasis can be com-
mon in children and occur alongside other parasitic diseases.  Parasitological 
diagnosis based upon microscopy of parasite ova or larvae underestimates true 
infection prevalence, and as NCPs reduce the intensity of infection(s) with pre-
ventive chemotherapy, the diagnostic sensitivity also declines.  In Uganda and 
the Kingdom of Saudi Arabia, for example, school-based disease control has 
been ongoing over the past decade, and there is a need to develop more sensi-
tive methods of parasite detection and disease surveillance.  Against this two-
country backdrop, the application of novel diagnostics was investigated to re-
veal the current status of infections in school children.  Parasitological- and se-
rological-based methods were compared against the implementation of real-
time PCR methods to detect DNA from faecal or dried blood spot specimens.  
Diagnostic performance was then compared, and its epidemiological signifi-
cance discussed for each country setting.  
Method: In Uganda, Buliisa District, a total of 271 children were enrolled.  
Stool, urine and blood were collected and examined for schistosomiasis, giar-
diasis and malaria using a selection of commercially available RDTs in the field, 
then compared against real-time PCR methods with TaqMan® probes in the la-
boratory.  In the Kingdom of Saudi Arabia, Al-Majardah District, a total of 163 
children were enrolled for this study.  As faecal samples could not be collected, 
blood and urine samples were inspected.  Children were interviewed by ques-
tionnaire and collection of intermediate snail hosts made. In the following up, 
all children positive for schistosomiasis where re-examined one year later.   
Results: In Uganda, Buliisa District, the overall prevalence of S. mansoni was: 
44.1% by microscopy of duplicate KK smears from two consecutive stools, 
56.9% by urine-CCA dipstick, 67.4% by DNA-TaqMan® and 75.1% by 
antibodies to SEA- ELISA.  Giardiasis was 41.6% by QUIK CHEK™ RDT, and up 
to 87.0% of children were excreting Giardia DNA.  The prevalence of heavy 
infection by real-time PCR assay (Ct ≤ 19) was 19.5%.  Notably, giardiasis was 
positively associated with egg-patent schistosomiasis and two Giardia assem-
blages, A and B, were found.  Co-infections thereof varied by school and by age.  
A total of 138 (55.8%) cases of malaria were diagnosed for P. falciparum 
(PfHRP-2-detecting RDTs), and 45 samples (18.2%) were positive for pan-Plas-
modium species (PfHRP-2 and pan-pLDH test lines). Upon analysis of dried 
blood spots with real-time PCR, a total of 198 (80.1 %) cases for any Plasmo-
dium spp. was detected and compared to real-time PCR of faecal samples.  In 
the Kingdom of Saudi Arabia, Al-Majardah District, using urine-CCA strip 
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assessment and SEA-ELISA, the prevalence of S. mansoni was 15.3% and 
combined S.mansoni/haematobium was 34.3%, respectively. Molecular DNA 
analysis using the CO1 gene alongside morphological identification of collected 
snails demonstrated the presence of Bulinus forskalii in this area and the local 
absence of Biomphalaria at the time of the survey. 
Conclusion: Using a combination of diagnostic methods, vital contemporary 
epidemiological information on schistosomiasis, giardiasis and malaria was re-
vealed and then compared across the two countries using the ASSURED crite-
rion.  Foremost, whilst real-time PCR methods with TaqMan® probes have the 
greatest potential in Uganda, in Saudi Arabia however, owing to the difficulties 
in obtaining a stool, this method is inappropriate.  Nonetheless, DNA-based di-
agnostic platforms will be essential in future public health settings where prev-
alence and intensity of infections continue to fall, as improved sensitivity is re-
quired.  Furthermore, the ability to simultaneously co-detect several infectious 
and parasitic diseases will boost disease surveillance efficiency and capacity.    
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Chapter 1:  General Overview                                                   
1. Neglected Tropical Diseases (NTDs)  
Neglected Tropical Diseases NTDs have a substantial  detrimental health im-
pact on the populace of the developing world, especially in communities 
trapped within poverty (WHO, 2017a); from actions of prominent international 
NTD lobbyists, the prominence given to NTDs has increased and  NTDs are rec-
ognised as a public health scourge of comparable importance to HIV, malaria 
and tuberculosis (Hotez et al., 2006a). A disease may be deemed ‘neglected’ 
when overall funding is inadequate, lower than its need, and insufficient for ef-
fective prevention and/or control.  Most affected by these debilitating diseases 
are the poorest of the poor, and most vulnerable within tropical and subtropi-
cal populations of the world. More than 1 billion people – a seventh of the 
world’s population, are suffering from one or more NTD (WHO, 2009b, Deribe 
et al., 2012). The list of NTDs includes helminth, e.g. STH infections (ascariasis, 
trichuriasis and hookworm infection) and schistosomiasis as well as those of 
protozoan, bacterial or viral origin (Utzinger et al., 2012). With a lack of inno-
vative diagnostic tools, effective treatment chemotherapies, incomplete sanita-
tion and inadequate knowledge regarding disease transmission, many vulner-
able people at risk of significant ill-health. Several NTDs often coexist with pov-
erty because they thrive where access to clean water, putting approximately 
500 million people in sub-Saharan Africa susceptible to co-infection (Hotez and 
Kamath, 2009).  
Polyparasitism may also cause long-term effects on child growth, hinders intel-
lectual development and can interfere with iron absorption (anaemia) (Müller 
et al., 2016). The principles and strategies of control NTDs include improv-
ing access to safe, clean drinking water as well as basic sanitation and im-
proved housing. The implementation of these strategies could prevent the 
spread of the diseases and potentially eradicated (Hotez et al., 2007, Feasey et 
al., 2009). Prevention strategies available to combat these NTDs may be at the 
cost of less than US$0.50 per person per year - making the elimination of these 
NTDs a feasible goal, yet over half a million deaths occur annually (Hotez et al., 
2007, Hotez and Pecoul, 2010). A diverse group of disease-specific partner-
ships represent the different communities involved in NTDs have made a sig-
nificant contribution to scaling up of programmes. One of those, the BMGF 
funded the SCI programme which started in 2002. Uganda, one of the six coun-
tries developed a control strategy for treating about three-quarters of SAC with 
preventive chemotherapy, decreasing infection intensity and creating a ‘de-
mand’ for continuous implementation of the effective large-scale control pro-
gramme (Fenwick et al., 2009, Fenwick and Jourdan, 2016). With progress and 
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challenges towards the targeted delivery of treatments, there are genuine pro-
spects to transition from control to elimination of NTDs, or to confirm the pres-
ence or absence of further transmission (Molyneux et al., 2018, Rosenberg et 
al., 2016, French et al., 2018).   
Over the last decade, substantial progress in control and elimination has been 
brought the transmission of the disease under control in different countries 
due to medicine donations. It has been shown that five of the ten diseases 
(Guinea worm disease, lymphatic filariasis, leprosy, sleeping sickness and 
blinding trachoma) would eventually be eliminated and the other five (schisto-
somiasis, STH, Chagas disease, visceral leishmaniasis and onchocerciasis) have 
made advanced changes in control over the past 10 years (Hotez et al., 2016). 
These promising developments encourage researchers to continue to target 
these long-term debilitating diseases impacting the most vulnerable 
populations (Hotez et al., 2006b). NTDs are typically addressed through ﬁve 
strategies: preventive chemotherapy, intensified disease management, vector 
control, veterinary public health measures for neglected zoonotic diseases, and 
through improved water and sanitation (Molyneux et al., 2017, Molyneux et al., 
2018).  
In 2013, the World Health Assembly approved Resolution WHA 66.12, which 
defined strategies for NTDs with clear targets and milestones for 17 NTDs, and 
endorsed the WHO NTD Roadmap goals linking NTDs to universal health cov-
erage (Molyneux et al., 2017). An integrated control approach, highlighting 
multiple NTDs is imperative to track the spread of disease transmission 
(Clements et al., 2010). An initial investment of more than $785 million to sup-
port NTD programs, strengthen drug distribution, and increase research 
and development towards combatting NTDs is needed from developed coun-
tries, and commitment from developing countries to improve their uptake and 
reported compliance in the last mass drug administration (MDA), are the foun-
dations to achieve NTD elimination (Mableson et al., 2014, Molyneux, 2013, 
Molyneux et al., 2018). Most importantly, NTDs that currently lack appropriate 
tools for large-scale use. Hence, in general, disease management is presently 
more complex and costly to manage as there are inherent challenges for their 
diagnosis, treatment, and follow-up (Rosenberg et al., 2016). 
The focus of my thesis is slightly wider than the remit of NTDs alone, but I spe-
cifically aim to address a key NTD, schistosomiasis, alongside its occurrence 
with two other important medically important diseases, giardiasis and malaria. 
To help position the connections between these three diseases, I will review 
aspects of the lifecycle and epidemiology, to highlight connects and deficits be-
tween actions of each disease individually or collectively. 
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2.1 Schistosomiasis 
Schistosomiasis is a particularly important NTD caused by infection with 
intravascular digenetic trematodes of the genus Schistosoma. Some 700 million 
people worldwide are exposed to schistosomiasis, with an estimated 200 mil-
lion people actively infected (Osakunor et al., 2018). Both intestinal (i.e. S. man-
soni) and urogenital (i.e. S. haematobium) schistosomiasis have been widely 
reported, and the majority of infection occurs in sub-Saharan Africa amongst 
the most impoverished communities (Figure 1) (Colley et al., 2014). Moreover, 
in Africa, around 300,000 deaths due to schistosomiasis are reported annually 
(Weerakoon et al., 2018). Due to a lack of hygiene and sanitation facilities, 
mainly basic healthcare facilities, infection is almost unavoidable.  
Infected children are highly likely to become chronic sufferers with attendant 
fibrosis and an elevated risk for the development of  hepatosplenomegaly, 
hepatic fibrosis, portal hypertension, and colonic polyposis (for the intestinal 
forms of schistosomiasis caused by S. mansoni, S. japonicum, S. intercalatum, 
and S. mekongi) and bladder thickening, ulceration, and polyposis, along with 
hydronephrosis and renal dysfunction (for urinary schistosomiasis caused 
by S. haematobium) (Osakunor et al., 2018, Gray et al., 2011a). Globally, schis-
tosomiasis,  as expressed in DALY,  causes an estimated at 3 million DALYs, and 
costing approximately $57 million annually (Tekle et al., 2012). 
 
Figure 1: Map is demonstrating the global distribution of different types of Schistosoma spp. 
(The key species are illustrated by different coloured ), with sub-Saharan Africa have the high-
est burden of infection (Weerakoon et al., 2018) 
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2.2 Lifecycle  
Adult schistosome worms (male and female) exist inside visceral blood vessels 
of their definitive hosts and are commonly known as vascular blood flukes (Fig-
ure 2). Within the blood vessels, sexual reproduction occurs to fertilise eggs, 
and then the eggs are laid inside the blood vessel either to be shed into the 
environment through faeces or urine or are retained in host tissues where 
they induce an inflammatory response (Figure 3) (Gryseels et al., 2006).  
The eggs hatch in freshwater sources allowing free-swimming miracidia to be 
released, which then infect a specific freshwater snail intermediate host. Inside 
the snail asexually reproduces takes place, creating numerous daughter sporo-
cysts that contain cercariae. After around 4-6 weeks, thousands of cercar-
iae (the larval form infectious for human beings) release into the freshwater 
(Gryseels et al., 2006). The most widespread types, S. mansoni and S. haemato-
bium, require a suitable snail intermediate host of the genus; Biomphalaria spp.  
and Bulinus spp. species respectively. From this intermediate snail host come 
the cercariae, which infect their definitive host (humans) by penetrat-
ing the skin. Inside the human, the cercariae can then form into an adult capa-
ble of producing about 3,000 eggs per day. The process of migration and 
maturation takes about 4 to 6 weeks post-infection in S. mansoni and around 
90 days in S. haematobium (Colley et al., 2014, Gryseels et al., 2006). Under-
standing the fundamental schistosome life-stages are essential for developing 
long-term strategies and tools for the control/elimination of the disease.   
 
Figure 2: The lifecycle of the most common human Schistosoma spp. illustrating that transmis-
sion occurs in water by percutaneous transmission (Centre for Disease Control, 2017) 
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2.3 Schistosomiasis transmission  
2.3.1 Snail hosts 
In Egypt in 1915, the lifecycles of the African schistosomes were first de-
scribed by Robert T. Leiper (1881-1969) which demonstrated the vital im-
portance of freshwater snails as an essential intermediate host for this para-
sitic fluke (Stothard et al., 2017b). Freshwater snails of Biomphalaria and Buli-
nus genera  (Gastropoda: Planorbidae) are responsible for the transmission of 
intestinal and urogenital schistosomiasis, respectively (Abe et al., 2018).  
Both genera are widely spread in various parts of the Middle East and Africa 
(Hotez et al., 2012). It has been suggested that miracidia at the first larval stage 
can recognise specific macromolecular glycoproteins on different snail species, 
allowing them to partially target and penetrate the suitable snail species and 
develop into infectious cercariae (Wang et al., 2016). There are more than 400 
species of freshwater gastropod detected in the whole of Africa, but only a few 
of them restricted to the two genera can harbour the parasitic Schistosoma 
worms (Hotez et al., 2012). Their characteristics, locations and habitats are 
summarised in Table 1.  
Table 1: Summarizing the characteristics, locations and habitats of intermediate hosts for hu-
man schistosomiasis (Madsen, 1992, Rollinson et al., 2001, Abe et al., 2018) 
  
Environmental conditions such as temperature, pH and conductivity can also 
affect the development of these snails and therefore effect disease transmission 
to humans (Liang et al., 2007). It has been documented that conductivity may 
have an extremely adverse effect on snail density (Rowel et al., 2015). Lower 
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pH results have also been suggested to an increase of snail density (Levitz et al., 
2013). However, there is still a particular discrepancy in findings (Opisa et al., 
2011, Rowel et al., 2015).  
Although specific for each species, there is evidence for the influence of tem-
perature on survival, growth and fecundity of the freshwater snail. The opti-
mum temperature for aquatic mollusc’s development and survival is between 
15°C.  and.  25°C, but mortality increases after 30°C and over 40°C degrees will 
cause death (Kazibwe et al., 2006, Opisa et al., 2011). A recurrent concern has 
been that the host snails’ taxonomy not always been entirely distinguished, and 
the traditional morphology-based character has been inaccurately used for ex-
tended times as very similar species can be different from others in their com-
petence (Bakuza et al., 2017). Molecular taxonomic tools for the identifica-
tion and classification have conclusively been proved in deciphering the phylo-
genetic relationship of snail populations. A method like targeting the mitochon-
drial gene CO1 in a PCR and subsequent DNA sequencing has accurately al-
lowed for the identification of very different species from Bulinus spp. and Bi-
omphalaria spp. populations (Kane et al., 2008, Jørgensen et al., 2007, Stothard 
and Rollinson, 1997). 
2.3.2 Human hosts   
Since human hosts become infected by direct penetration of the skin, avoiding 
contact with infected water is the key to preventing disease spread. Many im-
poverished communities rely on freshwater that is contaminated by human 
and animals waste as a primary source for their daily household activities such 
as drinking and bathing so that decreasing disease transmission based on con-
trolling is quite difficulties  (Colley et al., 2014). 
WASH control measures require to be implemented to minimise the rate of 
human infection (Grimes et al., 2015).  Sanitation strategies to prevent excreta 
eggs from contaminating water sources, and eventually providing access to 
soap and clean water may reduce levels of cercariae and miracidia and there-
fore the rates of infection (Tchuenté et al., 2017). Targeting population, SAC, 
children who are living close to freshwater sources, where schistosomiasis is 
focally transmitted, is vital for control disease, by providing effective medica-
tion, such as, PZQ for those most in need (Grimes et al., 2014, Stothard et al., 
2013a). The analysis of the local people's living styles, patterns and habits will 
improve our knowledge required to effectively manage the disease transmis-
sion and help in developing control strategies toward elimination (WHO, 
2009a). 
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2.4 Pathogenesis and symptomatology  
2.4.1 Intestinal schistosomiasis 
Schistosomes localise in the portal and mesenteric veins, with the disease in-
volving the liver, spleen, and gastrointestinal tract, where egg execrating, and 
eventually release into the environments through faeces (Colley et al., 2014). 
However, some of these eggs become trapped in the intestinal wall and can 
lead to multiple-granulomata formation. Subsequently, the muscularis mu-
cosa becomes involved, and the overlying mucosa undergoes hyperplastic 
changes, the submucosa becomes thickened and dark, swelling (inflammation) 
of various parts of the digestive tract and yellowish patches may be seen 
(Pearce and MacDonald, 2002). Diarrhoea, abdominal pain or swelling of the 
abdomen also can be seen in the chronic stage due to this inflammatory re-
sponse (Figure 3); other gastrointestinal manifestations can be presented such 
as anaemia, enteropathy and rectal bleeding, and rectal prolapse (Bustinduy et 
al., 2013, Green et al., 2011). 
 
Figure 3: A schematic diagram representing the development  of both Th1 and Th2 immune 
response to parasite antigens (Pearce and MacDonald, 2002) 
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2.4.2 Urogenital schistosomiasis 
Schistosoma haematobium localises in the vesical plexus (venous network 
around the bladder), where female worms lay eggs into the urine (Colley et al., 
2014). Initially, the eggs produced by adult worms in their venous locations are 
highly immunogenic molecules, known as a soluble egg; they enter into urinary 
tract tissue, and trigger pro-inflammatory immune responses to schisto-
some eggs, resulting in granuloma formation (Figure 3-above) (Pearce and 
MacDonald, 2002, Gray et al., 2011b). It has been found that haematuria, dysu-
ria and frequent urination were more frequently associated with urinary tract 
pathologies of infection (UTPs) which can be observed within three months of 
infection (Figure 4) (De Souza and Olsburgh, 2008). Over extended periods, 
immune downregulation and reduction of granuloma sizes are exchanged by 
collagen and fibrotic lesions, eventually leading to strictures, calcifications and 
urodynamic abnormalities which might persist post-infection and despite 
treatment (Wilson et al., 2007, Colley and Secor, 2014). Hydronephrosis, kid-
ney failure and death are also long-term sequelae (Smith and Christie, 1986). S. 
haematobium also provides the pre-conditions for squamous cell carcinoma 
development, a distinguishing feature of this Schistosoma species, believed to 
cause around 16% of all bladder cancers in Egypt (Zaghloul, 2012). 
 
Figure 4: Microscopic histological images of the urinary tract with S. haematobium eggs pre-
sent produced by Fadel, H (Fadel, 2018). (A) The presence of S. haematobium eggs leads to the 
transitional epithelium of the ureter, (B) S. haematobium eggs trap in the muscle layer of the 
bladder potentially causing urodynamic disorders, (C) The terminal spine of S. haematobium 
eggs is presented in the muscle layer of the bladder  
2.5 Diagnostics  
2.5.1 Direct parasitological methods 
Microscopic examination of excreta (stool, urine) remains the standard gold 
test for diagnosis of Schistosoma spp., but has some well-known limitations 
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(Gray et al., 2011a). The diagnosis of intestinal schistosomiasis is widely per-
formed by egg detection using the microscopy-based KK  (Figure 4). According 
to the WHO recommended thresholds (light: 1-99 EPG, moderate: 100-399 epg, 
heavy: ≥400 epg)(Hawkins et al., 2016). Despite the low sensitivity of the test 
in populations who have received previous treatment with PZQ, it is still widely 
used in limited resource-settings as its simplicity and relatively low-cost, and 
ability to detect other parasitic diseases such as STH (Colley et al., 2014).  
Table 2: Microscopic examination of the Schistosoma egg morphology, (CDC, 2016)  
 
          The microscopic detection of excreted S. haematobium eggs, when 10 ml 
of urine is syringe-filtered, usually through polycarbonate filters with a  pore 
size of 8–30 μm, is often considered as the gold standard diagnostic (Colley et 
al., 2014). Based on the WHO guideline, egg counts for S. haematobium are 
given as eggs per 10 mL of urine (ep10mL), and intensities of infections are 
categorised as light (1–49 ep10mL) and heavy (≥ 50 ep10mL) (Stete et al., 
2012). However, the sensitivity of these methods in single stool or urine sample 
examination is limited by day-to-day variation in egg excretions leading to 
measurement error in estimating the presence of infection (Tchuenté et al., 
2017). This is particularly accentuated in areas with high proportions of light 
intensity infections (Booth et al., 2003, Weerakoon et al., 2018). The increase 
of large-scale interventions and repeated mass treatment with PZQ will signif-
icantly decrease the prevalence and intensities of schistosome eggs. As a 
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consequence of the increase of low-intensity schistosome infections, more light 
infections will be often missed if single samples are examined by standard 
methods, resulting in a high underestimation of infection. Therefore, there is a 
need to develop and validate more sensitive diagnostic tools (Tchuenté et al., 
2017, Bergquist et al., 2017). 
2.5.2 Antigen detection tests 
As the burden of schistosomiasis is decreasing, emphasises 
the importance and essential need for more sensitive methods, apart from the 
standard diagnostic methods (Bergquist et al., 2017, Stothard et al., 2014, 
Weerakoon et al., 2018). The detection of circulating adult worm or egg anti-
gens in blood, urine, or sputum is now proven to be highly satisfactory as a di-
agnostic test (Hawkins et al., 2016, Dawson et al., 2013, Adriko et al., 2014, 
Knopp et al., 2015, Stothard et al., 2006, Tchuenté et al., 2012). CCA and CAA 
which  are released from the vomitus of worms (Van Dam et al., 1996), are fre-
quently used as target after around 3 weeks post as well as to evaluate the 
treatment response to the active worm burdens (Stothard, 2009, Van Lieshout 
et al., 2000, Dawson et al., 2013).  
The sensitivity of both CAA in serum and CCA in urine samples are not generally 
different, enhancing their use in low-high transmission setting (De Jonge et al., 
1990, Polman et al., 1995, Stothard, 2009, Danso-Appiah et al., 2016). The CCA 
test has some drawback in diagnosing S. haematobium infection but has better 
sensitivity for detecting S. mansoni infections than single and triplicate KK 
thick smear (Stothard et al., 2006, Ayele et al., 2008, Knopp et al., 2015, 
Koukounari et al., 2013).  
Although the test is readily applicable in the field and stable at average room 
temperatures, its use in national control programs is often restricted due to its 
current price which is around US 1.75 dollars (Stothard, 2009). The advantage 
of this test is a convenient and efficient method for screening and mapping 
schistosomiasis in poor resource setting with medium to high transmission 
(Coulibaly et al., 2013, Colley et al., 2013, Stothard et al., 2011). However, col-
lecting urine samples on different days may be required for more accurate di-
agnosis because of daily fluctuation of levels of CCA in the urine. Also, it has 
been shown that the CCA positivity is strongly associated with the intensity of 
infection (Tchuenté et al., 2012, Stothard, 2009, Stothard et al., 2006, Kittur et 
al., 2016).  
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2.5.3 Antibody detection tests 
ELISA is a simple, sensitive, and RDTs, which has been applied for detection of 
the SEA from a small amount of human blood (Smith et al., 2012, Stothard et al., 
2009).  The SmSEA in the ELISA format has been shown to hold great prom-
ise for early diagnosis of schistosomiasis in a higher-risk setting (Hinz et al., 
2017, Stothard et al., 2009). This test is commonly used in travellers' medicine 
clinics where often only light infection can be detected. Currently, a commer-
cially-produced SmSEA-ELISA kit is available which is considered to be suitable 
for field use (Stothard et al., 2009, Stothard et al., 2014). Indeed, us-
ing crude and purified egg antigens of S. mansoni in ELISA  may result in 
an overestimation of areas of high transmission since it does not discriminate 
between active and past infections and because false positives are present due 
to cross-reactivity with other parasites as hookworms (Correa-Oliveira et al., 
1988, Stothard et al., 2009, Stothard et al., 2014).  
Using a finger-prick blood sample, the test performed well for the diagnosis of 
both S. mansoni and S. haematobium infections in pre-school children (Stothard 
et al., 2009). The test was at least as sensitive as duplicate KK and a single urine 
filtration for detection of S. mansoni and S. haematobium, respectively 
(Coulibaly et al., 2013). The sensitivity of the test was however decreased in 
children aged under three years (Dawson et al., 2013). In a comparing study for 
SmSEA-ELIZA, alkaline phosphatase assay (APIA), circumoral precipitin test 
(COPT) and KK, suggested that, for field work, the whole targeting population 
can be diagnosed by SmSEA-ELIZA or APIA. Then, KK and COPT would be suit-
able tests for confirmation of the positive cases only as detected earlier (Noya 
et al., 2002).  
2.5.4 DNA-based diagnostics for schistosomiasis 
To overcome some of the drawbacks of other diagnostic procedures, remarka-
ble progress has been made in upgrading the diagnostic accuracy for schisto-
somiasis by using the PCR technique (Weerakoon et al., 2018). The conven-
tional PCR methods for the detection of Schistosoma DNA in human samples 
have been published in different studies (Pontes et al., 2002, Pontes et al., 2003, 
Sandoval et al., 2006, Weerakoon et al., 2018, Gobert et al., 2005, Gomes et al., 
2006). In the beginning, DNA isolation from faecal specimens was hindered by 
time-consuming procedures and the presence of substances that inhibit the 
PCR products, but there is nowadays newly, and even faster methods have been 
developed for DNA isolation which has significantly decrease these difficulties 
(Verweij et al., 2004). However, real-time chemistries (rtPCR) has advantages 
over traditional PCR methods: notably, simultaneously amplifies and 
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visualising the quantities of amplified DNA products, reliably identifying indi-
viduals with light-intensity infections, less labour-intensive (Weerakoon et al., 
2018, Ten Hove et al., 2008). This technique has been applied for the detection 
of the Schistosoma infections in humans, moreover, in determining the inten-
sity of infection as determined by the cycle threshold (Ct) value (Verweij and 
Stensvold, 2014, Gomes et al., 2006, Pillay et al., 2014). This rtPCR technique 
has also been improved for detecting multiple DNA targets in a single reaction 
mixture, which has been evaluated successfully for case detection, and  for dis-
criminating between S. japonicum, S. mansoni, and S. haematobium, and as an 
critical approaches for detecting and monitoring schistosomiasis control pro-
grams (Verweij and Stensvold, 2014, Gobert et al., 2005, Ten Hove et al., 2008). 
At present, a new, high sensitive PCR approach that allows the genus- and spe-
cies-specific amplification of the main 5 Schistosoma species (S. japonicum, S. 
mansoni, S. haematobium, S. intercalatum, and S. bovis) has been developed 
based on ribosomal DNA (rDNA) that generated very sensitive and specific am-
plification (Sandoval et al., 2006). Indeed, PCR identification of S. mansoni has 
documented to be a superior tool in diagnostic accuracy compared to the KK 
and urine CCA tests in high-endemic setting (Lodh et al., 2013, Melchers et al., 
2014, Obeng et al., 2008). Although a more desirable rtPCR assay for detecting 
both S. mansoni and S. haematobium, combined with internal control is 
required for control schistosomiasis on criteria for determining the thresholds 
between high, and low to moderate transmission settings, this real-time PCR 
only used for detection S. mansoni DNA which will be described in chapter 2. 
2.6 Control and prevention  
Currently, PZQ is the only available PC recommended by the WHO distributed 
for the treatment of both urogenital and intestinal schistosomiasis (Knopp et 
al., 2016, French et al., 2018). Insufficient funding in developing countries such 
as Africa has led to inadequate access to many untreated individuals (Hotez and 
Pecoul, 2010). In 2002, the SCI highlighted the requirement of an MDA with 
PZQ (Fenwick et al., 2009, Fenwick and Jourdan, 2016). Fortunately, in 2007 
Merck KGaA agreed to supply 200 million tablets of PZQ as part of a 10- year 
donation via the World Health Organisation (WHO). Later in 2012, the pharma-
ceutical sector has made committed for a donation of up to 250 million tablets 
annually, until schistosomiasis is eliminated (Tchuenté et al., 2017). Although 
the MDA programme is receiving continued financial support, some people 
who are at high risk of disease in remote regions of Africa are still not being 
treated (Stothard et al., 2013a). It has been advised to take the tablet with food 
and water as clinically significant food-drug interactions increase bioavailabil-
ity (Castro et al., 2000).  
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The mechanism of action of PZQ involves disrupting calcium ion (Ca2+) chan-
nels which are the only moiety so far identified as the molecular target, but the 
evidence is indirect (Doenhoff et al., 2008). PZQ does not affect immature schis-
tosomes, and the death rate of adult worms can be difficult to measure because 
of their intravascular sites. Therefore the therapeutic response of PZQ is cur-
rently assessed using egg clearance 3 to 4 weeks after treatment (Doenhoff et 
al., 2008, Sousa-Figueiredo et al., 2012). The main side effects of the drug are 
stomach discomfort with or without nausea, and headaches and it is recom-
mended to use during pregnancy. These side effects are commonly mild and 
transient, which are not usually required medical attention (Utzinger et al., 
2003). A single right dose of PZQ of 40 mg/kg, is recommended directly by the 
WHO for schistosomiasis control (Stothard et al., 2013a). SAC target the most 
vulnerable children during their growth as they are at the risk of intellectual 
impairment and stunting (Mafe et al., 2005). A dose-pole has been developed 
to help healthcare professionals when treating children in the target settings 
(Figure 5) (Montresor et al., 2005). 
 
Figure 5: Pictorial representation of the current WHO dose-pole which corresponds to a 
number of PZQ tablets (600 mg each) (left) and the new dose poles – Ugandan model (center) 
and a model for the rest of Africa (right) with new height thresholds added to allow for treat-
ment of PSAC (<6-year old). ¾ of a tablet division illustrated,  as an example, for child  need 
rather than a single tablet (Sousa-Figueiredo et al., 2010a) 
By using school infrastructure, the deworming school-age children can easily 
be implemented through MDA programmes in which a single oral dose of 
albendazole and PZQ periodically administered (WHO, 2013b). The demand 
for PZQ and national distribution of PZQ based on the baseline prevalence of 
the selected schools (see Table 3 for recommended values).   
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Table 3: Recommended treatment strategy for schistosomiasis in preventative chemotherapy 
PZQ  (WHO, 2009b, Stothard et al., 2014) 
 
Snail-control is a method that has been rarely incorporated into epidemiologi-
cal studies and control strategies since the comprehensive implementation of 
MDA. However, the intermediate host of the parasite represents not only 
fundamental requirement for the development of the infective stage of the 
parasite but also the site of exponential multiplication of cercaria individuals 
from one miracidium (Madsen, 1992). This enhances the importance of estab-
lishing control with targeting both the parasite and the vector to prevent trans-
mission. The different effective integrated control strategies of the intermedi-
ate host of schistosomiasis are summarised in Table 4.  
Table 4: Summarizing most commonly snail control strategies used in countries like Japan, 
Iran, Lebanon, Saudi Arabia (Sokolow et al., 2016, Madsen, 1992, Rollinson et al., 2013, Coelho 
and Caldeira, 2016, Pointier and Jourdane, 2000) 
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2.7 Schistosomiasis in Uganda and Saudi Arabia  
Schistosomiasis has been of substantial public health importance in many 
countries of sub-Saharan Africa for long-times, particularly in Uganda. In 2002, 
an NCP was established for delivering PZQ once every two years to all SAC 
(aged 5-15 years) (Kabatereine et al., 2007). Although both species of Schisto-
soma are found in Uganda,  S. mansoni  is the most prevalent, and approxi-
mately 20 million people within 73 Ugandan districts are estimated to be at risk 
of infection, with the shorelines of the Lakes Albert and Victoria and nearby 
communities being the highest transmission zones (Figure 6) (WHO, 2013b).  
Due to environmental and malacological reasons, disease transmission is 
thought unlikely in areas of high altitude, mountainous regions, hot 
and cold places where the conditions are not suitable for snail habitats to de-
velop (Kabatereine et al., 2004, Stanton et al., 2017). These Lakes are a funda-
mental part of Ugandan life, where water-contact activities are occurred in the 
regular daily base such as laundry,  bathing children play in the freshwater 
(Loewenberg, 2014, French et al., 2018). Many fishing communities alongside 
the lakes may also expose to this parasitic infection daily (Fuhrimann et al., 
2016, Dunne et al., 2006). Until the clean water is available and basic sanitation 
is developed, the goal of controlling morbidity to be reached by 2020, along 
with elimination as a public health problem is an unrealistic goal (Tchuenté et 
al., 2017, French et al., 2018). 
In Saudi Arabia, schistosomiasis is one of the significant health problems, espe-
cially in the province of Asir (Figure 6) (Al-Madani, 1991, Shati, 2009, Al-
Zanbagi, 2013, Lotfy and Alsaqabi, 2010). In 2004, a research study showed 
that Saudian people accounted for almost  61.2 % of total infected cases re-
ported, and infection is most frequently detected in the age group of  15–39 
years, providing evidence about the endogenous source of infection (El-
Shahawy et al., 2016). Infection rates by gender were four times higher than 
females (Barakat et al., 2014). Overall, 75 % of total infection was S. mansoni, 
and the prevalence was more common in most of the southwestern region with 
a focus in Hail in the North. Schistosoma haematobium was restricted to a few 
foci in the southwestern region in Jazan and Asir  (Figure 6), and both prov-
inces are bordering Yemen, where the spread of schistosomiasis is still high 
(Barakat et al., 2014, El-Shahawy et al., 2016, Lotfy and Alsaqabi, 2010). Minis-
try of Health statistical data in 2008 confirmed that Saudis are more common 
to be infected than immigrant populations; the percentage of infection was 55.5 
% and 45.5 % for Saudis and emigrant populations, respectively (Barakat et al., 
2014).  
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In view of this, it is possible that the actual prevalence of schistosomiasis in the 
provinces may be underestimated than those shown in the Annual Health Re-
ports, especially in Asir region where schistosomiasis control has apparently 
little development. It is, therefore, important to address different factors which 
make the application of schistosomiasis control measures ineffective and to im-
plement new diagnostic tools for better estimation of the prevalence in Asir 
Province and others (Al-Madani, 1991, Stothard et al., 2014).  
 
Figure 6: An outline map for schistosomiasis transmission in Uganda and Saudi Arabia. On the 
left-hand side, the prevalence and location of S. mansoni parasitological surveys and average 
district level prevalence in Uganda as illustrated by Global Atlas (Distribution of schistosomia-
sis survey data in Uganda, online access (http://www.thiswormyworld.org/maps/distribu-
tion-of-schistosomiasis-survey-data-in-uganda). An outline map of the KSA with capital Riyadh 
depicted (on the right-hand side). Major administrative boundaries are shown, and the associ-
ated status of schistosomiasis therein is indicated by shaded circles. (A) Al-Jouf; (B) Tabuk; (C) 
Hail; (D) Al-Madena and Al Monawarah; (E) Al Qasim; (F) Riyadh; (G) Najran; (H) Tardif, Mak-
kah, Jeddah, Al Qunfudhah and Alith; (I) Bishah and Asir (J); Jazan (K) (Stothard et al., 2014) 
3.1 Giardiasis 
Giardiasis, is a common gastrointestinal parasite of mammals, including hu-
mans characterised by acute or chronic diarrhoea, caused by protozoan 
parasites in the genus Giardia (Harhay et al., 2010). This protozoan was initially 
named Cercomonas intestinalis by Lambl in 1859 (Kofoid and Christiansen, 
1915). Giardia duodenalis (syn.  Giardia lamblia ) is a flagellated parasitic mi-
cro-organism, is a dominant parasitic species detected worldwide, and the only 
species commonly causing disease in humans (Thompson, 2000). The 
morphological features of this parasite exist in two forms: the dormant, infec-
tive cysts and the vegetative, disease-causing trophozoites. Cysts are egg-
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shaped and approximately 8-12 µm long and 5-9 µm wide. They are enclosed 
by a 0.3-0.6 µm thick cyst wall, that has a fibrillose structure (Figure 7).  It is 
carried in the intestinal tract of human, and many different animals with expe-
rience clinical signs shortly after an incubation period of 1 to 14 days (average 
of 7 days) and usually lasts 1 to 3 weeks of acquiring infection in some individ-
uals, but many others remaining asymptomatic for a remarkably long period 
(Stark et al., 2007).   
 
Figure 7: Morphology of Giardia trophozoites (A) Schematic and (B) Scanning electron micro-
graph (SEM) of Giardia trophozoite structure. A ventral view of a Giardia trophozoite shows its 
teardrop shape with nucleus (N), median body (MB), funis (fn), ventral disc (vd) and four fla-
gellar pairs (afl = anterior flagella, pfl = posterior-lateral flagella, vfl = ventral flagella, cfl = cau-
dal flagella). Scale bar = 5 μm (Dawson and House, 2010) 
In addition to fatty to watery diarrhoea, which is a hallmark of acute and 
chronic giardiasis in children, the presence of G. duodenalis can result into mal-
absorption; some studies have shown that some infected children are at higher 
risk of impaired growth with a decrease in cognitive function in endemic areas, 
and possibly reduced productivity in adulthood (Fletcher et al., 2012, Escobedo 
et al., 2014). Occasional outbreaks are documented in people, as the result of 
mass exposure to contaminated water or food, or direct contact with infected 
individuals (Robertson et al., 2010). Humans are considered to be the most 
important reservoir hosts for human giardiasis, but the parasite also infects do-
mestic and wildlife animals (Appelbee et al., 2005, Day, 2007). The ge-
netic characterisation of G. duodenalis isolates has revealed the different spe-
cies and subspecies in humans and domesticated animals (livestock and pets), 
and infection transmitted from animals to humans is currently thought to be of 
relatively primary importance in the natural spread of human giardiasis (Esch 
and Petersen, 2013, Thompson, 2000). Nevertheless, G. duodenalis can 
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be considered as a species complex, and there is evidence that its assemblages 
represent distinct species-specific isolates (Minetti et al., 2015), and some ge-
netic types of G. duodenalis belonging to assemblages A and B isolates should 
be considered potentially zoonotic (Sprong et al., 2009). 
3.2 Lifecycle  
Transmission and lifecycle Giardia has a two-stage with cysts and trophozoites 
(Figure 8). The infection is acquired through the ingestion of mature cysts, 
which are excreted in the faeces (Olson et al., 1999, Adam, 2001). Ingestion of 
as few as 10-25 cysts may be sufficient to occur an infection in some individuals 
(Smith, 1993), while several species of livestock (sheep, cattle, goat) may get 
infected by few cysts in surface water sources. However, an infected person 
might execrate up to 900 million cysts per day and can be transmitted directly 
between hosts, or on various fomites such as food or specific water sources 
(e.g., untreated municipal water, backwoods streams, and lakes) contaminated 
with human or animal faeces. Stable cysts in the environment are evacuated 
into the faeces, usually can survive for up to 77 days in tap water at 8 ° C, but 
this decreases with increasing temperature, e.g. 54 days at 21° C and four days 
at 37 °C (Cole et al., 1989).  
Once arrived and differentiated in the lumen of the duodenum, some of the 
trophozoites begin to reproduce. The parasite generation time is 6-12 hours in 
vitro (Ankarklev et al., 2010). Both diploid nuclei divide into four diploid nuclei 
and are multiplies in the intestinal tract by longitudinal binary fission (Yu et al., 
2002). Earlier, the two nuclei of one trophozoite were suggested to be equal in 
length and the quantity of DNA (Yu et al., 2002, Kabnick and Peattie, 1990) 
being organised on five major chromosomes (Adam, 2001). However, studies 
highlighted differences in chromosome size and number in both nuclei 
(Tůmová et al., 2007).  
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Figure 8: Lifecycle of G. duodenalis. (A) shows a schematic an overview of the life stages of G. 
duodenalis. (B) and (C) shows in SEM, colonisation of the host intestinal epithelium by Giardia 
trophozoites after infection. In (C) circular lesions due to securely attachment of  the parasite’s 
ventral adhesive disk  with  the intestinal epithelial surface (Dawson and House, 2010) 
3.3 Epidemiology  
G. duodenalis occurs worldwide and is particularly common in warm climates 
(Adam, 2001). The main route of G. duodenalis infection is via the faecal-
oral route and can occur through direct exposure to and ingestion of infectious 
cysts.  Other means of transmission include direct contact with infected person 
(anthroponotic transmission) or animals (zoonotic transmission), or by 
ingestion of contaminated food (foodborne transmission) or water 
(waterborne transmission) (Cacciò and Ryan, 2008, Yoder et al., 2010). Risk 
factors for acquiring clinical infection include young age, using un-boiled water, 
and exposed to pathogens from poorly managed animal faeces (Cacciò and 
Pozio, 2001, Mohammed Mahdy et al., 2008).  Giardia infection contributes 
substantially to the 2.5 million deaths that occur annually as the result of diar-
rhoeal diseases; the worst affected are those inhabiting developing countries 
(Bello et al., 2011, Upcroft and Upcroft, 2001).  
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Giardia is considered the most frequent cause of diarrhoea for animals and hu-
mans (Farthing, 1997), making giardiasis one of the most common parasitic hu-
man diseases, and approximately 280 million people suffering from sympto-
matic giardia infection globally (Coelho et al., 2017, Cacciò et al., 2005). The es-
timated prevalence is 2 to 5% in developed countries and reaching 40% in de-
veloping countries (Upcroft, 2001, Nkrumah and Nguah, 2011). In developed 
countries, infections with Giardia are most common and is regarded as a re-
emerging disease (Thompson, 2008, Thompson, 2000). Current statistics 
probably underestimate the actual incidence of giardiasis because the report-
ing for a given disease varies between different surveillance systems and is 
only reportable in certain countries (David et al., 2011). There is currently a 
paucity of epidemiological data concerning the prevalence, incidence and 
economic cost of giardiasis in African countries. Although Some small studies 
(Table 5) highlighted the prevalence among different age groups 
(predominantly children) in individual communities in Uganda, with 
considering there is no national surveillance system for this parasite in most 
African countries. Thus, there is a need for epidemiological data on giardiasis 
in many African countries due to economic costs and the adverse effects on 
livestock such as wasting and malnutrition and lost productivity.  
Table 5: Summary of current epidemiological G. duodenalis studies in Uganda which include 
human infections.  Previous epidemiological studies on Giardia have indicated cross-species 
transmission between primates, gorillas, cattle and humans living nearby or using similar wa-
ter sources (Graczyk et al., 2002, Johnston et al., 2010, Ankarklev et al., 2012, McElligott et al., 
2013) 
 
Estimating of the economic impact of giardiasis could not  be found for Africa. 
However, the economic impact in the United States of America (USA) has been 
estimated at $282 million annually (Scharff, 2012, Cork, 2011). In contrast to 
USA agribusiness, African countries is a largely self-sufficiency farming system 
for subsistence of individuals and/or groups (Verheye, 2000). In Uganda, as an 
example, where human-livestock-wildlife interaction is high due to habitat 
disturbance, the occurrence and spread of giardiasis in the animals and human 
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population would lead to the cross-species transmission which can make con-
trol programs more complex (Figure 9). It could also lead to malnutrition in 
both animals and humans exacerbating the problem of malnutrition in humans 
further (Johnston et al., 2010, Hunter and Thompson, 2005, Goldberg et al., 
2008).  
 
Figure 9: Diagram showing essential cycles of transmission for maintaining Giardia. As well as 
direct transmission, water and food may also play a critical role in the transmission of the 
parasites. Question marks demonstrate the unclear frequent interaction between different 
hosts (Hunter and Thompson, 2005) 
3.4 Molecular characterisation of Giardia  
Isolates of G. duodenalis are morphologically indistinguishable but can differ 
genetically infecting humans and other mammals (Thompson, 2000, Monis et 
al., 2003). The nucleotide sequence analysis of several housekeeping genes (e.g. 
β-giardin, GDH, TPI and the small subunit rRNA gene for  phylogenetic investi-
gation of Giardia assemblages, revealed the existence of eight different assem-
blages, referred to as assemblage A to H (Monis et al., 2003, Cacciò and Ryan, 
2008, Lasek-Nesselquist et al., 2010), further divided into sub-assemblages 
AI, AII, AIII, BIII and BIV(Amar et al., 2002, Cacciò et al., 2002). Each host spe-
cies can be infected with specific assemblage (Table 6), but among these as-
semblages, only A and B are commonly detected in humans (Vanni et al., 2012). 
Globally, assemblage B is more frequently found than assemblage A in humans, 
excluding specific regions of South America and Mexico (Cacciò and Ryan, 
2008, Vanni et al., 2012). However, a mixture of co-infecting parasite genotypes 
within a host have been observed from time to time, e.g. due to ingestion of 
genetically distinct strains of Giardia cysts or re-infection with different Giardia 
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species carrying another assemblage (Sprong et al., 2009, Geurden et al., 2009, 
Levecke et al., 2009).  
An additional interpretation for this phenomenon could be as a result of al-
lelic and genetic heterogeneity and/or genetic recombination that was docu-
mented to be a more frequent occurrence in assemblage B then A (Jerlström-
Hultqvist et al., 2010a).     
Table 6: Molecular characterisation of G. duodenalis isolates and the association of vertebrate 
host species structure genotype with a transmission cycle 
(Modified CDC, 2013) 
However, the possible source of zoonotic Giardia infections and the association 
between infected animals such as beavers and waterborne outbreaks in people 
has led to classifying Giardia as a zoonosis (WHO, 1979).  So far, genetic analy-
sis of three distinct human isolates of G. duodenalis have been fully sequenced 
in detail and are available at http://giardiadb.org/giardiadb/. 
 In 2007, the 11.7 Mbp WB-assemblage A G. duodenalis genome expressed as 
approximately 4,800 predicted encoding genes was published (Morrison et al., 
2007), followed in 2009 with those of GS-assemblage B (Franzen et al., 2009). 
The sequenced genomes of human assemblage A isolate WB and assemblage B 
isolate GS showed 77% nucleotide and 78% amino-acid identity in 4,300 
orthologous proteins. Due to these genetic differences, both genotypes were 
considered as two different species (Franzen et al., 2009, Monis et al., 2009), 
and analysis of P15-assemblage E G. duodenalis genome isolated from a pig in 
2010 was strengthened this assumption (Jerlström-Hultqvist et al., 2010b). 
 The molecular analysis of these three isolates identified a highly conserved 
set of core genes (4,557 genes, 91% of the genome) common to all isolates. Ge-
nomic differences were detected in multigene families, for example, VSPs. The 
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average amino acid identity between the different isolates is 78% (A–B), 81% 
(E–B), and surprisingly, 90% (A–E) revealing a close relationship between spe-
cies (Jerlström-Hultqvist et al., 2010b, Franzen et al., 2009). These differences 
may lead to changing in the parasite survivability and pathogenicity inside the 
intestinal lumen (Nash, 2002). Therefore, research into the hypothesised dif-
fering pathogenicity of assemblages is critical for the further understanding of 
the variability in symptoms observed for management, intervention and con-
trol of giardiasis cases. Nevertheless, the roles of various animals in the trans-
mission of human giardiasis established in different research studies remain 
subjects of current research.  
3.5 Clinical symptoms and pathology 
Giardiasis causes a broad spectrum of gastrointestinal symptoms. In its acute 
phase occurring approximately 1-3 weeks after infection (Gardner and Hill, 
2001), an infected person can suffer from greasy or fatty stools, abdominal 
pain (stomach ache), nausea or vomiting and diarrhoea. Chronic (or recurrent) 
infections can lead to dehydration, malnutrition, fatigue, weight loss, and im-
paired bowel function (e.g. inability to absorb vitamin B12) (Olivares et al., 
2002). It was reported that 98% of the drug-cured children in a hyperendemic 
area with G. duodenalis became re-infected within six months (Gilman et al., 
1988). This is dramatic because giardiasis negatively affects childhood men-
tal and physical development of infected children (Berkman et al., 2002). Fur-
thermore, giardia infections are suggested to be associated with arthritis, aller-
gies, chronic fatigue and irritable bowel syndrome (Gaston and Lillicrap, 2003, 
Hanevik, 2012, Bartelt and Sartor, 2015). In many cases, the parasite can colo-
nise within the small intestine without any clinical symptoms (asymptomatic 
passage). The factors influencing the clinical outcome (symptomatic vs asymp-
tomatic) are unclear but could include infective dose, differences in immune 
responses, virulence factors that help to cause disease, and evade immune sys-
tems (Figure 10)(Farthing, 1997, Buret, 2007, Bartelt and Sartor, 2015).  
Thus, the virulence factors probably play a role in pathogenicity, and maybe as-
semblage and/or sub-assemblage specific, depending on their complement of 
virulence factors.  
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Figure 10: The proposed determinants and mechanisms of G. duodenalis pathology within the 
intestinal, adapted from (Bartelt and Sartor, 2015) 
3.6 Diagnostics  
G. duodenalis is usually diagnosed by microscopic examination of stool samples 
for the presence of cysts and/or trophozoites. The excretion of the parasite can 
be highly variable among individual, and thus an analysis of multiple stool 
specimens is highly recommended to increase the sensitivity (McHardy et al., 
2014). Other suggested techniques for the detection of G. duodenalis are con-
centration techniques using freshly preserved stool samples for detec-
tion of vegetative stages (Mank et al., 1995a).  
The alternatives for microscopic diagnosis of G. duodenalis include detection of 
Giardia antigen by  DFA technique, and the ELISA test used to detect specific 
antigens in stool samples (Maraha and Buiting, 2000, Garcia and Shimizu, 1997, 
Garcia and Garcia, 2006, Hanson and Cartwright, 2001, Johnston et al., 2003, 
Mank et al., 1997). Compared to microscopy, immunoassay tests have en-
hanced the sensitivity of detection particularly for stool samples contain-
ing low numbers of cysts with a reduced number of samples required for ex-
amination (Mank et al., 1997) but still, multiple stool samples are needed to 
confirm negative results (Hanson and Cartwright, 2001). The second diagnos-
tic alternative is G. duodenalis DNA detection in faeces by a real-time polymer-
ase chain reaction (RT-PCR), which has shown more sensitivity than detection 
of cysts by microscopy and immunoassay and also can further reduce the re-
quired number of stool samples is needed for analysis (Verweij et al., 2003).  
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DNA-based approaches have also been extensively covered with different 
studies for classification of subgroups of G. duodenalis based upon various tar-
get genes. From humans and animals, G. duodenalis strains have been isolated 
and classified as different genotypes, and certain stains can infect humans that 
are clustered in assemblage A and B (Monis et al., 1996, Minetti et al., 2015), 
while several studies have suggested the association between assemblages and 
differences in clinical symptoms. The findings of these studies are difficult to 
compare and sometimes are even conflicting. These will be further discussed 
in chapters 3 and 4. 
3.7 Treatment  
The duration of infection and characteristic symptoms are highly variable. Gi-
ardiasis is often self-limiting with a mean duration of six weeks (Taylor and 
Wenman, 1987). Giardiasis can be treated with some antibiotic therapy, includ-
ing nitroimidazole derivatives (MTZ or Tinidazole), benzimidazole compounds 
or acridine dyes (Hahn et al., 2013). MTZ or tinidazole are more often used in 
humans, but other drugs (e.g., furazolidone or paromomycin) may be 
recommended in some cases. MTZ has efficacy of 80-95% (Gardner and Hill, 
2001). Treatment success depends on the crucial information obtained from 
the medical history, nutritional and immune status of the infected person such 
as drug-resistant, reinfection or post-Giardia lactose intolerance (Müller et al., 
2008, Solaymani-Mohammadi et al., 2010). Therefore, it is sometimes essential 
to increase the doses, expand the duration of treatment, or to use an alternative 
drug or a combination of treatments. For instance, the infected person that 
have a medical intolerance, or patients that are infected with resistant strains, 
can be treated with quinacrine, alone or in combination with nitroimidazole 
(Escobedo and Cimerman, 2007).  
Currently, recommendations are made for the preferred treatment in different 
clinical situations for giardiasis include quinacrine hydrochloride or MTZ for a 
duration of 5 to 10 days, and can be expected to cure over 90% of individuals 
(Gardner and Hill, 2001, Nash et al., 2001, Escobedo and Cimerman, 2007). In 
developing countries long-term drug regimens, complex regimens are prob-
lematic, as medicines are frequently purchased in large-quantities which rep-
resent less than a single day's dose and effective therapies of short duration are 
preferable in rural communities (Hossain et al., 1982). In an attempt to assess 
the efficacy of a shorter duration of treatment in giardiasis, two studies were 
conducted using single-dose tinidazole versus single-dose MTZ and single-dose 
tinidazole versus a 3-day course of MTZ, concluding that  a single oral dose of 
tinidazole is  highly effective for treating giardiasis and is equal in efficacy to a 
3-day therapy with MTZ (Speelman, 1985). 
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4.1 Malaria  
Malaria is a life-threatening disease caused by a protozoan of the genus Plas-
modium spp. parasites, and commonly associated with poverty and leading to 
a significant economic impact (Gallup and Sachs, 2001, Worrall et al., 2005). 
There are more than 100 Plasmodium species can infect more than one verte-
brate host (e.g., reptiles, amphibians, birds, and humans (Millar and Cox-Singh, 
2015). In 1897 Ronald Ross (Scottish physician working in India) explored a 
developing form of a malaria parasite fed on malarial patients, further develop-
ment of the malaria parasite in the body of the mosquito and described the 
complete life cycle of malaria (Cox, 2010). However, there are five spe-
cies of Plasmodium (single-celled parasites) can infect humans and cause ill-
ness: P. falciparum, P. malariae, P. vivax, P. ovale, and  P. knowlesi. Comparison of 
falciparum and non-falciparum, in particular, P. ovale and P. malariae, have 
been documented to be in charge of around 25% of imported malaria infection 
in Europe but is often neglected due to its associated with a less severe clinical 
course (Ruas et al., 2017).  
Although P. falciparum is the most prevalent species and responsi-
ble for most malaria-related deaths globally, the use of sensitive molecular de-
tection methods for malaria have improved the detection of higher levels of co-
infections of P. ovale and P. malariae with P. falciparum than previously thought 
(Mueller et al., 2007). Thus, morbidity and mortality associated with non-falci-
parum species have been underestimated. Additionally, current control meth-
ods are focused on the reduction of P. falciparum infections. However, this may 
not equally decrease the prevalence of non-falciparum species (Phillips, 2001). 
Thus, the accurate determination of the current prevalence and distribution of 
non-falciparum malaria is important so that the response to control ap-
proaches can be monitored and improved. This process will aid malaria control 
efforts globally and will form an essential part of the future goals towards ma-
laria elimination (Phillips, 2001, Mueller et al., 2007, WHO, 2017b).  
4.2 Lifecycle  
Malaria is caused by a parasite of the Plasmodium genus, which is the most 
common parasitic infection worldwide. The disease is transmitted by the bite 
of a female Anopheles mosquito, though the mosquito's saliva (Figure 11), and 
congenital transmission, although rare, is also a possible mode of transmission 
(Natama et al., 2017, Martín-Dávila et al., 2018). During a blood meal, an 
Anopheles female mosquito infected with malaria injects sporozoites into the 
human host. These sporozoites infect liver cells where they multiply by cell di-
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vision for 10-15 days and form schizonts. At maturity, schizonts lysate and re-
lease merozoites. For some species (except P. falciparum), the liver infection 
can become latent and allow the parasite to survive for a long time in the body, 
and become disappeared from the blood (Soulard et al., 2015). This explains 
the long-term relapses for two of the species that infect humans: P. vivax and P. 
ovale. Currently, five species of the Plasmodium genus are known to cause ma-
laria in a human host: P. falciparum, P. vivax, P. ovale (now split into subspecies 
P. ovale curtisi and P. ovale wallikeri), P. malariae and P. knowlesi (Fuehrer and 
Noedl, 2014). A sixth Plasmodium parasite, P. cynomolgi, has been reported in 
only one naturally-acquired case of human malaria (Ta et al., 2014).  
 
Figure 11: The mosquito and human life cycle of the Plasmodium parasite (CDC. 2011) 
4.3 Epidemiology 
In 2016, almost half of the world's population - was at risk of contracting 
malaria. Most malaria infection and deaths have reported in sub-Saharan 
Africa. However, the WHO Regions of Southeast Asia, the Americas and the 
Eastern Mediterranean are also affected (Figure 12). In 2016, 91 countries 
were experiencing continued malaria transmission (WHO, 2016b). Some 
groups in the population are at much higher risk than others of contracting ma-
laria and being seriously ill: infants, children under 5, pregnant women, people 
living with HIV or AIDS, non-immune migrants, shifting populations and trav-
ellers. According to the latest World Malaria Report, published in November 
2017, there were 216 million infections of malaria in 2016, up from 211 million 
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in 2015. An estimated 445, 000 deaths from malaria in 2016, a figure similar to 
that of the previous year (446,000) (WHO, 2016b). The WHO Region of Africa 
bears a disproportionate share of the global burden of malaria. In 2016, 90% 
of malaria cases and 91% of deaths from this disease occurred in this region. 
Some 80% of the malaria burden was in some 15 countries - all in sub-Saharan 
Africa except India (Christiansen-Jucht et al., 2014).  
 
Figure 12: The percentage of the population at risk of malaria based on the 2016 World Ma-
laria Report (WHO, 2016b) 
In areas of intense malaria transmission, children under 5 years of age are es-
pecially at risk of infection, illness and death; more than two-thirds (70%) of 
deaths from malaria occur in this age group, while in areas of lower transmis-
sion, many cases occur in older children and adults (Nmadu et al., 2015, 
Roberts and Matthews, 2016, Carneiro et al., 2010). However, malaria 
remains a major killer of children under five, and a child dies every two minutes 
(Bhatt et al., 2015). Despite reports that malaria-related hospital admissions 
have declined in several African regions, Uganda was one of four countries in 
East Africa that had an increased number of malaria admissions from 2000-
2010 (Okiro et al., 2011). It has one of the highest prevalence rates of malaria 
in the whole of Africa (Figure 13). The Ugandan National Malaria Indicator Sur-
vey 2014-15 estimated that the malaria prevalence of local children 
ranges from  6–59 months of age was 29.9% by using RDTs ((UBOS), 2015). By 
blood examination, the estimated prevalence of Plasmodium spp. was  97% P. 
falciparum, 6% P. malariae, 1% P. ovale, and <1% P. vivax ((UBOS), 2015).  
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Figure 13: Shows the prevalence of P. falciparum malaria in Sub-Saharan Africa in heat map 
format, in both 2000 (a) and 2015 (b), generated by the Malaria Atlas Project (Oxford, 2017). 
It can be seen in Uganda within the red circular; there are still hot spots that have an estimated 
prevalence of around 50%, even though the substantial reduction of malaria prevalence across 
countrywide  
It has been previously reported that the prevalence of malaria in Uganda is be-
tween 48% and 55.8% (Proietti et al., 2011, Oguttu et al., 2017, Maziarz et al., 
2017). Previous studies in 2011 have shown that 60.6% of infection with Plas-
modium species occurred in Lake Albert, on the western border of Uganda 
(Green et al., 2011). The geographical map of Uganda with prevalence hotspots 
of up to 50% as shown in Figure 14, in Lake Albert, outlined in black, is closed 
to areas of high malaria prevalence.  
 
Figure 14: A geographical map of Uganda (left), followed by a malaria prevalence heat-map 
(right), generated by the Malaria Atlas Project (Oxford, 2017) highlighting the average preva-
lence of P. falciparum infection in Uganda. Overall prevalence was determined at 15.83%. 
However, the prevalence across the midline of the country (shown by a red line) and Lake Al-
bert (outlined in black) is considerably higher  
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Although P. falciparum is the most common malaria species in Uganda (Yeka et 
al., 2012), there are only a small number of recent papers on the distribution of 
non-falciparum in Uganda. The majority of research performed in Uganda has 
focused purely on P. falciparum infections, and in some studies, no attempt was 
made to distinguish between species. There is also a lack of data available on 
malaria in individuals living at higher altitudes in many regions of Uganda as it 
is thought that there is generally only a low prevalence of malaria. However, 
over the last 20 years, there are reports of increasingly frequent epidemics oc-
curring in the highlands of Africa which is attributed to many factors including 
climate change (Idro et al., 2005). It has also been documented that individuals 
living in these highland areas are more susceptible to severe disease owing to 
the lack of acquired immunity (Lindblade et al., 1999, Idro et al., 2005, Wandiga 
et al., 2010). 
4.4 Clinical symptoms  
It usually takes between 5 and 30 days, depending on the species of Plasmo-
dium, malaria transmission levels and host immunity. Symptoms are mostly 
caused by parasite activation of a proinflammatory cytokine cascade which 
plays a central role in the pathogenesis. At first for all species of malaria, some 
cases develop much milder symptoms that can be misdiagnosed as influ-
enza or other viral infection including fever, chills, malaise, headaches, nausea, 
abdominal and back pain, respiratory problems (Bartoloni and Zammarchi, 
2012). In all types of malaria, the periodic febrile response (fever) is caused by 
rupture of mature schizonts of the Plasmodium parasite and may present with 
three stages; a cold stage (lasting 30-60 minutes on average); a hot stage (2-6 
hours); then a sweating stage (2-3 hours). This occurs daily in P. falciparum 
infection, but every third day in P. vivax or P. ovale infection (Bartoloni and 
Zammarchi, 2012). Apart from anaemia, most physical findings in malaria are 
often non-specific and offer little aid in the diagnosis, although enlargement of 
some organs may be seen such as hepatomegaly and splenomegaly which are 
common complications, along with normochromic, normocytic anaemia and 
thrombocytopenia. Early stage malaria may progress into severe malaria rap-
idly, with complications such as cerebral malaria (including seizures and 
coma), respiratory and renal failure can also be developed and progress to 
death within hours or days if the infected person remains without treatment 
(Bartoloni and Zammarchi, 2012).  
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4.5 Diagnostic tests 
4.5.1 Microscopy  
The current reference is a microscopic examination of the thick film using 
Giemsa stain (GS), although stains such as Fields and Wrights can also be ap-
plied (Tangpukdee et al., 2009). This method is widely used as the best tool for 
diagnosing malaria in the field due to its low cost, ability to diagnose all species 
of malaria independently and determine the parasite density (Tangpukdee et 
al., 2009).  
Ideally, this examination should be the first step after conducting a clinical in-
vestigation for public signs of predictors. In the GS, the blood elements are 
concentrated on a much smaller surface than in the thin smear, which speeds 
up the search for parasites. The destruction of the erythrocytes makes the 
recognition of the parasites more difficult, but the sensitivity gain over thin 
smear is approximately 20-fold. If the presence of parasites is detected, the spe-
cies can be identified more quickly in the thin smear because to the parasite's 
shape (ring, kitten) is added the appearance of red blood cells (normal or en-
larged and deformed, the presence of granulations or not) which provides ad-
ditional indications. Also, blood should be taken when the patient's tempera-
ture is rising, but it is never advisable to postpone the blood test if there is sus-
picion of malaria. One must be aware that microscopic examination, even in the 
hands of an expert, is far from having a sensitivity of 100% (Wongsrichanalai 
et al., 2007). It does not detect very low parasite densities, as they often are in 
non-immune travellers under chemoprophylaxis (Larréché et al., 2014). This is 
also the case for all tests currently available. In addition, the cyclic nature of 
parasite multiplication and sequestration in the target organs further reduces 
the likelihood of a positive outcome. The NPV is therefore not 100%. Quantita-
tive buffy coat (QBC) fluorescent microscopy can be used to increase the 
sensitivity of malaria diagnosis, but less readily available due to its expense, 
and not preferable for species-specific diagnosis (Tangpukdee et al., 2009). 
This is why it is imperative to repeat the malaria test (s) after 12-24 hours in 
the absence of a documented alternative diagnosis. 
4.5.2 Rapid diagnostic tests 
In recent years, new techniques based on immunochromatographic tests using 
whole blood have been developed for the RDT. These methods are based on the 
detection of Plasmodium antigens, either protein-2 (HRP-2) rich in plasmodial 
histidine or lactate dehydrogenase (pLDH), the latter being present only in P. 
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falciparum infections. These RDTs are quick, easy to use tests that do not re-
quire expensive reagents or electricity, and diagnose malaria with high sensi-
tivity and specificity (Feleke et al., 2017, Doctor et al., 2016, Tseroni et al., 2015, 
Fancony et al., 2013). There are currently over 200 RDTs available, contrib-
uting to 270 million sales in 2015 (WHO, 2016b).  Many products are available 
and can detect all Plasmodium species, with different performances. These tests 
have in common the lack of a clear standard and therefore a potential for a var-
iable quality from one batch to another. In industrialised countries, these tests 
have been used until recently in addition to microscopy, because of the rela-
tively variable performance obtained in the various studies. HRP-2-based tests 
were more reliable than those based on pLDH for CP- for the diagnosis of P. 
falciparum (0.08 versus 0.13). Third-generation tests (HRP-2) had CP equiva-
lent to second-generation tests but higher CP + (98.5 versus 34.7).  
The results for the detection of P. vivax were significantly worse (CP- 0.24 for 
HRP-2 and 0.13 for pLDH).  It should be noted, however, that these tests were 
all evaluated against a "gold standard". sub-optimal (microscopy)(Mappin et 
al., 2015). Most RDTs diagnose only P. falciparum malaria; however, some can 
distinguish between species. For example, the Standard Diagnostics (Gyeonggi-
do, Republic of Korea) SD Bioline RDT can differentiate between P. falciparum 
and non-falciparum malaria (pan). Some RDTs have also been formulated to 
diagnose P. vivax, but these are less common compared to P. falciparum tests 
(Lee et al., 2008). These RTDs, therefore, have the main potential to make the 
diagnosis of P. falciparum faster and more accurate, especially in non-special-
ized laboratories where inexperienced staff work. Indeed, learning these tests 
is easy, and a suitable option for use in areas where microscopy is not feasible, 
with results showing sensitivity and specificity of up to 99.5% and 98% respec-
tively (Tadesse et al., 2016). RDTs are cost effective compared to microscopy, 
with one of their only downsides being that species-specific diagnosis is not 
entirely possible. It has also been shown that RDTs may miss low-intensity in-
fections (Golassa et al., 2013). The main limitation is that rapid tests cannot be 
used to estimate parasite density. It should be noted that HRP-2-based assays 
can detect circulating antigens even after parasite clearance (2-4 weeks) and 
therefore cannot be used to evaluate treatment efficacy (Kattenberg et al., 
2012). 
4.5.3 Molecular detection of human Plasmodium species 
The rise of molecular biology has made it possible to develop new techniques 
based on the identification of Plasmodium DNA as amplified by the PCR. By 
targeting short nucleotide sequences which are related to the Plasmodium 
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genome on either side of the portion of interest (primers), and especially to the 
use of a thermostable enzyme, Taq polymerase (Chien et al., 1976).  
DNA is copied/multiplied exponentially to become detectable either by its 
visualisation under UV light (in the standard PCR) or by detecting fluorescence 
at each duplication by probes fluorescent or by SYBR Green technology (in the 
PCR in real- time). This molecular approach can detect very weak parasitic con-
centrations and distinguish different infectious species even if they are present 
simultaneously in the same individual (mixed infections)(Heid et al., 1996, 
Livak et al., 1995). Many other techniques, using different primers and probes 
(for real-time PCR), have been developed or modified in order to increase the 
sensitivity and specificity. This technique has been developed and reaching 
thresholds detection rate of  0.006 parasites /μl (Cnops et al., 2011b), or that 
developed with combining classical PCR and real-time PCR (nested rtPCR) to 
reach a threshold of 0.5 parasite /μl, for samples taken from filter papers (Tran 
et al., 2014).  
Most of these PCR techniques have been developed by targeting the coding 
gene the small subunit of rRNA (18S rRNA). Indeed, this gene found in all 
eukaryotes contains regions both highly conserved and variable, and it has 
been the most studied in Plasmodium. Five copies of this gene are dispersed on 
different chromosomes of the parasitic genome (Rooney, 2004, McCutchan et 
al., 1988). Nevertheless, other genes have also been used, but less frequently, 
as targets for the molecular identification of Plasmodium. For example, an the 
cytochrome b (cytb) gene, which also has a highly conserved region (Farrugia 
et al., 2011), the gene encoding the circumsporozoite protein (csp), which was 
used to identify P. falciparum and P. vivax (Brown et al., 1992), and dihydro-
folate reductase (dhfr) (Barker Jr et al., 1992). These techniques are designed 
in Monoplex (amplifying a single target) or in Multiplex (amplifying one or 
more targets). As an illustration, Chew et al. (2012) have developed a Hexaplex 
PCR capable to simultaneously identify six plasmodial species that infect hu-
mans (Chew et al., 2012). The precision of these techniques made it possible to 
discriminate between different species during mixed infections but also to dif-
ferentiate the two subspecies of P. ovale (P. ovale walikeri and P. ovale curtisi), 
long misunderstood (Oguike et al., 2011, Calderaro et al., 2012).  
Many factors can explain the differences in sensitivities of these different tech-
niques, among others: the type of reagents used, the standards used for quan-
tification, dilutions made, types of thermocyclers, methods of analysis and in-
terpretation of data, (Alemayehu et al., 2013). In addition to the molecular iden-
tification of Plasmodium generally performed on blood material is liquid, dried 
on filter paper, or deposited and stained on the blade (Cnops et al., 2010), or 
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from RDTs (Cnops et al., 2011a), the use of other organic fluids is nevertheless 
described in the literature. Also, there have been reported in respective work 
evidence of possible detection by PCR Plasmodium in saliva and urine 
(Mharakurwa et al., 2006, Nwakanma et al., 2009). On the other hand, it has 
been documented that P. falciparum could be detected in the faeces of large Af-
rican primates (Liu et al., 2010a). 
4.5.3.1 Molecular diagnosis of malaria by using faecal and blood DNA  
Detection of parasite DNA fragments in fDNA by PCR appears an 
unconventional approach, as none of the malaria life cycle stages develops in 
the digestive tract; however, it is known that Plasmodium DNA can be detected 
from blood entering into the bowel lumen. For surveillance of tropical diseases, 
traditionally since faecal samples are collected and used for diagnosing intesti-
nal parasites such as schistosomiasis, it may be possible to combine, and co-
investigate malaria prevalence using faecal samples would increase the 
amount of epidemiological information collected without substantially increas-
ing costs. However,  there is little-published data in this field, with only one past 
attempt of diagnosing malaria using human fDNA (Jirků et al., 2012), and lim-
ited current reports mixed reviews on whether it applies to diagnose malaria 
using faecal DNA.  
Most of the literature carried out over the years  presented here is from studies 
on different  species of monkeys and apes, for example, and have inspected ma-
caques (Macaca spp.) (Abkallo et al., 2014, Siregar et al., 2015, Kawai et al., 
2014), howler monkeys (Alouatta spp.) (de Assis et al., 2016), gorillas (Gorilla 
spp.) (Weimin et al., 2010), chimpanzees (Pan troglodytes) and bonobos (Pan 
paniscus) (Weimin et al., 2010). One study was conducted experimentally in the 
laboratory with induced infections in mice (CBA mice) (Abkallo et al., 2014), 
while another survey carried out on different samples collected from various 
wild bird species in Washington National Zoological Park (E. S. Martinsen, 
2015). In the current literature, only one study has evaluated the possibility of 
detecting Plasmodium spp. using faecal samples collected from mankind (Jirků 
et al., 2012), with another research conducted on different biological samples 
from human  (saliva and urine ) (Putaporntip et al., 2012). 
 In comparison to faecal DNA, It has been found that 63% of the birds analysed 
was found to be positive by blood DNA PCR (bPCR), whereas all examined birds 
were found to be negative via fDNA PCR (fPCR) (E. S. Martinsen, 2015). This 
may be due to the composition of bird faeces being different to that of mam-
mals, due to previous reports of the possibility of diagnosis in monkey species.  
56 | P a g e  
 
Other reports have shown that it is likely to detect malaria infection using fDNA 
extracts of various mammal species. For instance,  Abkallo et al. (2014) showed 
that the malaria DNA could be detected in faeces consistently after 78 hours of 
post-infection during erythrocytes from P.yoelii yoelii infected mice. Another 
interesting finding from Abkallo et al. (2014) was that malaria parasite could 
be diagnosed in the pre-erythrocytic stage infection by using fPCR and have 
detection limit almost twice as high as bPCR. This finding is supported with 
another research concluded that fPCR could be applied for detecting malaria 
infection before it is viewed under a microscope, and this is because the 
parasites not being existed within a blood vessel during the erythrocytic cycle 
(Kawai et al., 2014).  
Interestingly, the study performed by Abkallo et al. (2014), on samples col-
lected from a macaque, and has detected two malaria species, one species was 
found by using blood DNA,  and another species being detected in faecal sam-
ples. It was suggested that one species was still in the pre-erythrocytic stage of 
life cycle, therefore was not detectable by microscopy. The estimated preva-
lence of zoonotic malaria infection in a population of chimpanzees, bonobos 
and gorillas was found to be between 32% and 48% based on fPCR (Weimin et 
al., 2010).  This was not compared to bPCR since researchers face severe diffi-
culties in obtaining blood samples from wild mammals. However, the 
estimated sensitivity of fPCR based on repeated examination of samples found 
to be  57% (Weimin et al., 2010), whereas bPCR was more sensitive for the 
diagnosis of malaria infection reaching  93% as documented by Da Costa Lima 
et al. (Da Costa Lima et al., 2013). It is undoubtedly that PCR platform will be 
useful in front-line malaria diagnosis, but a higher sensitivity would be 
necessary before using this method as a reliable surveillance method within 
a malaria elimination environment. Siregar et al. (2015) highlighted a more 
promising result, where bPCR has been used for detecting a Plasmodium spp., 
and found that the prevalence of 53.1% among reservoir macaque species, 
while by using fPCR reaching a sensitivity of 96.7% with no false positives 
observed. This finding was found to be much more sensitive than the detection 
of the parasite using prepared thin film under the microscope. It was 
documented that the comparison between fPCR and bPCR directly could not be 
performed, probably due to inadequate extraction techniques, however, with 
high sensitivity, the possibility of diagnosing malaria quickly with a non-inva-
sive technique would have a significant impact for malaria epidemiology in the 
future. The only available study was performed on human faecal samples, con-
ducted by Jirků et al.,  (Jirků et al., 2012), showed that the sensitivity of 
diagnosing P. falciparum using fPCR compared to microscopy was 100%. This 
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is another promising result, however with a sample size of only 16 patients, 
there is a lack of reliability associated with such conclusions.  
4.5.3.2 Diagnosis of blood-borne parasites using PCR on faecal DNA 
There is limited information available for the performance of DNA diagnostic 
tests for blood-borne parasites using faecal DNA. Hornok et al. (2015) con-
ducted a study for detecting Babesia Canis from stool samples produced by bats 
of the Chiroptera genus. This study showed that in a total of 196 faecal samples 
assessed, the DNA of Babesia Canis was only amplified by PCR from five bat 
fDNA samples. This was concluded to be one of two things, the bat's infection 
with Babesia Canis, alternatively, the bats have eaten blood-sucking flies 
(e.g. Stomoxys spp.), which is the host-feeding behaviour of the relevant hosts. 
Hamad et al. (2015) looked at detecting Leishmania major through non-inva-
sive techniques, using faecal samples from Western Lowland Gorillas (Gorilla), 
with similar methods as the study above, by extensive collections of faecal sam-
ples from wild mammals. 13.2% of these faecal samples were considered to be 
positive using fPCR, of which some were undergoing for sequencing and shown 
to be the same as those in cases of cutaneous leishmaniasis in humans (Hamad 
et al., 2015). Although these findings were concluded from different parasites 
families, the results were based on using similar fPCR methodologies. So, this 
method can be applied for detecting different blood parasites using non-
invasive fPCR. As previously mentioned, PCR has a much higher detection rate 
than microscopy or RDT, being able to detect 1-5 parasites per microliter 
(Tangpukdee et al., 2009). PCR is time consuming, often taking over an hour to 
set up a reaction and around two hours to run. This combined with a high run-
ning cost and the need for electricity and freezer storage for reagents makes 
PCR less accessible in sub-Saharan Africa. 
4.6 Control and Prevention 
Malaria is a diffculte disease to control mainly due to the highly adaptable nat-
ural, requiring a mix of prevention and treatment methods. IVM is a concept 
introduced by the WHO to promote sustainable, environmentally beneficial 
and cost-effective strategies for the control livestock diseases, particularly vec-
tor-borne diseases, using different options to avoid major impacts on biodiver-
sity (Sutherst, 2004). These strategies are location and vector population 
dependent. Environmental methods used for mosquito control often include 
biological control agents, including larvivorous fish and copepods, or bacterial 
larvicide, which have had a demonstrable role in integrated control 
when breeding sites are relatively few or are easily identified and treated such 
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as drinking water sources (Phillips, 2001). These options have limited or no ad-
verse effects on the environment or beneficial organisms.  
Other methods include IRS is the process of spraying the inside of dwellings 
with an insecticide to kill mosquitoes that spread malaria. Prevention can be 
insecticide-treated nets which are safe for use as personal protection and dur-
ing pregnancy. As some Anopheles mosquitoes feed indoors (endophagic), nets 
provide barrier protection against biting, while the insecticide hampers 
indoor-feeding mosquitoes upon landing on the net (WHO, 2017b). Other 
methods of prevention that are not as widely used include the release of sterile 
genetically modified mosquitoes into an uninhabited forested area. It is 
hypothesised that in the future, this will wipe out all strains of infected mosqui-
toes, reducing the mosquito population and decreasing Plasmodium infection 
rates drastically (Benedict and Robinson, 2003, CDC, 2015).  
4.7 Treatment  
Malaria is a preventable disease that can be cured with antimalaria medicines. 
The primary goal of treatment is to achieve a complete cure, that is, rapid and 
complete elimination of plasmodia in the patient's blood, to prevent uncompli-
cated malaria from progressing to a severe form potentially fatal or chronic in-
fection causing anaemia. From a public health perspective, the goal of 
treatment is to reduce the transmission of infection by decreasing the 
infectious reservoir and to prevent the emergence and spread of antimalarial 
drug resistance (WHO, 2015a). For all patients suspected of having malaria, 
parasitological confirmation of the diagnosis should be obtained by micro-
scopic examination or using an RDT before starting treatment. Treatment 
should be administered on the basis of clinical examination only if it is impos-
sible to carry out diagnostic tests within 2 hours after consultation.  
Prompt treatment, within 24 hours of the onset of fever, with a safe and effec-
tive antimalarial drug, is essential to allow recovery and prevent life-threaten-
ing complications (Trampuz et al., 2003). WHO recommends ACTs to treat un-
complicated malaria caused by P. falciparum. Combining 2 active ingredients 
that have different modes of action, ACTs are the most effective antimalarials 
available today. Currently, WHO is recommending 5 ACTs for P. falciparum ma-
laria. The selection of ACTs should be based on the results of therapeutic effi-
cacy studies against local strains of P. falciparum malaria. ACTs are the main-
stay of the recommended treatment for P. falciparum malaria, and since no 
other artemisinin derivative should be on the market for several years, their 
effectiveness must be preserved (Smithuis et al., 2010).  
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WHO recommends that national malaria control programs regularly monitor 
the efficacy of existing antimalarials so that selected treatments remain effec-
tive (Bhatt et al., 2015). In areas of low transmission, a single dose of prima-
quine should be added to malaria treatment to reduce transmission of infection 
(White, 2013).  Screening for glucose-6-phosphate dehydrogenase (G6PD) de-
ficiency is not necessary because a low single dose of primaquine is both effec-
tive at blocking transmission and unlikely to have toxic effects in subjects defi-
cient in G6PD, regardless of the genotypic variants involved (Eziefula et al., 
2014). 
Plasmodium vivax infections should be treated with chloroquine in areas where 
there is no resistance to it. In regions with chloroquine-resistant strains of P. 
vivax, infections should be treated with ACT, preferably a combination in which 
the drug associated with artemisinin has a long half-life (Price et al., 2009). 
With the exception of the combination of artesunate + sulfadoxine-py-
rimethamine (AS + SP), all ACTs are effective against P. vivax infections in the 
blood stage (Liu et al., 2014, Price et al., 2009). In order to prevent relapses, 
primaquine should be added to treatment; the dosage and frequency of admin-
istration should be adjusted according to the enzymatic activity of the glucose-
6-phosphate dehydrogenase (G6PD) of each patient. Severe malaria should be 
treated with injectable artesunate (intramuscular or intravenous) for at least 
24 hours, followed by a full 3-day ACT once the patient can tolerate oral medi-
cations. When injectable treatment cannot be administered, children younger 
than six years of age with severe malaria should receive rectal artesunate treat-
ment before being referred immediately to a centre for complete parenteral 
treatment (WHO, 2015b). It is imperative that artemisinin-based injectables 
and artesunate-based suppositories not be used as monotherapy. Initial 
treatment of severe malaria with these drugs must be completed by a full 3-day 
ACT. This ensures complete healing and prevents the development of re-
sistance to artemisinin derivatives (WHO, 2015a, WHO, 2015b).  
In recent years, ACTs have become significantly more accessible. By the end of 
2016, 80 countries had adopted ACTs as first-line treatment. The estimated 
number of full-treatment ACTs purchased from manufacturers increased from 
311 million in 2015 to 409 million in 2016. According to reports, more than 
69% of these purchases were made for the public sector. The number of full-
treatment ACTs distributed in this sector increased from 192 million in 2013 
to 198 million in 2016. Most (99%) were in the WHO African Region (WHO, 
2016b). 
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5. The importance of polyparasitism   
 Gastrointestinal parasitism with helminths and protozoa of tropical animals 
and equatorial Africa is frequent, varied and sometimes massive in subjects 
particularly receptive. Climatic conditions favour and accelerate biological cy-
cles of internal parasites who find a host more easily definitive that the latter is 
in direct contact and frequent with the environment where the larval life 
(Hotez et al., 2006a, Hotez et al., 2008). Natural and diversity of polyparasitism 
vary according to the regional conditions more or less favourable to the ecology 
of each species involved (temperature, hygrometry, turbulence, nature of soil 
and flora, presence or absence of intermediate hosts regular, vicarious or wait-
ing, possibly parasite tanks if it is a particularly ubiquitous species) (Viard et 
al., 1997, Mupfasoni et al., 2009). Synchronised and consecutive transmission 
of malaria, soil- and water-borne diseases of helminth infection, are among the 
most prevalent afflictions in areas of poverty in the developing world, particu-
larly in many parts of sub-Saharan Africa (Hotez et al., 2016, Green et al., 2011). 
The combined infections highlight that integrated control programs should be 
flexible and targeting multiple parasitic diseases simultaneously to reduce 
transmission of several diseases, and improved surveillance of multiple tropi-
cal diseases, in the most vulnerable population, SAC (Hotez et al., 2006a, Hotez 
et al., 2007, WHO, 2004). Data published on joint tropical diseases produce con-
flicting data. It has been suggested that helminthiasis can have direct and indi-
rect effects on the course of malaria in developing countries (Kwenti et al., 
2016). However, various studies have illustrated  that co-infection with hel-
minths increase susceptibility to malaria infection (Nacher et al., 2002), and is 
associated with increased gametocyte production (Nacher et al., 2001),  signif-
icantly decreased haemoglobin concentrations (Oladele et al., 2014), and a 
higher risk of severe malaria. On the contrary, other studies have suggested 
helminth infections may prevent the likelihood of malaria by reducing acute 
clinical presentations, parasite loads and fatal complications such as kidney 
failure (Shapiro et al., 2005). These inconsistent results may be due to different 
research designs, different geographic areas,  and regulation of the host im-
mune system by different parasite species (Degarege et al., 2012). 
6. Quantitative polymerase chain reaction 
The technological concept of the PCR, discovered by Kary Mullis in 1983 
(Mullis, 1987 ), and which earned him the Nobel Prize in Chemistry in 1993, 
has now become an almost universal tool in the field of biology. PCR is a highly 
sensitive and specific methodology for the detection of nucleic acids. Its use has 
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extended considerably to many applications, including the quantitative analy-
sis of specific nucleic acids (DNA and cDNA) in a given sample (Figure 15). The 
first approaches to gene quantification by PCR or reverse transcriptase gene 
transcripts (RT-PCR) were based on a titration analysis using standard nucleic 
acid (or external standard) and the development of a calibration range ob-
tained by serial dilution of the external standard (Noonan et al., 1990). The re-
sult of the analysis gives an estimate of the relative amount of the target matrix 
relative to the standard. However, the accuracy of the results obtained is very 
often limited, because of the considerable variability of efficiency from one PCR 
to another.  
 
Figure 15: The process of a PCR reaction, showing denaturation at 95⁰C, followed by annealing 
at 60⁰C, then a final extension step at 72⁰C, making two complementary DNA strands 
(Leicester, 2017) 
The introduction of a co-amplified internal standard during the same PCR re-
action partially corrected the tube-to-tube variability and led to the develop-
ment of two different quantification methodologies: those by differential PCR 
and those by competitive PCR. In the approaches of quantification by 
differential PCR (or RT-PCR) (Frye et al., 1989), an endogenous sequence, that 
is to say belonging to a so-called reference gene present in the tested sample 
(endogenous sequence of a gene present as a single copy by haploid genome or 
transcript of a domestic gene whose transcription is constant and independent 
of the extracellular environment), serves as an internal standard. The standard 
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endogenous sequence is coamplified with the target sequence during the same 
PCR reaction using two specific primer pairs. The method makes it possible to 
evaluate the relative amount of target gene corresponding to the reference 
gene, the latter making it possible to normalise the quantity and quality of nu-
cleic acid extracted. Nevertheless, quantification using an endogenous gene as 
an internal standard requires exceptionally standardised application condi-
tions to ensure that the amplification of the two different sequences (target 
gene and reference gene) is performed with identical efficiencies. 
The introduction of a fluorescent reporter molecule into the PCR reaction for 
the detection of PCR products by a fluorometric method has led to the recent 
development of quantitative real-time PCR techniques (Higuchi et al., 1993). 
The latter is no longer based on end-point detection of the PCR products 
formed but on an analysis of the kinetics of the PCR reaction by means of a sys-
tem capable of detecting "in a closed tube" the PCR products formed after each 
amplification cycle. The TaqManTM probe (Figure 16) is an oligonucleotide 
fragment labelled with two fluorophore groups at it's 5 ', and 3' ends (Livak et 
al., 1995). The 5 'end carries the donor fluorophore which is a derivative of flu-
orescein (FAM, TET, JOE, HEX or VICTM). At the 3 'end is the quencher fluoro-
phore which is usually a rhodamine derivative (TAMRA). Due to the proximity 
of the two fluorophore groups, linked to the small size of the probe (25 to 30 
nucleotides, i.e. less than 55 angstroms between the two fluorophores), the en-
ergy absorbed by the excited fluorophore donor is transferred by FRET to the 
fluorophore acceptor. Since the excitation spectrum of the TAMRA does not 
overlap the emission spectrum of the donor fluorophore, the quencher absorbs 
the energy transmitted to it but emits no fluorescence (Figure 16)(Navarro, 
2015).  
The peculiarity of the TaqManTM system is to exploit the 5'-3 'nuclease activity 
of the DNA polymerase which makes it possible to hydrolyse the probe 
hybridised to its specific target during the stage of elongation of the primers 
(Holland et al., 1991). Cleavage of the probe during this step has the effect of 
removing the two fluorophores, to release the donor fluorophore quenching 
effect exerted by TAMRA and thus restore its fluorescence emission. The 
intensity of the fluorescence emitted by the donor fluorophore, commonly re-
ferred to as reporter fluorophore in a TaqManTM probe, is measured at the end 
of each amplification cycle. 
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Figure 16: The basic process of amplicons detected by using a labeled probe specific for 
the target sequence within gDNA. During annealing, the probe binds to its intramolecular com-
plement in the amplicon. During extension, the probe cleaved as a result of the 5′ nuclease ac-
tivity of the DNA polymerase enzyme, detaching the quencher from the reporter and produces 
an emission of fluorescence. This is then quantified by rtPCR apparatus (Navarro, 2015) 
By its mode of operation, the TaqManTM system uses particular amplification 
conditions in two stages, a denaturation step at 95 ° C. and a second step com-
bining hybridisation and elongation carried out at an identical temperature 
(around 60 ° C.). Since the probe can only be cleaved when hybridised to its 
complementary strand, the extension temperature of the primers must be com-
patible with the hybridisation temperature of the probe. The Tm of a TaqManTM 
probe must, therefore, be high and close to 70 ° C, which imposes a rigorous 
design of the primers but facilitates the application of a standard thermocycling 
profile. In addition, the TaqManTM system requires the use of a DNA polymerase 
that must have a 5'-3 'exonuclease activity whose efficiency will determine the 
quality and intensity of the signal emitted (Kreuzer et al., 2000). The cleavage 
of the probe being irreversible, the TaqManTM system does not allow the estab-
lishment of a post-PCR fusion curve. 
The development of a new type of TaqManTM probes, the TaqManTM - MGB 
probes (Kutyavin et al., 2000),  made it possible to overcome certain limitations 
of the TaqManTM system. The introduction at the 3 'end of a molecule with an 
affinity for the MGB or nucleus increases the Tm of the probe and more strongly 
stabilises its interaction with the DNA matrix, which makes it possible to draw 
probes of smaller size (13 to 20 nucleotides) and able to hybridise with a matrix 
rich in dinucleotides GC or AT. Moreover, in a TaqManTM-MGB probe, the re-
porter fluorophore is associated with a non-fluorescent quencher; which 
makes it possible to detect two different targets (or multiplex) during the same 
PCR reaction. These chemical modifications made to the TaqManTM probes also 
made it possible to extend the applications of this chemistry to genotyping by 
allelic discrimination. 
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7. Justification and rationale of the present study  
7.1 Schistosomiasis  
Improved coverage of PC with PZQ across sub-Saharan Africa has been the aims 
of the WHO for some time. In 2014, 49 million SAC received treatment, equating 
to a coverage level of 34.6% within this age groups (WHO, 2016a). However, 
many children living in several parts of sub-Saharan Africa, particular in 
Uganda are not targeted in MDA programmes (Stothard et al., 2013a). 
Therefore further parasitological surveys are essential to determine the dis-
ease prevalence in these remote regions to enable PZQ to be administered.  
Resources available for the control are often limited, making it essential to 
know the distribution of schistosomiasis at different settings in Uganda for 
effective treatment regimens with PZQ.  The impact of S. mansoni on communi-
ties living on the shoreline of Lake Albert has been studied in depth 
(Kabatereine et al., 2004, Seto et al., 2012, Dunne et al., 2006, Levitz et al., 
2013), yet the prevalence of intestinal schistosomiasis is still a substantial bur-
den within these communities. SCI, an international charity, is led by Fenwick 
that has been in charge of treating SAC in Uganda since 2003 (Loewenberg, 
2014). Typically, traditional parasitological methods of diagnosis that visualise 
parasite ova underestimate true prevalence. Using the Kingdom of Saudi Arabia 
as a contemporary example, the primary care health system plays a critical role 
in schistosomiasis control activities since 1977 (Lotfy and Alsaqabi, 2010). So, 
the implementation of new diagnostic methods within PCH is important for 
moving forward from control to elimination (Stothard et al., 2014). Our study 
aims to reassess parasitological- and serological-based methods alongside real-
time PCR across a landscape where disease control is ongoing in Buliisa Dis-
trict, Lake Albert, and Asir region, Saudi Arabia and focus upon examination of 
children of school-age, using several different techniques alongside TaqMan® 
assay in attempt to produce the current picture of Schistosoma spp. prevalence 
in the selected study sites.   
7.2 Giardiasis  
Giardia duodenalis occurs worldwide and causes an estimated 2·5 million cases 
of diarrhoea in developing countries annually (Mahdy et al., 
2009). Giardia affects mainly children and has a wide range of clinical 
manifestations (Thompson and Monis, 2004). Although seven main genotypes 
of G. duodenalis have been identified (A–G), only genotypes A and B are com-
monly responsible for human infection (Thompson, 2004). The reasons behind 
the variability observed in giardia infection in humans are not fully understood, 
65 | P a g e  
 
and there is no clear evidence between the infecting genotype (A or B) and any 
clinical manifestation (Cacciò et al., 2005). In Uganda, epidemiological studies 
on G. duodenalis have found cross-species transmission between primates, go-
rillas, cattle and humans living nearby or using similar water sources (Graczyk 
et al., 2002, Johnston et al., 2010). The majority of studies from Uganda focus 
on the zoonotic potential of giardiasis and not the pathological effects on the 
human population. This is the first epidemiological study to determine the 
prevalence and associated risk factors of G. duodenalis assemblages undertaken 
in ﬁve primary schools around Lake Albert, Uganda. 
7.3 Malaria  
As part of the WHO Global Technical Strategy for Malaria 2016-30, it has been 
highlighted that diagnostic testing has fallen behind in the fight against malaria 
(WHO, 2015a). Malaria surveillance data is often unreliable, making pro-
gramme planning challenging. In 2015 it was estimated that only 19% of ma-
laria cases were detected by surveillance systems (WHO, 2016b). Efforts in re-
ducing burden in the high burden African countries have intensified recently 
through a combination of intensified malaria control and tools, notably long-
lasting insecticide-treated nets (ITNs), IRS of insecticides, ACTs, and intermit-
tent preventive therapy (IPT) for high-risk groups (Yeka et al., 2012). Without 
adequate surveillance data, the actual prevalence of malaria cannot be 
determined, making control and prevention efforts complex, especially with 
the aims of malaria elimination in many countries within the next 10-15 years 
(WHO, 2017b, WHO, 2015a).  Drug resistance is a growing problem, particu-
larly to artemisinin compounds, the mainstay of modern malaria treatment 
(Singh et al., 2018),  and another problem that cannot be monitored effectively 
without adequate surveillance methods. As previously illustrated, little re-
search has been undertaken in the field of diagnosing malaria using fPCR. Only 
one study has been found to use this method on human samples, and with a 
small sample size of 16, this is not adequate to gain a good estimate of the reli-
ability of this diagnostic method (Jirků et al., 2012). This is the first study that 
will assess the potential of TaqMan™ Assay targeting mitochondrial genome 
18S as previously described by Shokoples et al. (Shokoples et al., 2009) to di-
agnose malaria and determine species-specific Plasmodium in humans from ei-
ther blood spot or faecal samples. Evaluating the effectiveness of a new species-
specific surveillance approach fits in with the objectives of the WHO global 
technical strategy for monitoring and assessment of disease prevention and 
control programmes of malaria (WHO, 2015a). 
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8. Aims of the thesis and study objectives  
8.1 Aims  
The overall aim of the thesis is to explore different diagnostic platforms for 
providing insights into the epidemiology and surveillance of important para-
sitic diseases, with attention on schistosomiasis, giardiasis, and malaria 
(Plasmodium spp.)  in Uganda, a country where the disease burdens are still 
high despite large-scale control (see Table 7- below). These diagnostics can be 
used as a surveillance tool, in lower endemic countries, e.g. Kingdon of Saudi 
Arabia, not only to determine that infection levels of these parasitic infections 
are also sustained below target thresholds (WHO 2015a). By making a 
comparison between country settings, I hope to develop the dicussion on how 
to monitor, evaluate, and assess the impact of different control and 
intervention measures being implemented against these parasitic diseases.  
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Table 7: Tabulated summary of schistosomiasis, giardiasis, and malaria diagnostics 
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8.2 Objectives 
Specific study objectives of the thesis are:  
(i) To explore the geographical distribution of the parasitic infection 
among school children by assessing the infection prevalence of the 
target species and conducting spatial analysis;  
(ii) To describe the extent and geographic distribution of schistosomiasis 
infections among school children in Uganda and Saudi Arabia using 
advanced diagnostic tools for addressing the impact of nation-wide 
preventive chemotherapy via MDA campaigns;  
(iii) To understand the impact of school location and household condi-
tions, as well as behavioural components, on schistosomiasis trans-
mission and infection intensity among schoolchildren, to be served as 
evidence-based information to guide future schistosomiasis infection 
control strategies;  
(iv) To document the distribution of intermediate snail hosts in the 
different settings in Uganda and Saudi Arabia, and exploring the 
impact of physico-chemical parameters of the water body including 
pH, conductivity on an abundance of intermediate snails  
(v) To perform moleclare idenfitfcation of collected intermiadiate snail 
gost using a DNA-based molecular technique as an advanced-tool for 
species-specific identification. 
(vi) To determine the current prevalence and to identify risk factors asso-
ciated with Giardia infection in selected school children in ﬁve pri-
mary schools on the shoreline of Lake Albert, Uganda, by using a 
rapid antigen test and TaqMan® probe-based assays from faecal DNA; 
(vii) To shed light on putative interactions between giardiasis, intestinal 
schistosomiasis and anaemia in theses school children; 
(viii) To identify the taxonomic assemblages of Giardia within school 
children, by using assemblage-specific TaqMan®TPI probes with con-
firming their presence by sequence analysis of β-giardin gene, to iden-
tify potential coinfections, risk factors and pathologies associated with 
differing assemblages; 
(ix) To conduct an epidemiological assessment  of malaria  infections in 
Low-high altitude in the Buliisa district of Uganda  and application of 
molecular techniques as diagnostic quality control for species-specific 
TaqMan® method to provide a more sensitive tool for species identifi-
cation; 
(x) To explore the possibility of the implementation of the TaqMan® assay 
as a platform to monitor, evaluate and assess the impact of different 
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public health interventions to control and eliminate critical 
communicable diseases. 
This thesis examines the extent to which these objectives can be achieved when 
the assessment is carried out not as a stand-alone initiative, but in conjunction 
with NTDs teams in Saudi Arabia and Uganda, utilising locally available tech-
niques and resources. This assessment is carried out to provide evidence to 
decision-makers: 1) when and where most of the disease burdens have been 
lightened, and interventions at national levels can be scaled up or down, or 2) 
when the distribution and extent of the disease burden are not previously well 
documented, but the information is needed to develop effective control 
strategies or to raise awareness on the necessities of developing the strategies. 
Especially for the giardiasis, schistosomiasis and malaria infection control, 
components of the interventions can be tailored based on the risk factors iden-
tified, where there are relatively limited resources, and the complementary in-
terventions can be rolled-outed for small-scale implementation on top of pre-
ventive chemotherapy. Although parasitological tools provide a cost-effective 
platform to minimise the financial expenditure of general disease assessments, 
this was not investigated formally, and focus was given to epidemiological sur-
veillance using alternative approaches alongside molecular methods for 
accurate estimation of NTDs (Table 7).  
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8.3 Thesis layout  
The thesis chapters for this Ph.D. will be laid out per the following structure:  
Chapter 1 Background and literaturere review: Describes the current 
knowledge of NTD with focusing on schistosomiasis, giardiasis, and malaria, as 
well as different diagnostic approaches for the epidemiology of these communi-
cable with details about the current prevalence and national control activities 
within in the study locations; 
Chapter 2 Surveillance of intestinal schistosomiasis during control: a 
comparison of four diagnostic tests across five Ugandan primary schools in the 
Lake Albert region; 
Chapter 3 An extensive burden of giardiasis associated with intestinal schisto-
somiasis and anaemia in school children on the shoreline of Lake Albert, 
Uganda; 
Chapter 4 Molecular characterisation and taxon assemblage typing of giardia-
sis in primary school children living close to the shore of Lake Albert, Uganda;    
Chapter 5 Non-invasive surveillance of Plasmodium infection by real-time PCR 
analysis of ethanol preserved faeces from Ugandan school children with intes-
tinal schistosomiasis  
Chapter 6 Evaluation and implementation of new approaches for surveillance 
of schistosomiasis: application of molecular DNA methods for snail species 
identification combined with immuno-diagnostics using urine-CCA strip test 
and finger-prick blood SEA-ELISA in schoolchildren in Saudi Arabia; 
Chapter 7 General discussion provides implications of strategies using alter-
native diagnostic tools and advanced molecular techniques in the studies pre-
sented, related to control or elimination of the critical communicable diseases 
mentioned, and outlines suggestions for future work. 
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Chapter 2: Surveillance of intestinal schistosomiasis during 
control: a comparison of four diagnostic tests across five 
Ugandan primary schools in the Lake Albert region 
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2.1 Abstract  
Introduction:Programmatic surveillance of intestinal schistosomiasis during 
control can typically use four diagnostic tests, either singularly or in 
combination, but these have yet to be cross-compared directly. Our study 
assembled a complete diagnostic dataset, inclusive of infection intensities, from 
258 children from five Ugandan primary schools. The schools were purposely 
selected as typical of the endemic landscape near Lake Albert and reflective of 
high- and low-transmission settings.  
Methods: In Buliisa District, a total of 258 (5-10 years old) were enrolled. Children 
were also interviewed with a standardised questionnaire to ascertain recent PZQ 
treatment history. A field-based, duplicate Kato-Katz thick smear slides were pre-
pared from provided two stool samples each stool. Urine-CCA dipstick and SEA- 
ELISA from a single finger-prick blood sample were used to test for schistosome 
antigen/antibody, respectively, following manufacturer’s instructions. DNA-Taq-
Man® assays were performed in each aliquot of stool spiked with Phocine Herpes 
Virus (PhHV-1) to act as an internal control for each DNA extraction and later real-
time PCR assay for inhibition.  
Results: Overall prevalence was: 44.1% by microscopy of duplicate KK smears 
from two consecutive stools, 56.9% by urine-CCA dipstick, 67.4% by DNA-
TaqMan® and 75.1% by SEA-ELISA. A cross-comparison of diagnostic 
sensitivities, specificities, positive and NPVs were undertaken, inclusive of 
latent class analysis (LCA) with an LCA-model estimate of prevalence by each 
school. The latter ranged from 9.6% to 100.0%, and prevalence by the school 
for each diagnostic test followed a static ascending order or monotonic series 
of KK, urine-CCA dipstick, DNA-TaqMan® and SEA-ELISA.  
Conclusion: We confirm that KK remains a satisfactory diagnostic standalone 
in high-transmission settings, but in low transmission, settings should be aug-
mented or replaced by urine-CCA dipsticks. DNA TaqMan® appears suitable in 
both endemic environments though is only implementable if resources permit. 
In low-transmission settings, SEA-ELISA remains the method of choice to 
evidence an absence of infection. We discuss the pros and cons of each 
technique concluding that future surveillance of intestinal schistosomiasis 
would benefit from a flexible, context-specific approach both in choice and 
application of each diagnostic method, rather than a single one-size fits all 
approach.  
Keywords: Schistosoma mansoni, KK, urine-CCA, SEA-ELISA, DNA-TaqMan®, 
latent class analysis  
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2.2 Introduction  
Developing appropriate diagnostics tools, methods and protocols to track 
parasitic diseases before, during and after control is an essential component 
within the multi-disciplinarily of parasitology. It has been previously 
highlighted (Stothard and Adams, 2014) and with regard to schistosomiasis, 
intestinal schistosomiasis poses a considerable public health burden in Uganda 
(Loewenberg, 2014). Since 2003 there has been an active NCP against it 
(Kabatereine et al., 2006, Kabatereine et al., 2007, Fenwick et al., 2009, Stanton 
et al., 2017),  as primarily based on preventive chemotherapy campaigns 
(Montresor et al., 2012, Stothard et al., 2013b). Despite much progress in the 
delivery of PZQ treatments to SAC, infections with S. mansoni continue to be 
pervasive, particularly along the immediate shoreline of Lake Albert (Seto et 
al., 2012, Al-Shehri et al., 2016). Moving some 10–20 km inland, however, the 
prevalence of infection by school can decline dramatically, at least if measured 
by faecal egg-patency for if more sensitive diagnostic tools were used, such as 
urine-antigen dipsticks, such declines are less precipitous (Stothard et al., 
2006, Stothard et al., 2017a). 
The incongruence between ‘estimated’ and ‘true’ prevalence is a well-known 
diagnostic dilemma in surveillance of intestinal schistosomiasis primarily due 
to an operational compromise between imperfect detection tools and 
insufficient specimen sampling (Bergquist et al., 2009, Stothard et al., 2014, 
Utzinger et al., 2015). Nonetheless, if control programmes are to be monitored 
effectively and also permit evidence-based adaptation or revision of control 
tactics (Tchuenté et al., 2017), infection dynamics at an individual level need to 
be captured alongside any broader changes in the epidemiological landscape 
amenable to measurement (Hawkins et al., 2016, Stothard et al., 2017a). As the 
strive towards elimination grows (Hawkins et al., 2016, Colley et al., 2017), 
previous diagnostic shortcomings are revealed highlighting new diagnostic 
needs that guide future target product profiles (Utzinger et al., 2015, Hawkins 
et al., 2016, Savioli et al., 2017, Tchuenté et al., 2017, Weerakoon et al., 2018). 
At an individual level, often the school-aged child, the diagnostic repertoire for 
surveillance of intestinal schistosomiasis within NCPs has remained 
surprisingly meagre; for many years, it has been exclusively founded on 
parasitological methods alone (Stothard et al., 2014), with only sporadic 
application of serological methods (Chernet et al., 2017, Hinz et al., 2017). With 
the growing need for modernisation and interest in the adoption of more 
sensitive disease diagnostics in general (Mabey et al., 2004, Solomon et al., 
2012, Stothard and Adams, 2014). In recent years, there have been two critical 
developments that centre upon scale-up in the use of urine-CCA dipsticks 
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(Colley et al., 2013, Sousa-Figueiredo et al., 2013, Foo et al., 2015, Danso-Appiah 
et al., 2016, Greter et al., 2016, Kittur et al., 2016) and development of DNA-
detection platforms with real-time PCR with parasite-specific TaqMan® 
hydrolysis probes (Ten Hove et al., 2008, Mejia et al., 2013, Easton et al., 2016, 
Weerakoon et al., 2018). Furthermore, recent application of more sophisticated 
statistical modelling such as latent class analysis (LCA) (Hadgu et al., 2005), has 
advanced diagnostic tool performance comparisons beyond the direct need of 
a fixed reference ‘gold’ standard which, for schistosomiasis, is something we 
currently do not have (Shane et al., 2011, Ibironke et al., 2012, Koukounari et 
al., 2013, Beltrame et al., 2017). 
In this study, we attempt to make a diagnostic comparison for surveillance of 
intestinal schistosomiasis in schoolchildren across five primary schools using 
four methods namely: microscopy of duplicate KK smears from two 
consecutive stools, urine-CCA dipsticks, real-time PCR of stool with a 
Schistosoma-specific TaqMan® probe (Table 7) and serological analysis of 
finger-prick blood for antibodies against schistosome SEA. Diagnostic 
congruence was first assessed by empirical cross-tabulations, assuming a ‘gold 
standard’, then later by LCA with disease prevalence by the school also 
estimated with an LCA model. 
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2.3 Methods 
2.3.1 Study area, participants and ethical approval  
Field sampling and examinations of children took place in May 2015 in five 
primary schools in Buliisa District located within the Lake Albert region. Three 
of which have been visited previously as sentinel surveillance sites of the NCP 
(Kabatereine et al., 2007) and the global positioning system locations (GPS) 
known (Figure 17). The schools Walakuba (GPS 01°50.323N, 031°22.740E), 
Bugoigo (GPS 01°54.004N, 031°24.750E) and Runga (GPS 01°43.828N, 
031°18.603E) were located on the immediate shoreline, while Biiso (GPS 
01°45.516N, 031°25.236E) and Busingiro (GPS 01°44.090N, 031° 26.855E) 
were over 10 km away inland which aimed to represent the current control 
landscape across high- and low-endemic settings, respectively.  
 
Figure 17: A schematic map of the 5 sampled primary schools in the Lake Albert region, with 
major towns Masindi and Hoima shown 
After obtaining written informed consent and verbal assent (Figure 18), a pre-
target of 60 children of equal gender aged between 5 and 10 years of age were 
enrolled and requested to provide two stool samples on consecutive days, a 
single urine sample and single finger-prick blood sample. Children were also 
interviewed with a standardised questionnaire to ascertain recent PZQ treat-
ment history (Appendix 3). All participants were provided with a single PZQ 
(40mg/kg) treatment by the attending nurse following WHO guidelines 
(Montresor et al., 1998). The Ugandan Council for Science and Technology and 
the Liverpool School of Tropical Medicine granted approval for this study. 
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Figure 18: Reflecting the enrollment of children in Biiso school for grade 1 to 3, and different 
steps performed following school-based survey protocol for NTDs control for each school 
(Montresor et al., 1998). During the survey, A-Each participant 5-10-year-olds are interviewed 
together with parents or caregivers to determine symptoms and potential risk factors for 
parasitic infection using a standardised interview questionnaire. B-A participant information 
sheet and an informed consent form were provided to all eligible children, who enrolled into 
the study only after at least one parent provides consent as well as received health education 
sheet about schistosomiasis and STHs, transmission, ill effects and prevention. C- Participants 
provided faecal, urine and blood samples with numerical coding for each sample to be 
diagnosed for schistosomiasis, STHs and malaria under field conditions. D-All study 
participants in the following day, who are positive for parasitic infections offered anti-malaria, 
a single dose of PZQ (40mg/Kg), albendazole(600mg) tablet calculated according to the weight 
and height of each child (See page 34) (left) and the new dose poles – Ugandan model (center) 
and a model for the rest of Africa (right) with new height thresholds added to allow for 
treatment of PSAC (<6-year old). ¾ of a tablet division illustrated,  as an example, for child  need 
rather than a single tablet (Sousa-Figueiredo et al., 2010a), and crushed into flavoured fruit 
syrup before administration   
2.3.2 Diagnostics: faecal microscopy with Kato-Katz  
Duplicate KK thick smear slides (41.7 mg templates) were prepared from each 
stool received after first sieving through a 212 µM metal mesh (Montresor et 
al., 1998). Schistosome- eggs were viewed by microscopy (×100 magnification) 
(Figure 19), quantified and expressed as EPG of faeces with the intensity of 
infection classified as: light (1–99 EPG), medium (100–399 EPG) and heavy ( 
⩾400 EPG) following the WHO guidelines (Montresor et al., 1998). For quality 
control and validation, 10% of the slides were randomly selected and re-exam-
ined by a second senior technician. For later DNA analysis, a 0.8 g aliquot of 
78 | P a g e  
 
sieved stool was each prepared and stored in 95% ethanol before 
transportation to the UK for processing.  
 
Figure 19: Preparation of a duplicate KK thick smear and reading slides at camp in the study 
location. All collected samples were transferred to field laboratory located in the camp in 
Bugoigo and processed as follows. First, A-A duplicate KK thick smear was prepared by VCD 
teams from each stool sample on microscope slides using 41.7 mg punched plastic templates. 
After a clearing time of 30-45 min, the slides were examined under a light microscope by expe-
rienced laboratory technicians. The numbers of schistosome-eggs and STHs (i.e. A. lumbricoides 
and T. trichiura) were counted and recorded separately (Appendix 2). For quality control, B-
10% of the slides were re-examined by the senior technician from VCD and Hajri AL-shehri 
with assisting by Professor Russell. A result was assumed to be false-positive or false-negative 
if the result from the initial reading did not agree with the quality control as well as the third 
reading. Relationship between egg- and S. mansoni infection intensity. Egg-based infection 
categories are based on microscopy with standard cut-offs (Stothard et al., 2017a): infections 
with 1–99 epg were classified as light-intensity, those with 100–399 epg as moderate, and 
those with ≥400 epg as heavy-intensity infections 
2.3.3 Diagnostics: schistosome antigens urine-CCA dipsticks  
The commercially available urine-CCA dipstick was used to test for 
schistosome antigens in each urine sample received following manufacturer’s 
instructions (Rapid Medical Diagnostics, Pretoria, South Africa). The CCA test 
can detect active S. mansoni infection. After adding one drop of urine and one 
drop of the buffer to the cassette, the CCA antigen attaches to the monoclonal 
antibody on the membrane of the sample. An antigen-antibody complex forms 
as the liquid moves along with the cassette and fixes to another monoclonal 
antibody. If positive, a pink line appears on the strip. A further line is produced 
indicating the validity of the test (Figure 20 A). The test should be read after 
20 minutes of adding the buffer. The strength of the pink line correlates to the 
intensity of schistosome infection. So, the test result was classified by visual 
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inspection against a colour chart as used previously (Sousa-Figueiredo et al., 
2013), by two individuals as negative, trace (±), light positive (+), medium 
positive (++) and heavy positive (+++) (Figure 20 B). In this setting, all trace 
reactions were later considered to be positive as justified previously upon 
biological causality and by prior epidemiological analyses (Standley et al., 
2010, Sousa-Figueiredo et al., 2013, Adriko et al., 2014). 
 
Figure 20: Detailed photograph of POC-CCA cassettes with control and result bands. To the left 
(A), POC-CCA shows endemic area for schistosomiasis infected SAC living in Runga village. To 
the right (B) POC-CCA shows classified visually into four infection status groups  
2.3.4 Diagnostics: schistosome serology with SEA-ELISA  
The SEA-ELISA is referred to as an IEDM (indirect egg detection method for 
diagnosis Schistosomiasis. A commercially available ELISA kit (IVD Inc.; 
Carlsbad, USA) was used to test for host antibodies (IgG/M) to soluble egg 
antigens (SEA) using a field-based ELISA test following manufacturer’s instruc-
tion (Appendix 1: AccuDiag™ Schistosoma IgG ELISA Kit). A lancet was used to 
withdraw approximately 100 µl of a finger-prick blood sample from each child 
and stored in a 1.5ml Eppendorf tube at room temperature. After 2 hours, the 
samples were centrifuged for 3 minutes at 9,000 rpm, and serum from each 
child was harvested. 2 µl of harvested serum was then collected, and diluted in 
2:80 with specimen dilution buffer before loading a total of 100 µl into each 
ELISA micro-well (Figure 21 A). Upon completion, the micro-titre plate was 
placed on a white card to view the visual colour of each reaction as graded into 
pale yellow (light positive), yellow (medium positive) and dark yellow (heavy 
positive), Figure 21 B and C,  upon visual comparison with the control sera as 
recorded previously (Stothard et al., 2009). Two laboratory technicians 
analysed the colour change to improve reliability.  
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Figure 21: A-Performing a field-based ELISA test following manufacturer’s instruction by Hajri 
Al-Shehri under supervision Professor.Russell. B- Demonstrating colour change (clear to yel-
low), reflecting schistosome antibody detection, and highlighting the high prevalence of 
S.monsonia detected by ELISA in high transmission setting (Runga) compared to C- low 
transmission setting (Busingiro) 
2.3.5 DNA diagnostics: TaqMan® real-time PCR  
After transfer to the UK, each aliquot of stool was spiked with PHV (PhHV-1) to 
act as an internal control for each DNA extraction and later real-time PCR assay 
for inhibition following protocols of Meurs et al. (Meurs et al., 2015, Ten Hove 
et al., 2008), which targetted a 77 base pair segment within the ribosomal 
internal transcribed spacer (ITS-2) region which can be identified using 
S.mansoni (GenBank: AF503487) as reference sequence (Meurs et al., 2015, 
Obeng et al., 2008). Schistosome DNA was detected with the Schistosoma-
specific primers of Ssp48F (5'GGT CTA GAT GAC TTG ATY GAG ATG CT'3) and 
Ssp124R (5'TCC CGA GCG YGT ATA ATG TCA TTA'3) and TaqMan® probe Ssp78T 
(ROX -TGG GTT GTG CTC GAG TCG TGGC– Black Hole Quencher-3) as developed 
by (Meurs et al., 2015, Obeng et al., 2008). DNA-TaqMan® assays were 
performed in a Chromo-4 with Opticon monitor Version 3.1. (Biorad, Hemel 
Hempstead, UK) with Biorad iQ™ Supermix and thermal cycling conditions of 
15 minutes at 95°C, followed by 50 cycles, each of 15 s at 95°C, 20 s at 60°C, and 
25 s at 72°C. The infection intensity was classified according to Ct values: 
negative (Ct > 45), light positive (35 > Ct ⩽ 45), medium positive (25 > Ct ⩽ 35), 
and heavy positive (Ct ⩽ 25) (see Figure 22). 
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Figure 22: TaqMan® probe-based detection of S. mansoni -DNA with categorising infection 
intensity based on the cycle threshold (Ct) as described in the above text. In Graph A, qRT-PCR 
were performed on stool samples from Busingiro children, 4.0% (2/50) of children with heavy 
infection, 4.0% (2/50) with moderate, and 16.0% (8/50) with light infection based on the cycle 
threshold (Ct) value of the Schisto-PCR plus positive control (+VE). In Graph B, RT-PCR-based 
infection categories are based on known egg counts samples by microscopy with standard cut-
offs: sample with 72 epg was classified as light-intensity (Ct-43), a sample with 200 epg as mod-
erate (Ct-29), and sample with 600 epg as heavy-infection (Ct-23). The solid line indicates the 
Ct-value for each sample individually with standard deviation +/-5 being adjusted using cut-off 
value Ct-20 heavy, 30 moderate, and 40 light infections for pairwise comparisons with multiple 
testing sample 
2.3.6 Data management and statistical analysis 
All data collected in the field and processed in the laboratory were recorded on 
proforma data sheets (Appendix 2 and Appendix 3). These were then double 
entered in Microsoft Excel prior to the generation of summary tables for prev-
alence and intensity of infection (Table 8 and Table 9). Empirical estimates of 
sensitivity, specificity, NPV and PPV was calculated in R statistical package v 
2·10·1 (The R Foundation for Statistical Computing, Vienna, Austria) and SPSS 
software (v 24.0, SPSS Inc., IBM, USA) assuming the urine-CCA as the ‘gold’ 
standard against the remaining three diagnostic tests (Table 10). For percent-
age values, 95% confidence intervals (95% CI) were estimated using the exact 
method (Armitage et al., 1994). We have decided to assume the urine-CCA as 
the gold standard for our descriptive analyses (i.e. empirical estimates of diag-
nostic performance), since there have been extensive evaluations of urine-CCA 
dipsticks (Colley et al., 2013) and WHO recommendation of its use in surveil-
lance mapping (Danso-Appiah et al., 2016).  
Subsequently, to tackle the inherent problems with diagnostic measurement 
error, we employed an LCA and full information maximum likelihood estima-
tion (Table 11). LCA allows grouping of categorical data (in the current study 
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not infected and infected from the diagnostic tests under examination) into la-
tent classes indicating S. mansoni infection via a probability model. Given the 
well-known epidemiological landscape of Lake Albert region, such a model was 
designed to allow LCA estimated prevalence of S. mansoni to vary by school 
(Table 11). Through this approach, model-based estimates of sensitivity and 
specificity across diagnostic tests without assuming a gold standard were also 
obtained. The classification certainty of this model was evaluated through en-
tropy; values of entropy near one indicate high certainty in classification while 
values near zero indicate low certainty (Celeux and Soromenho, 1996). LCA 
assumes the relationships between the observed variables (i.e. diagnostic tests 
in the current study) are accounted for by their class membership and thus 
conditioning on class membership (i.e. the disease status in the current study) 
such that if the model estimated disease status is misclassified by one test, the 
probability that it will be misclassified by another test would not be affected. 
We assessed this assumption by speculating the standardised residuals for 
each response pattern from the diagnostic tests as estimated from the LCA 
model. Further technical details of these models in the context of schistosomi-
asis have been described elsewhere, and thus they are not repeated here 
(Ibironke et al., 2012). The LCA model was fitted using MPlus version 7.3 
(Muthén and Muthén, 2015). 
2.4 Results 
2.4.1 Prevalence of intestinal schistosomiasis  
A total data set was assembled from 258 children with a prevalence of intesti-
nal schistosomiasis by each diagnostic test presented, see Table 8. Overall 
prevalence of intestinal schistosomiasis was: 44.1% (95% CI; 38.0–50.2) by 
microscopy of duplicate KK smears from two consecutive stools, 56.9% (95% 
CI; 50.8–63.0) by urine-CCA dipstick, 75.1% (95% CI; 69.8–80.4) by SEA-ELISA, 
and 67.4% (95% CI; 61.6–73.1) by DNA-TaqMan® assay.  
Table 8: Prevalence (%) of S.mansoni by school according to each diagnostic test with 95 % 
confidence intervals 
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        As was expected the prevalence of infection at Runga and Walakuba was ob-
served to be highest locally, exceeding 50% in all methods, whereas the prevalence 
of infection at Busingiro was lowest falling well short of 50% by any methods. How-
ever, pooling infection status by being positive by any test revealed that just under 
half of the children attending this school could be considered to be ‘free’ from in-
fection. For the total data set only just over a quarter of children (n=69) could be 
considered to have no evidence of intestinal schistosomiasis demonstrating the per-
vasiveness of intestinal schistosomiasis in the Lake Albert region.  
2.4.2 Prevalence of S. mansoni by school distance from Lake Albert  
The geographical proximity of each of the five schools to Lake Albert shoreline 
is depicted in schematic in Figure 23 A; on-the-ground shortest distance to the 
lake shoreline can be ranked in the following order of Walakuba (0.2 km), 
Runga (0.4 km), Bugoigo (0.9 km), Biiso (9.4 km) and Busingiro (13.2 
km)(Figure 23 B). Notably, both Runga and Bugoigo schools are located for 
safety and convenience on slightly higher ground behind each village so as not 
to flood, which during wetter periods has detrimentally affected Walakuba in 
the past (J.R.S., personal observation).  
 
Figure 23: Prevalence of S. mansoni by school distance for each diagnostic method, and by any 
positive test criterion. A, schematic map of the 5 sampled primary schools in the Lake Albert 
region, with major towns Masindi and Hoima shown. The grey area is Lake Albert while the 
grey hatched area is the lowland plain where inflowing and outflowing Victoria and Albert Nile 
rivers, respectively make their course. B. Prevalence of S. mansoni by school for each diagnostic 
method, typically reveals a wide range of prevalence by a method for each location 
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2.4.3 Infection intensity by school distance from Lake Albert  
While diagnostic comparisons are made on the basis of binary associated with 
endemic setting data, it is worth noting that infection intensity also varied by 
school setting, in that ‘heavy intensity’ infections or ‘strong positive’ by any test 
were particularly common at Runga, but were rare at Busingiro, Table 9. As 
shown in Figure 23 B, the changing prevalence by school for each method is 
apparently visible in that the prevalence of inferred from each diagnostic test 
typically followed a static ascending order or monotonic series of KK, urine-
CCA dipstick,  SEA-ELISA, and DNA-TaqMan® Assay although the relative 
position of the estimated prevalence by urine-CCA at Runga slightly exceeds 
SEA-ELISA and DNA-TaqMan® Assay. 
Table 9: The prevalence with intensity measured by each diagnostic method for S. mansoni 
across the five primary schools 
 
2.4.4 Urine-CCA as an arbitrary gold standard  
Assuming the urine-CCA as an arbitrary gold standard, the diagnostic perfor-
mance for the three remaining tests is shown along with diagnostic accuracy 
and Cohen’s kappa statistic, Table 10. The sensitivity of SEA-ELISA is the high-
est (96.6%) but also has the lowest specificity (53.2%), with the highest NPV of 
all methods. By contrast, the sensitivity of KK is the lowest (76.9%) but also has 
the highest specificity (99.1%), with the highest PPV of all methods.  
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Table 10: Diagnostic comparison of sensitivity (SS), specificity (SP), negative predictive value 
(NPV) and positive predictive value (PPV) of each method against urine-CCA dipstick as ‘gold 
standard’ 
 
2.4.5 Empirical and LCA modelling of estimates of diagnostic 
performance 
On the basis of LCA analysis, the sensitivity and specificity of each method can 
be estimated on the basis of their latent class assignment which highlights the 
trade-off between diagnostic specificity (i.e. false positive) and sensitivity (i.e. 
false negative). In this analysis, sensitivity and specificity of SEA-ELISA and 
urine-CCA are broadly equivalent with DNA-TaqMan® appearing to have 
slightly lower sensitivity and specificity. Estimating the prevalence of infection 
by school with LCA, Table 11, reveals a lower prevalence than that on the basis 
of positivity by any test but follows the same static ascending order or mono-
tonic series (Figure 23 B). It is evident that at Runga intestinal schistosomiasis 
is universal whereas at Busingiro around 9.6% of children are suspected of har-
bouring infections. 
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Table 11: Latent class analysis (LCA) estimates of sensitivity and specificity and LCA model of 
the prevalence of S. mansoni by school with 95 % CIs for each diagnostic method 
 
The LCA model generated similar sensitivity for SEA-ELISA and urine-CCA but 
was slightly lower for DNA-TaqMan®, Table 4. KK was again shown through 
LCA to have the highest specificity among all the four tests. The specificity of 
89.3% (95% CI; 80.9–97.6) for the urine-CCA test was acceptable but for the 
SEA-ELISA and the DNA-TaqMan, specificities were less so and estimated to be 
49.5% (95% CI; 39.4–59.6) and 57.5% (95% CI; 48.6–66.5), trending as with 
empirical calculations, see Table 11. Furthermore, LCA estimated infection 
prevalence of S. mansoni by the school to be lower than that on the basis of 
positivity by any test (for the latter see Figure 23 B). Nevertheless, both of 
these approaches suggested that intestinal schistosomiasis was universal at 
Runga, however, at Busingiro LCA estimated a prevalence of S. mansoni infec-
tion to be 9.6% (95% CI; 9.0−18.4), much lower than that revealed by positivity 
upon any test. 
Finally, the entropy of the LCA model was estimated to be 0.921. This indicated 
a clear delineation of classes in the fitted model standardised residuals for each 
response pattern from the four diagnostic tests from this model were between 
−2 and 2, evidencing that local independence of the four diagnostic tests is not 
obviously violated. 
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2.5 Discussion  
2.5.1 Current reference standard, Kato–Katz thick smear 
Owing to the complicated developmental and population biology of the schis-
tosome within the mammalian host, it is well known that accurate detection of 
intestinal schistosomiasis by any biomarker can be problematic and has been 
the topic of at-length discussions previously (Bergquist et al., 2009, Stothard et 
al., 2014, Utzinger et al., 2015). Foremost, the insensitivity of the KK, especially 
in the detection of light egg-patent infections or in patients with a recent his-
tory of PZQ treatment, is perhaps the most obvious obstacle to overcome 
(Kongs et al., 2001, Koukounari et al., 2013, Leuenberger et al., 2016). 
Indeed, how we debate and assess the significance of egg-negative infections is 
changing alongside measuring morbidity associated with intestinal schistoso-
miasis which goes beyond what KK assessments can offer (King, 2015). Never-
theless, KK can still be promoted as a field-applicable standalone and appropri-
ate in high-endemic settings, as seen here in both Runga and Walakuba, where 
prevalence and intensity of infection were high. Nonetheless, KK has several 
deficits when applied to lower transmission settings, as exemplified by the 
other schools sampled here and is more misleading perhaps than informative. 
To compensate, De Vlas et al. (1993) developed a useful corrective prevalence 
chart which took into account infection intensity; however, its uptake was not 
as good as anticipated (De Vlas et al., 1993). It is also outside the scope of the 
present paper to discuss economic cost-benefit of faecal microscopy (Meurs et 
al., 2015) other than that mobile microscopy with handheld devices offers 
some attractive cost-saving solutions for surveillance of intestinal schistosomi-
asis in high-endemic areas (Stothard et al., 2005, Bogoch et al., 2014). However, 
as control programmes move forward towards elimination, the KK methodol-
ogy will be inappropriate and will be unable to provide sufficient quality epi-
demiological information for precision mapping of disease foci (Tchuenté et al., 
2017, French et al., 2018, Molyneux et al., 2018, Weerakoon et al., 2018).  
The latter is pivotal in the local intensification of delivery of treatments and 
surveillance interventions to confirm interruption of transmission (Rollinson 
et al., 2013, Stothard et al., 2017a, Bergquist et al., 2017). Indeed, from the in-
formation reported here, we would suggest that control efforts in locations 
such as Busingiro should be intensified rather than reduced. 
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2.5.2 Alternative  technique for diagnosing schistosomiasis 
Of the remaining diagnostic methods, the diagnostic pros and cons of each 
method have been discussed elsewhere often using the ASSURED framework 
(Bergquist et al., 2009, Stothard et al., 2014, Utzinger et al., 2015). DNA-
TaqMan® methods are, however, increasingly gaining favour and offer a 
multiplex DNA-platform for co-detection of several NTDs as well as many other 
infectious agents (Verweij and Stensvold, 2014, Llewellyn et al., 2016, 
Maksimov et al., 2017, Verweij et al., 2007, Won et al., 2016); much more so 
than other any other current biomarker method can provide (Ten Hove et al., 
2008, Solomon et al., 2012, Mejia et al., 2013, Easton et al., 2016). There also is 
the suggestion that DNA-TaqMan®  could become an acceptable ‘gold’ standard 
(Meurs et al., 2015, Weerakoon et al., 2018), and whilst we ultimately share 
some enthusiasm in this there are some impediments to discuss. Foremost, 
DNA-TaqMan® requires specialist equipment and is not currently amenable to 
point-of-contact settings although there is growing interest in the use of more 
field-friendly methods (Minetti et al., 2016, Weerakoon et al., 2018), such as 
loop-mediated isothermal amplification (LAMP) (He et al., 2016) and 
recombinase polymerase amplification (RPA) (Rosser et al., 2015). Nonethe-
less, from our results here the DNA-TaqMan® has been somewhat outper-
formed upon consideration of Table 8. In our opinion, perhaps the most 
significant advantage of  DNA-based platform is that DNA-TaqMan® assays can 
cross-over into environmental monitoring through detection of 
environmental(e) DNA and therefore broaden the vision of schistosomiasis 
control in general potentially uniting clinical and environmental surveillance 
(Rollinson et al., 2013, Stothard et al., 2017a, Stothard et al., 2017b). 
2.5.3 LCA-model for  evaluation of diagnostic tests  
In the absence of a ‘gold’ standard diagnostic test and complexity of the chang-
ing epidemiological landscape in which tests are being applied in Uganda 
(Standley et al., 2010, Adriko et al., 2014, Al-Shehri et al., 2016), our analysis 
presented in Table 10 postulated that urine-CCA dipsticks could be an ‘error-
free’ standard which, in Table 11, was further explored by LCA. Here the prob-
abilistic statistical model applied does not assume any ‘gold’ standard and 
therefore points towards the urine-CCA as having near-optimal diagnostic 
scores of sensitivity (99.1%) and specificity of (89.3%). Moreover, these scores 
are significantly better than those reported previously by empirical compari-
sons (Stothard et al., 2006) and illustrate how advances in statistical modelling 
developed elsewhere on urine-CCA dipsticks (Knopp et al., 2015, Koukounari 
et al., 2013) can provide a deeper insight into diagnostic score evaluations over 
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and above simple empirical calculations (Colley et al., 2013, Danso-Appiah et 
al., 2016).  
Nonetheless,  a theoretical issue of adopting LCA-models exclusively is an 
assumption of independence of tests which, given the biological biomarkers 
employed here could be somewhat confounded; KK detects eggs directly, DNA-
TaqMan® measures Schistosoma-DNA in the stool (presumably from excreted 
eggs), and SEA-ELISA detects antibodies to secreted egg-antigens. Thus, these 
three methods are somewhat interrelated to similar biomarkers of the egg 
itself although will have each have differing physical, biochemical and 
physiological components Table 9. However, the urine-CCA dipstick is less 
directly connected to egg biomarkers for it utilises carbohydrate-antigens re-
leased from feeding worms of either sex, and hence offers an alternative bi-
omarker appraisal. Since violations of the conditional independence assump-
tion can lead to biased LCA estimates of accuracy and prevalence, performing 
and reporting checks of whether assumptions are met is essential which was 
why we compared LCA estimates of diagnostic performance with empirical 
ones, concluding each of the diagnostic tests used. In addition, speculation of 
standardised residuals from the LCA model indicated that the assumption of 
local independence of the four diagnostic tests under examination was not 
obviously violated.  
2.5.4 Field applicability-assured urine-CCA diagnostic test 
Over and above the routine diagnostic scores of sensitivity, specificity, negative 
and PPVs with or without LCA models, however, it is also necessary to further 
consider each diagnostic tool against the ASSURED criteria (Kosack et al., 
2017). This seeks to understand whether a diagnostic test can be used at scale 
and is ultimately useful in several clinical and epidemiological surveillance 
settings (Mabey et al., 2004, Peeling et al., 2006, Stothard and Adams, 2014). 
The roll-out of the urine-CCA test has been discussed previously (Stothard, 
2009), and it is pleasing to see it become further endorsed at the policy level 
(Danso-Appiah et al., 2016). The most desirable features of this test are its af-
fordability, stable commercial production, the use of urine-sampling, the speed 
of analysis and a short time to obtain results which has a very pragmatic con-
sideration for the end-user in this emphasis. All of the above potentially make 
the dissemination of epidemiological results back to the local community ob-
tained by the urine-CCA dipstick much quicker, which is vital to increase local 
ownership of preventive chemotherapy campaigns in future (Tchuenté et al., 
2017). 
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2.6 Concluding Remarks  
The study has shown that intestinal schistosomiasis continues to be a public 
health challenge on the shoreline of Lake Albert which now presents as a het-
erogenous epidemiological landscape of high- and low-transmission settings. A 
total of four diagnostic tests were each assessed regarding contemporary sur-
veillance for intestinal schistosomiasis finding that KK sampling is a satisfac-
tory diagnostic standalone in high-transmission settings but in low-transmis-
sion settings should be augmented or replaced by urine-CCA dipsticks. DNA-
TaqMan® appears suitable in both endemic settings though is only imple-
mentable if resources permit. In low-transmission settings, SEA-ELISA remains 
the method of choice to evidence an absence of infection. In the dearth of a di-
agnostic ‘gold’ standard for intestinal schistosomiasis, LCA offered useful com-
putations of diagnostic performance between tests. 
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2.7 Appendix  
Appendix 1: AccuDiag™ Schistosoma IgG ELISA Kit adapted 11-11 2015, omline access 
(http://www.rapidtest.com/pdf/Schistosoma%20IgG%20_8209-35(11-11-2015).pdf)  
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Appendix 2: Manual data collection sheet used to collate diagnostic information 
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Appendix 3: Example of a hardcopy of the questionnaire used in the study 
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3.1 Abstract  
Introduction: Water-borne parasitic diseases associated with poverty still 
blight the lives of African school children. In Uganda, intestinal schistosomiasis 
is still common along the shoreline of Lake Albert, despite ongoing control, and 
co-infection with giardiasis and malaria is poorly described. To shed light on 
putative interactions between diseases, a prospective cross-sectional 
parasitological survey was undertaken across five primary schools on the 
shoreline of Lake Albert.  
Methods: Stool samples from a total of 254 school children, aged 5-10 years, 
were examined by microscopy and RDTs, with additional quantitative real-time 
PCR assay for detection of Giardia DNA. Each child was interviewed, 
anthropometric measurements taken, and a finger-prick blood sample was also 
collected from each child and tested for malaria with haemoglobin levels 
measured. Associations between disease and health status were assessed.    
Results: Intestinal schistosomiasis (46.5%), giardiasis (41.6%) and malaria 
(56.1%) were prevalent, and a quarter of children were anaemic (<115 g/L). 
Up to 87.0% of children were excreting Giardia DNA, and the prevalence of 
heavy infection by quantitative real-time PCR assay (Ct ≤ 19) was 19.5%, being 
positively associated with light, moderate and heavy egg-patent 
schistosomiasis, as well as with anaemia and being under-weight.   
Conclusion: In this setting, an extensive burden of giardiasis was revealed with 
heavy intensity infections associated with egg-patent intestinal 
schistosomiasis and anaemia. To improve child health, greater attention on 
giardiasis is needed, along with exploring joined-up actions across diseases 
that promote better water hygiene and sanitation measures that better co-or-
dinate interventions on the ground.  
 
Keywords: Schistosoma, Giardia, Plasmodium, epidemiology, co-infection, con-
trol  
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3.2 Introduction 
In impoverished regions of sub-Saharan Africa and in addition to malaria, wa-
ter-borne parasitic diseases pose a significant threat to the well-being of chil-
dren. In parts of Uganda, for example, intestinal schistosomiasis is hyper-en-
demic along the shorelines of the Great Lakes and is particularly rife around 
Lake Albert (Kabatereine et al., 2004, Dunne et al., 2006, Loewenberg, 2014). 
Local aetiological factors include favourable freshwater snail habitats, poor lo-
cal sanitation and hygiene, as well as extensive levels of daily water contact by 
shoreline communities (Stothard et al., 2004, De Moira et al., 2007, Rowel et al., 
2015). While an extensive burden of malaria is known (Booth et al., 2004, 
Sousa-Figueiredo et al., 2010a, Wilson et al., 2011, Brooker et al., 2012), the 
occurrence and extent of another waterborne, poverty-related disease, giardi-
asis, has yet to be investigated. In 2003, a NCP against schistosomiasis and in-
testinal worms was launched at Pakwach (see Figure 24) (Fenwick et al., 
2009). Since then there have been substantive actions to deliver PZQ and al-
bendazole by MDA to at-risk children attending primary schools and adults in 
endemic areas (Seto et al., 2012). Owing to high levels of re-infection, an 
extensive burden of intestinal schistosomiasis remains, and children with the 
hepatosplenic and gastrointestinal disease can still be found (Bustinduy et al., 
2014). 
Giardiasis is caused by Giardia spp., a binucleate flagellated protozoan, and is 
associated with ingestion of infectious cysts on foods or in drinking water, as 
contaminated by faecal waste from humans and (or) animals carrying patent 
or cryptic infections (Painter et al., 2015, Halliez and Buret, 2013). Although 
infections with Giardia spp. may be acute and self-limiting, chronic disease, 
such as persistent diarrhoea, leads to malabsorption and weight loss (Savioli et 
al., 2006, Escobedo et al., 2014, Katz and Taylor, 2001, Huang and White, 2006). 
Many people with Giardia infection remain asymptomatic, and therefore it took 
many years until the parasite was classified as a pathogen (Mank et al., 1995b, 
Thompson and Monis, 2004, Halliez and Buret, 2013, Escobedo et al., 2014). 
In low and middle-income countries, the prevalence of human giardiasis can 
vary widely, typically from 0-30%, and depends on which diagnostic is applied. 
It can be almost universal in specific populations (Halliez and Buret, 2013, 
DuPont, 2013). Diagnosis of G. lamblia is usually performed by microscopic 
examination of stool samples for the presence of cysts and/or trophozoites 
(Table 7). The excretion of the parasite can be highly variable, and therefore 
analyses of multiple stool samples and concentration techniques are recom-
mended to increase sensitivity (Danciger and Lopez, 1975, Hanson and 
Cartwright, 2001, Staat et al., 2011, El-Nahas et al., 2013). 
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Other suggested procedures for the detection of G. lamblia are concentration 
techniques and examination of freshly preserved stool samples for the detec-
tion of cysts and trophozoites of G.lamblia (Mank et al., 1997, El-Nahas et al., 
2013). The alternatives for microscopic diagnosis of G. lamblia include immu-
noassays for DFA and G. lamblia antigen detection (Garcia et al., 2000, Garcia 
and Garcia, 2006, Baig et al., 2012). Compared to microscopy, immunoassay 
tests have shown increased sensitivity with reduced number of samples re-
quired for examination (Garcia and Shimizu, 1997, Johnston et al., 2003, Mank 
et al., 1997, Mank et al., 1995a), but still multiple stool sample analysis is 
needed for optimal sensitivity (Hanson and Cartwright, 2001). The second di-
agnostic alternative is G. lamblia DNA detection in stool by quantitative real-
time PCR assay, which showed a higher sensitivity than microscopy and immu-
noassay analyses and can further reduce the required number of stool samples 
for analysis (Guy et al., 2004, Verweij et al., 2004, Schuurman et al., 2007, ten 
Hove et al., 2007, David et al., 2011, Verkerke et al., 2014). 
Co-infection with other poverty-related diseases, such as soil-transmitted hel-
minthiasis occurs, and with ascariasis, immunomodulation of the gut mucosal 
surface potentially favours chronic giardiasis (Teixeira et al., 2007, Redpath et 
al., 2014). Within Uganda, regular reporting and surveillance of giardiasis are 
very scant (Ankarklev et al., 2012, McElligott et al., 2013, Fuhrimann et al., 
2016). While the disease is zoonotic in livestock and an essential anthropozo-
onosis of the mountain gorilla (Hogan et al., 2014, Sak et al., 2014), the burden 
of giardiasis in school children is mostly unknown, as are any associations with 
intestinal schistosomiasis. 
This present investigation aimed to conduct a prospective cross-sectional par-
asitological survey to ascertain current levels of intestinal schistosomiasis, gi-
ardiasis and malaria among schoolchildren (5-10 years of age) on the shoreline 
of Lake Albert, Uganda. Associations between diseases were assessed and as 
three of the five schools first surveyed for intestinal schistosomiasis in 2002-
2003, a comparison through time was made. 
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3.3 Materials and methods 
3.3.1 Study location  
In June 2015 in Buliisa District, Western Uganda, a prospective cross-sectional 
parasitological survey, using parasitological methods augmented with RDTs, 
was undertaken within five primary schools. Three schools were selected on 
the basis that a baseline assessment had been undertaken in 2002-2003, and 
historical data were available from: Biiso (GPS co-ordinates: 01° 45.516 N, 031° 
25.236 E), Walakuba (GPS 01° 50.323 N 031° 22.740 E) and Runga (GPS 01° 
43.828 N 031° 18.603 E) (Balen et al., 2006, Kabatereine et al., 2007). Two ad-
ditional schools were selected Bugoigo (01° 54.004 N 031° 24.750 E) and Bus-
ingiro (GPS 01° 44.090 N 031° 26.855 E) on the basis that the former school 
was sited very close to the shoreline while the latter school was furthest away 
from the lake (~13 kilometres). Busingiro was accessible on a daily basis from 
Bugoigo, where the field team was encamped, and intestinal schistosomiasis 
was presumed to be minimal there allowing associations between diseases in 
the putative absence of Schistosoma mansoni to be assessed (see Figure 24). 
 
Figure 24: Inset, a sketch map of Uganda and study area (A). Outline map of the ﬁve schools 
inspected. The primary schools of Biiso and Busingiro are located on top of the escarpment 
whereas Bugoigo, Walakuba and Runga on the lakeshore plain. Once part of Masindi District, 
the schools are now located within Buliisa District after administrative areas were revised. The 
northern village of Pakwach was where the NCP against Bilharzia and intestinal worms was 
launched in 2003 
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3.3.2 Examination of children  
In liaison with the headmaster and class teachers, a pre-target enrolment of 60 
children per school, of equal gender, randomly recruited from classes primary 
1 to 3, was performed. Each child was asked a suite of questions using stand-
ardised questionnaire recording general demographics and epidemiological 
data pertinent to intestinal schistosomiasis, giardiasis and malaria (Appendix 
3 -Page 95). Finger-prick blood was collected from each child and tested for 
malaria by RDT (SD BIOLINE Malaria Ag P.f/Pan test, SD Diagnostics, Korea) 
and haemoglobin levels by HemoCue®portable haemoglobin photometer 
(HemoCue, CA 92630, USA). Children were considered anaemic if haemoglobin 
levels were below 115 g/L (WHO, 2011). Height was measured using a portable 
stadiometer (model 214; SECA, Hanover, MD), weight was recorded using a dig-
ital weighing scale (model 803; SECA, Hanover; MD) (see Figure 25). Both met-
rics were used for following growth indicators: a) height-for-age Z-score (HAZ) 
to assess stunting; b) weight-for-age Z-score (WAZ) to assess underweight; c) 
Body mass index (BMI)-for-age z-scores variations reflect the changes in nutri-
tional status (Onyango et al., 2008). Children were defined as stunted if their 
height-for-age Z score was -3 ≤ SD, as underweight if their weight-for-age Z 
score was -2 ≤ SD, and children with Z-scores between 1 and -2 SD were con-
sidered mildly malnourished.  
 
Figure 25: Participant enrollment and inclusion in study research. In each selected primary 
school, A-School administrators were requested to provide students’ enrolment list. B-Each 
selected subject was registered in a separate registration format and invited to participate in 
the study and was given a urine container and a plastic sheet with an applicator stick to bring 
approximately 4 g stool sample. C- Interview based questionnaire prepared in English and then 
translated into the local language and translated back to English was used to collect socio-de-
mographic and associated risk factor data for parasitic infection (Appendix 3 Page-95). Also, 
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body weight and height measurement were taken for each child in a standing and relaxed po-
sition while breathing normally. D-Finger-prick blood was collected from each child that was 
willing to give blood. This was done by a certified nurse in the research team 
3.3.3 Examination of stool specimens 
Each child was requested to provide a stool sample on two consecutive days. 
All stool samples received on the first day were tested for FOBT (Mission Test, 
Acon Laboratories, SanDiego, CA). In  Bugoigo and Runga schools, all children 
were tested with Quik-Chek tests for Giardia and Cryptosporidium 
(Giardia/Cryptosporidium Quik-Chek, Alere, UK) (see Figure 26 B). The Quik-
Chek RDT is typically used to measure clinically relevant giardiasis with a level 
of detection of 6000 cysts/ml of faeces. Owing to a limited supply of 100 Quik-
Check tests, only children from these two schools were tested while a more 
general detection of giardiasis was undertaken by recourse to real-time PCR 
assays. Duplicate faecal smears were prepared from each stool sample from 
consecutive days using the KK thick smear technique (41.7 mg) (see Figure 26 
A), and examined by compound light microscopy, and helminth egg tallies were 
recorded according to EGP of stool (light 1-99, medium 100-399, heavy 400+) 
(Sousa-Figueiredo et al., 2012). A later 10% re-read of slides was performed as 
quality control. After filtration through a metal mesh (212µm pore size), a small 
pellet-sized faecal sample from each child was preserved in absolute ethanol 
for later DNA extraction and real-time PCR analysis. 
 
Figure 26: Parasitological confirmation of S. mansoni and giardia diagnosis. A-Preparing KK 
slides and searching for Schistosoma- eggs. B-Reading GIARDIA/CRYPTOSPORIDIUM QUIK 
CHEK test (RDTs) used for qualitative detection and differentiation of Giardia cyst antigen 
and Cryptosporidium oocyst antigen in a single test device (Table 7) 
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3.3.4 Probe-based detection method for Giardia 
Upon arrival, gDNA was extracted, and detection of Giardia DNA was 
performed using the TaqMan® assay following primer, probes and protocols of 
Verweij et al. (Verweij et al., 2004) (see Figure 27). In brief, approximately 0.2g 
of faecal sample preserved in ethanol was vigorously shaken, centrifuged and 
the pellet was washed twice with 1000 µl of phosphate-buffered saline 
(abbreviated PBS). The sample then was suspended in 250 µl of  2% 
polyvinylpolypyrrolidone (PVPP; Cat-77627-25G, Sigma) before frozen 
overnight at - 20°C in a MagNA Lyser Green Beads (Product No. 03358941001, 
Roche). After tissue lysis treatment with proteinase K (Supplier No, BIO-37037, 
Bioline) for two hours at 55°C, DNA was then extracted from the pellet using 
the commercial QIAamp® DNA Mini Kit spin columns (Qiagen, Hilden, Ger-
many). In each sample, 103 plaque-forming units (PFU)/ml phocine 
herpesvirus-1 (PhHV-1) was added to the isolation lysis buffer, to serve as an 
internal control for the isolation.  
 
Figure 27: Onsite training with LSTM for improving diagnosis of intestinal parasitic infection 
by using a bead-beating procedure on stool samples preserved in ethanol prior to DNA isola-
tion and the performance of Multiplex TaqMan® Real-Time PCR assay with Dr Jaco J. Verweij 
and Dr Lucas Cunningham for detection and differentiation of giardiasis and other intestinal 
parasites by dual TaqMan® assays 
             The amplification reaction was performed as a duplex TaqMan® Real-
Time PCR assay in a volume of 25 μl, containing 12.5 µl ™ iQ Supermix 
(ProductNo.170-8860-MSDS, Bio-Rad), 1 μl of  forward primer (400nM)-Giar-
dia 18S-99 (5'GACGGCTCAGGACAACGGTT'3), and 1 μl of reverse primer 
(400nM)-Giardia18S-125 (5'TTGCCAGCGGTGTCCG3'3), 0.5  μl of G. lamblia- 
specific double (200nM)-labelled probe (JOE-CCCGCGGCGGTCCCTGCTAG-
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BHQ1),1μl of PhHV-1-specific primer (400nM)-PhHV-267s 
(5'GGGCGAATCACAGATTGAATC'3) and 1μl of PhHV (400nM)-337as 
(5'GCGGTTCCAAACGTACCAA'3), 0.5 μl of PhHV-1-specific double(200nM)-la-
belled probe (Cy5-TTTTTATGTGTCCGCCACCATCTGGATC-BHQ2), supplied by 
Eurofins scientific (Eurofins Genomics Anzinger Str. 7a 85560 Ebersberg, Ger-
many), 2.5 μl of nuclease-free H2O, and 5 μl DNA sample. Amplification 
consisted of 3 min at 95°C followed by 50 cycles of 15s at 95°C, 20s at 60°C and 
30s at 72°C. Negative controls (Eluted buffer), and positive controls (stools 
samples with confirmation cysts seen provided by diagnosis Lab in LSTM) was 
included in all reaction sets. High cycle threshold values (Ct-values) obtained 
by duplex TaqMan® Real-Time PCR assay are considered to be less 
reproducible due to deficient copy numbers of the specific target. Assays were 
performed in a Chromo-4 with Opticon monitor™ Version 3.1. (Bio-Rad, UK) 
and levels of infection categorised according to Ct-values: no infection (Ct ≥ 40), 
light (30 ≤ Ct≤ 39), moderate (20 ≤ Ct ≤29), and heavy (Ct ≤ 19) intensity infec-
tion. Samples were excluded if the amplification remained inhibited (Verweij 
et al., 2004). 
3.3.5 Statistical analysis 
All data collected in the field were recorded on pro-forma data sheets (Appen-
dix 3), then tabulated in Microsoft Excel with double entry cross-check. The 
analysis was performed with R statistical package v 2·10·1 (The R Foundation 
for Statistical Computing, Vienna, Austria) and SPSS software (v 24.0, SPSS Inc., 
IBM, USA). For percentage values, 95% confidence intervals (CI95) were esti-
mated using the exact method (Armitage et al., 1994). With an extensive bur-
den of giardiasis revealed by real-time PCR, greater focus was placed on explor-
ing the association of heavy infections with Giardia inclusive with: gender, age, 
the intensity of other parasitic diseases and clinical signs and symptoms in the 
examined children. A univariate logistic regression analysis was performed to 
study the association between infection status and the risk factors under 
consideration. The level of significance of p < 0.05 was set for multivariable 
analysis; the model was interpreted using adjusted ORs and 95% CIs. The 
prevalence of intestinal schistosomiasis at Runga, Walakuba and Biiso between 
2002 and 2015 was compared by a 1-tailed Z-test (Armitage et al., 1994).  
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3.3.6 Ethical approval 
The Ugandan Council for Science and Technology and the Liverpool School of 
Tropical Medicine granted approval for this study. Each child was examined by 
the project nurse, and PZQ (40 mg/Kg, Merck, Germany) and albendazole (400 
mg, GSK, UK) treatment were administered to all participants irrespective of 
their infection status. Children with a positive malaria RDT were each offered 
a take-home, 3-day course of Coartem (Lonart®, Cipla, India) with the first and 
third administrations directly overseen by the project nurse. 
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3.4 Results 
3.4.1 General characteristics  
A total of 274 children were initially recruited, however, owing to instances of 
failure to produce stool, a final dataset was composed of 254 children, mean 
age of 6.8 years (95% CI = 6.6, 6.9) with a balanced male (49.4%) to female 
(50.5%) ratio. From the questionnaire, 45% of children reported to have re-
ceived a deworming medication in the past year. Levels of itinerancy were low 
across the schools, with 9% reported to have moved into their current school 
location within in the past three years. Access to electricity at home was limited 
(11.2 %) as was access to tap water (17.8%), which varied by location: Bugoigo 
(0.0 %), Runga (0.0 %), Walakuba (11.3 %), Biiso (50.7 %) and Busingiro 
(46.4%). Typically, between a half to three-quarters of children reported fever, 
headache, tummy cramps and diarrhoea within the past week (i.e., recently) 
and previous month (i.e., previously), Figure 28.  
 
Figure 28: Pie charts of reported symptoms as reported on the questionnaire illustrate the 
majority of children have common complaints (recently – within the past week; previously – 
within the past month). A) fever, B) a headache, C) tummy cramps, D) diarrhoea 
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3.4.2 Prevalence of diseases 
The prevalence of infection across the five schools as shown in Table 12, egg-
patent intestinal schistosomiasis of 46.5%, giardiasis and malaria by RDT of 
41.6% and 56.1%, respectively. The prevalence of egg-patent intestinal schis-
tosomiasis at Walakuba and Runga was 82.0% and 86.8%, with the majority of 
children having heavy-intensity infections. Overall, the prevalence of Giardia 
by RDT was 41.6% but by real-time PCR increased to 87.0 % which was graded 
into light (27.1%), medium (40.5%) and heavy (19.2%) categories upon com-
parison with Ct values. Just over half of the children were positive for malaria 
by RDT, with triple co-infection in just under a fifth of the population. Over a 
quarter of children were judged anaemic (30.7 %), and FOB was found in 11.0% 
of stool samples. 
Table 12: Prevalence of infection by school across a total of 254 children aged between 5 and 
10 years of old 
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3.4.3 Associations with giardiasis 
Factors potentially associated with the presence of heavy Giardia infection as 
ascertained by real-time PCR were analysed, including all available socio-eco-
nomic data, are shown in Table 13. The prevalence of heavy Giardia infection 
was strongly associated with Runga school [OR, 5.7 (95% CI, 2.18–17.0)] while 
both age and gender had no noticeable impact as shown in Table 13. The 
positive association [OR, 2.3 (95%CI, 0.89-5.1)] with FOBT was marginal, but 
all egg-patent intestinal schistosomiasis infection intensities were positively 
associated some 3 to 4 times greater than those without schistosome eggs in 
stool. By contrast, there was no significant association with heavy giardiasis in-
fection and access to tap water [OR, 0.76 (95%CI, 0.29-1.7)]. There was a sig-
nificant association between anaemic children and heavy giardiasis [OR, 2.2 
(95%CI, 1.41-4.3)]. 
Table 13: Adjusted risk factors associated with heavy Giardia infection by real-time PCR 
 
The box-plots (as seen in Figure 29) children identified with heavy Giardia in-
fection against those that were not. The Weight-for-Age Z-score threshold of -2 
SD ≤,  24.5% of children with heavy infection showed evidence of wasting [OR, 
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0.66 (95% CI, 0.46-0.93)], compared to 18.0% who had either moderate, light 
or negative infection status Figure 29A. Height-for-Age (HAZ), heavy Giardia 
infection was not significantly associated with stunting [OR, 0.81 (95% CI, 0.62-
1.05)], Figure 29B. Body Mass Index (BMI) was not associated with heavy in-
fection [OR, 0.86 (95%CI, 0.61-1.21)], Figure 29C. Although there was an asso-
ciation with anaemia when considering a cut off of 115 mg/L, general levels of 
haemoglobin were not associated [OR, 0.98 (95%CI, 0.61-1.21)], Figure 29D.  
 
Figure 29: Box plots of biometric data and haemoglobin levels and heavy infection status with 
Giardia. A) Weight-for-age, B) Height-for-age, C) Body mass index, D) Haemoglobin levels 
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3.4.4 Intestinal schistosomiasis through time 
As resources available for control are often limited, it is essential to know the 
distribution of schistosomiasis to devise and target optimal intervention strat-
egies. Previous approaches in describing schistosomiasis in Africa have typi-
cally been made at the national level, using data from the few studies available 
within a country and then extrapolating these to the country as a whole. While 
such an approach may be effective for advocacy, it is of limited practical rele-
vance to the targeting of control efforts. Between 1998 and 2002, the Vector 
Control Division of the Ministry of Health undertook epidemiological surveys 
across the country, among both school and community populations. Schools 
were selected based on ecological differences in rainfall, altitude and tempera-
ture. Ecological zones were identified using a combination of expert opinion 
and ecological zone mapping (Kabatereine et al., 2004). In 2002, the prevalence 
and the arithmetic mean intensity of children with intestinal schistosomiasis at 
Runga, Walakuba and Biiso in 2002 versus 2015 was 95.2% (631 epg) v 86.7% 
(1723 epg), 90.4% (1026 epg) v 80.3% (814 epg) and 17.2% (52 epg) v 19.6% 
(198 epg) respectively. The declines (approximately 10%) in prevalence at 
Runga and Walakuba were statistically significant (p<0.05) while the small in-
crease at Biiso was not statistically significant  (p>0.3) (Stothard et al., 2017b).  
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3.5 Discussion 
3.5.1 Effects of parasitic burdens and environmental factors    
In this cross-sectional survey in 5 primary schools, an extensive burden of par-
asitic diseases, inclusive of co-infections, has been revealed, see Table 12. Tri-
ple infections of intestinal schistosomiasis, giardiasis and malaria affected just 
under a fifth of all sampled children. Although all were sufficiently fit to attend 
school, more general markers of ill-health, such as a half to three-quarters of 
children reported fever, headache, tummy cramps, diarrhoea (Figure 28), 
anaemia (30.7%) and FOBT (11.0%), revealed an underlying morbidity, 
inclusive of chronic wasting (Figure 29), previously seen in this area 
(Bustinduy et al., 2013, Green et al., 2011). Along the lakeshore, access to tap 
water is still very poor which no doubt helps both intestinal schistosomiasis 
and giardiasis flourish (DuPont, 2013, Grimes et al., 2015, Grimes et al., 2014, 
Mohammed Mahdy et al., 2008). Moreover, a concurrent malacological survey 
of the shoreline was undertaken and found numerous snails shedding schisto-
some cercariae, (Figure 30 below) (Stothard et al., 2017b), as upon several oc-
casions before (Rowel et al., 2015, Levitz et al., 2013). Clearly, there is a press-
ing need to establish and sustain safe water sources for both drinking and 
washing on the immediate shoreline as a foundation step towards promoting 
well-being (Bartram and Cairncross, 2010). 
 
Figure 30: Malacological survey involving eight sites around five selected schools was also car-
ried out to identify intermediate snail hosts and larval infection rate in the snail. The snails 
collected were checked for trematode infection by shedding to assess the establishment of 
transmission. The observation was also made on water contact habits of the study population 
(Stothard et al., 2017b)   
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3.5.2 Schistosomiasis  
The burden of intestinal schistosomiasis appears greatest at Runga and Wala-
kuba schools, which has been noted previously upon comparison with other 
locations along this lake (Balen et al., 2006, Kabatereine et al., 2007). Despite 
best efforts of control with school-based delivery by MDA of PZQ, the resultant 
declines in egg-patent prevalence (~10%) were small although statistically sig-
nificant. Whilst this is movement in the right direction, rather worryingly, there 
were large numbers of children with heavy intensity infections, Table 12. 
Looking to the future, a more aggressive treatment strategy against intestinal 
schistosomiasis is needed to gain and sustain control such as exploring bian-
nual treatment cycles in both children and adults as well as snail control for 
prevention of disease transmission (see Figure 30). The reported annual treat-
ment coverage was low (45.0%) and is in definite need of being raised. To do 
this, a more significant effort in time and resourcing for future MDA is needed, 
for example by expanding the period allocated for MDA at each school, to en-
sure that as many children receive treatment as possible. Similarly, in these 
high transmission settings biannual treatment cycles in both children and 
adults should be explored, as well as tackling the burden of infection in PSAC 
(Stothard et al., 2017b, Stothard et al., 2013a).  
3.5.3 Giardiasis 
Underlying the striking levels of intestinal schistosomiasis and malaria, with 
the pervasive nature of giardiasis is of concern and warrants greater attention 
on this waterborne disease in future, Table 12. Use of the Quik-Chek RDT re-
vealed that, whilst no cryptosporidiosis was encountered (Table 7), a consid-
erable number of children at Runga and Bugoigo were patently infected with 
clinically relevant Giardia (Figure 28). This was confirmed by real-time PCR 
and, by having a higher diagnostic sensitivity (Verweij et al., 2004, Easton et al., 
2016, Schuurman et al., 2007), found a larger proportion of children with some 
evidence of infection (Table 12). This points towards very high levels of expo-
sure likely by ingestion of cysts from lake water. Notably, livestock regularly 
enters into the lake and contaminate, and each day such water is directly drawn 
in plastic jerry-cans for drinking and domestic use (Figure 30), exacerbating 
exposure and fostering zoonotic potential (Thompson, 2004). When only heavy 
infections by real-time PCR were considered there was clear focalisation of 
chronic giardiasis at Runga, a positive association with egg-patent intestinal 
schistosomiasis as well as associations with FOBT and anaemia, Table 13.   
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3.5.3 Malaria  
Analysis of the blood by malaria RDTs has provided a much deeper insight into 
the complex dynamics and significance of Plasmodium infections in children 
living on the shorelines of Lake Albert in Uganda. Infection prevalence varied 
by village and was more common in children living in Biiso and Busingiro, Ta-
ble 12. Indeed, some of the most widespread parasitic infections in tropical and 
subtropical countries and many people suffer from multiple infestations are 
plasmodia and helminth species, and their extensive geographical overlap in 
the tropics means that the coinfection is commonly found (Brooker et al., 2007, 
Brooker et al., 2006). Thus, in the presence of helminth infections, the immune 
response evoked by helminth infections and probably modify immune re-
sponses to Plasmodium and consequently alter infection and disease risks 
(Sangweme et al., 2010).  Although all of the studied schools were located in 
regions of very high schistosomiasis and malaria endemicity (Booth et al., 2004, 
Yeka et al., 2012), there are climatic factors that may influence local anopheline 
biology (Ochieng’Opondo et al., 2016), with the potential favourable location 
for transmission of different Plasmodium species. The prevalence of Plasmo-
dium species detected in these communities will be discussed in details in 
chapter 5.   
3.5.4 Association with Giardia infection 
The strong association of heavy Giardia infection and egg-patent intestinal 
schistosomiasis remains to be fully explained (Table 13). While each disease is 
associated with water contaminated by faecal material, there are different 
major modes of exposure, namely oral ingestion of cysts and per-cutaneous 
transmission by cercariae, respectively. It is also reasonable to speculate that 
intestinal schistosomiasis alters the environment of the bowel to become more 
conducive for colonisation of ingested cysts (Bartelt and Sartor, 2015). For ex-
ample, the numerous schistosome egg-induced lesions that perforate and im-
munomodulate the mucosal surface (Bustinduy et al., 2013), perhaps promote 
chronic giardiasis. In terms of anaemia, while it is difficult to disentangle pre-
cisely the relative roles intestinal schistosomiasis, giardiasis and malaria are 
playing, there was a clear association with heavy giardiasis [OR, 2.2 (95%CI, 
1.41-4.39)]. Amongst other causal factors, this could be mediated by more gen-
eral gastro-intestinal inflammation and malabsorption, alongside daily blood 
loss as evidenced by FOBT (Wilson et al., 2011, Green et al., 2011). If anaemia 
is to be tackled effectively here, from a public health perspective, it is important 
to consider and tackle as far as possible all three diseases simultaneously. 
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It is outside the immediate scope of this chapter to discuss in full most appro-
priate interventions in the short and long-term, an immediate suggestion 
would be to expand preventive chemotherapy approaches to include other 
anti-parasitic drugs. The use of intermittent preventive treatment for malaria 
along with intensified vector management would appear appropriate here 
(Nankabirwa et al., 2014, Njau et al., 2013). Expanded access to treatment and 
combination therapies against Giardia is also needed, even though these have 
much longer administration regimes (Harhay et al., 2010). Moreover, the effi-
cacy of any drug should also be assessed and be cognisant of the underlying 
disease states resultant from other parasites. For example, the efficacy of drugs 
against Giardia may be confounded if schistosome egg-induced lesions fail to 
regress after PZQ treatment. Like-wise, incomplete management of giardiasis 
diminishes attempts to regain gut function, thus developing a strategy for 
multi-parasitic disease management is needed here. 
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4.1 Abstract  
Introduction: Giardia duodenalis is an important zoonotic parasite which 
can parasitise in the intestines of humans and various animals. However, the 
information about the prevalence and genetic diversity of G. duodenalis in 
Uganda is limited.  
Methods:  As part of an epidemiological survey for gastrointestinal parasites 
in school children across five primary schools on the shoreline of Lake Albert, 
the prevalence of giardiasis was 87.0% (n=254) as determined by real-time 
PCR analysis of faecal samples with a genus-specific Giardia 18S rDNA probe. 
Faecal samples were further characterised with taxon assemblage-specific TPI 
TaqMan® probes and by sequence characterisation of the β-giardin gene.  
Results: While less sensitive than the 18S rDNA assay, general prevalence by 
TPI probes was 52.4%, with prevalence by taxon assemblage of 8.3% (assem-
blage A), 35.8% (assemblage B) and 8.3% co-infection (A & B assemblages). 
While assemblage B was dominant across the sample, proportions of assem-
blages A and B, and co-infections thereof, varied by school and by the age of 
child; mixed infections were particularly common at Runga school (OR = 6.9 
[95% CI; 2.5, 19.3]) and in children aged 6 and under (OR = 2.7 [95% CI; 1.0, 
7.3]). Infection with assemblage B was associated with underweight children 
(OR = 2.0 [95% CI; 1.0, 3.9]). The presence of each assemblage was also con-
firmed by sequence analysis of the β-giardin gene finding sub-assemblage AII 
and further genetic diversity within assemblage B.  
Conclusion: To our knowledge, this is the first report of G. duodenalis prev-
alence and genotypes in the shoreline of the Lake Albert in Uganda, which 
extended the host range of G. duodenalis and provided basic data for control-
ling G. duodenalis infection in theses settings. To better explore the local 
epidemiology of giardiasis and its impact on child health, additional sampling 
of school children with assemblage typing would be worthwhile. 
 
Keywords: Giardia duodenalis; real-time PCR; assemblage B; β-giardin; wast-
ing  
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4.2 Introduction  
The binucleate flagellated protozoan Giardia duodenalis (syn. G. lamblia, G. 
intestinalis) is a common gastrointestinal parasite able to infect a variety of 
mammals(Adam, 2001, Helmy et al., 2014). Where sanitation and hygiene are 
poor, these parasites can cause acute and/or chronic giardiasis across all ages 
(Wegayehu et al., 2016, Rogawski et al., 2017, Tellevik et al., 2015, Muhsen and 
Levine, 2012). While levels of endemicity of giardiasis may vary across the 
world, it can be common in children living within low and middle-income 
countries (Laishram et al., 2012, Muhsen and Levine, 2012); for example, in 
Uganda giardiasis can be particularly rife (Al-Shehri et al., 2018, Fuhrimann et 
al., 2016), but its effect on child health is not fully appreciated but in Rwanda 
nearby, the very high prevalence of G. duodenalis in children aged 5 and under, 
was associated with being underweight (Ignatius et al., 2012). 
There are eight distinct groups or taxonomic assemblages (A to H) within 
Giardia currently recognised (Sprong et al., 2009, Almeida et al., 2010, Takumi 
et al., 2012). Assemblages A and B are typically held most responsible for  
human infections, with the latter assemblage associated with zoonotic 
transmission (Almeida et al., 2010, Feng and Xiao, 2011, Vanni et al., 2012, 
Asher et al., 2014, Thompson and Ash, 2016); each assemblage can be further 
divided into sub-assemblages, e.g. A: AI, AII & AIII and B: BIII and BIV on the 
basis of sequence variation within molecular markers e.g.GDH, β-giardin, small 
subunit ribosomal DNA (18S rDNA), and triose phosphate isomerase (TPI) 
(Durigan et al., 2014, Karim et al., 2015, Minetti et al., 2015). Despite efforts to 
investigate specific assemblages with disease symptoms and severity, there is 
no absolute association to date (Sprong et al., 2009, Thompson and Ash, 2016).  
In Uganda, general investigations on the epidemiology of giardiasis are 
increasing (Nizeyi et al., 1999, Graczyk et al., 2002, Nizeyi et al., 2002, Johnston 
et al., 2010), although only a single study has employed molecular methods of 
characterisation (Ankarklev et al., 2012). Ankarlev et al. (2012) investigated 
associations between taxon assemblages and Heliobacter pylori infection in 
apparently healthy children aged 0–12 living in Kampala, the capital. 
Assemblage B was found dominant and a risk factor for H. pylori infection 
(Ankarklev et al., 2012) and like in other parts of the world, assemblage B was 
more associated with symptomatic infections (Pelayo et al., 2008, Puebla et al., 
2014).  
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To shed light on the taxonomic assemblages of Giardia within school children 
living on the shoreline of Lake Albert, we undertook a molecular 
characterisation of previously characterised stool samples as reported by Al-
Shehri et al. (Al-Shehri et al., 2016). Faecal samples were further characterised 
with assemblage-specific TaqMan® triose phosphate isomerase (TPI) probes 
and the presence of each taxon assemblage confirmed by sequence analysis of 
the β-giardin gene (Table 7). Associations between taxon assemblage and col-
lected epidemiological data were explored. 
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4.3 Materials and Methods 
4.3.1 Faecal material and epidemiological information  
Faecal samples were available for further molecular analysis (see below) that 
were initially collected within the epidemiological survey of 254 school chil-
dren from five primary schools (Figure 24, Page-104) as reported by Al-Shehri 
et al. (Al-Shehri et al., 2016). Each sampled child underwent an epidemiological 
questionnaire and clinical examination; data on socio-demographical aspects 
and standard biometry were recorded (height with a clinical stadiometer, 
model 214; SECA, Hanover, MD and weight by weighing scales with a model 
803; SECA, Hanover; MD).  Heights and weights were used to assess stunting, 
height-for-age Z-score (HAZ), and wasting, weight-for-age Z-score (WAZ). 
Children were defined as stunted if their height-for-age Z score was -2 ≤ SD and 
underweight if their weight-for-age Z score was -2 ≤ SD (WHO, 2013a). Finger-
prick blood was collected from each child and tested for haemoglobin levels by 
HemoCue® portable haemoglobin photometer (HemoCue, CA 92630, USA). 
Children were considered anaemic if haemoglobin levels were below 115 g/L 
(WHO, 2011). 
During the surveys, all sampled stools were tested for FOBT (Mission Test, 
Acon Laboratories, San Diego, CA, USA), but owing to a limited supply of RDTs, 
only stools collected from Bugiogo and Runga were tested in-field with Quik-
Chek RDTs (GIADIA/CRYPTOSPORIDIUM Quik-Chek, Alere, Galway, Ireland). 
Stools were then stored in absolute ethanol for later DNA analysis.  
4.3.2 Molecular profiling of G. duodenalis assemblages  
After transfer to the UK and each faecal sample was spiked with PHV to act as 
an internal control for extraction and performance of later real-time PCR 
assays. gDNA was extracted, and detection of Giardia small-subunit ribosomal 
DNA was performed using TaqMan® assay following primers, probes and 
protocols of Verweij et al. (Verweij et al., 2004), as explained in chapter 3. 
These extractions were again retested with a duplex real-time PCR assay with 
assemblage-specific A and B probes using the triose phosphate isomerase (TPI) 
locus Table 14, published by Elwin et al., (Elwin et al., 2014).  
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Table 14: Summarizing of assemblage-specific primers and probes 
 
The real-time PCR analysis of faecal extractions from each school was 
completed in separate PCR plates that each contained negative and positive 
controls; a negative control (without gDNA template) of extraction elution 
buffer (10 mM Tris-HCl [pH 8], 1 mM EDTA) and a positive control (with 
reference genomic Giardia DNA template) from a heavily infected individual 
excreting approximately 1000 cysts per gram of faeces as estimated by 
microscopy. As a further quality control, reamplification of 10% of samples was 
undertaken to assess assemblage assay reliability. Assays were performed in a 
Chromo-4 with Opticon monitor™ Version 3.1. (Bio-Rad, UK). The infection 
was determined according to Ct values; for the 18S rDNA TaqMan® assay no-
infection was Ct ≥ 40 and positive infection Ct≤39 while for assemblages-spe-
cific probes was Ct ≤ 45, see Figure 31. 
 
Figure 31: Showing the results for Bugoigo School children tested for A and B Assemblages, 
including negative and positive controls   
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To further confirm assemblage A and B, the β-giardin gene was amplified from 
samples from six children using nested PCR following protocols of Minetti et al. 
(Minetti et al., 2015). PCR products were puriﬁed using the QIAquick® PCR 
Puriﬁcation kit (QIAGEN Ltd.) and were sequenced in both directions by Sanger 
sequencing. Nucleotide sequences and chromatograms were analysed and ed-
ited using Geneious software (Vejlsøvej55, 8600 Silkeborg, Denmark). Se-
quences from this study were aligned with each other and reference sequences 
downloaded from GenBank (listed below). The assemblages and sub-assem-
blages at each locus were identiﬁed by BLAST searches against the following 
reference sequences: β-giardin (accession nos. X14185.1–AI, AY072723.1– AII, 
DQ650649.1–AIII, AY072726.1–BIII, AY072725.1– BIV). 
4.3.3 Statistical analyses 
Statistical analysis was performed using Minitab Ltd® (Brandon Court, Unit E1-
E2 Coventry CV3 2TE UK). Binary logistic regression tests were performed to 
compare data from each school and as well as risk variables as an independent 
indicator to assess any associations with specific assemblages.  
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4.4 Results 
4.4.1 G. duodenalis and assemblages 
Out of the 254 samples examined, 221 tested positive (87.0%) by targeting Gi-
ardia 18S rDNA assay while 133 (52.3%) tested positive with TPI assemblage-
specific probes. Across Bugoigo and Runga schools, the prevalence of giardiasis 
by Quik-Chek RDT was 41.6% (Table 12-Page-111). Of the 133-tested positive 
by TPI probes, 21 samples were positive for assemblage A (15.8%) only, 91 
positives for assemblage B (68.4%) only and 21 positives for both assemblages 
A and B (15.8%), mixed assemblage infections Table 15. 
Table 15: Prevalence (%) of G. duodenalis and assemblages across all five schools by real-time 
PCR; the odds ratio of assemblages A, B or A/B by school compared against the total given (with 
95% Confidence Limits) 
 
Across these samples’ assemblage, A was less common than assemblage B, an 
approximate ratio of 1: 2.7, with assemblage B dominant. To ascertain if there 
was any amplification bias in assemblage detection, Figure 32 below (Graph 
A) shows a bivariate plot of Ct values for Giardia 18S rDNA TaqMan® probe and 
the corresponding Ct value of assemblage A TPI TaqMan® probe (18S rDNA = 
0.203 + 0.6991 TPI, with R-squared 34.91% (P <0.005), and positive correla-
tion (r=0.60); Figure 32 (Graph B) shows bivariate plot for assemblage B (18S 
rDNA = 0.228 + 0.6947 TPI, with R-squared 28.39 % (P <0.005), and positive 
correlation (r=0.54). The performance of each TaqMan® assay appeared equiv-
alent. Of note, however, is that mixed assemblage infections appear more com-
mon at Runga school where the local prevalence of assemblage A was also 
much higher.   
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Figure 32: Bivariate plot of Ct values for TaqMan® 18S DNA versus Ct value of assemblage-
specific TaqMan® TPI probe obtained for each sample with dashed lines showing the 95% pre-
diction interval. Graph A, using assemblage, A probe; Graph B, using assemblage B probe 
4.4.2 Epidemiological associations with an assemblage 
The most notable in Table 16 is the association of mixed assemblages in 
younger children (OR = 2.7 [95% CI; 1.0, 7.3]), and assemblage B was 
associated with the presence of FOBT (OR = 2.2 [95% CI; 1.0, 5.2]). It appeared 
that there was also a significant association of infection with assemblage B and 
children of lower weight-for-age, i.e. wasting (OR = 2.0 [95% CI; 1.0, 3.9])  
Table 16: Epidemiological associations cross-tabulated against available assemblage infor-
mation 
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4.4.3 Sequence analysis of the beta-giardin gene 
Table 17 details the point mutations with the six representative samples for 
the β-giardin gene, finding an exact match with sub-assemblage AII and no 
sequence within the three sample inspected. By contrast, each of the three 
samples for assemblage B was different and did not match either BIII and BIV 
precisely. The sequence from Sample 102 is particularly notable as there 
appeared to be allelic variation within the TPI gene as evidenced by split-peak 
chromatograms of A/G or T/C at three locations present within this region (see 
Appendix 4 supplemental figure).  
Table 17: Polymorphic sites in the β-giardin sequences in Giardia duodenalis assemblage A & 
B isolates 
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4.5 Discussion 
4.5.1 Application of real-time PCR to pathogen detection 
The high prevalence of giardiasis reported here by real-time PCR with the 18S 
rDNA probe analysis (87.0%) demonstrates that children living on the shore-
line of Lake Albert are at very high risk of both acute and more likely, chronic 
infections. The high burden of giardiasis was also corroborated in the field by 
the Quik-Check RDTs at Runga and Bugoigo schools confirming that some 
41.6% of children were patently shedding copious amounts of Giardia cysts 
within their stools (see chapter 3, Table 12). It is unsurprising perhaps that 
the levels are so high since this lakeshore environment has very poor local san-
itation and water hygiene, as well as being hyperendemic for intestinal schis-
tosomiasis, another waterborne disease (Al-Shehri et al., 2016). Nonetheless, 
the prevalence of giardiasis here is much elevated in comparison to other parts 
of the world (Thompson and Smith, 2011), although in Rwanda over 60% of 
rural children have been shown to be infected with Giardia by molecular typing 
methods (Ignatius et al., 2014). More broadly, the diagnostic sensitivity of real-
time PCR methods is known to be superior to alternative diagnostic methods, 
often revealing giardiasis to be more pervasive (Gotfred-Rasmussen et al., 
2016), and also creates opportunities for investigations of (sub) assemblage 
transmission dynamics (Thompson and Ash, 2016). 
4.5.2 Real-Time PCR Assay for Detection and Genotype  
Given the multi-copy nature of the 18S rDNA against the lower copy number of 
TPI, the diagnostic sensitivity of TPI probes is lower, such that just under a half 
of the infected cases detected by 18S rDNA were missed (Table 15). It has 
been stated previously that the detection limit of Giardia 18S rDNA probe assay 
is approaching 10 pg DNA/μL (Jaros et al., 2011). Presumably, that of TPI assay 
is much higher (Elwin et al., 2014) such that assemblage typing of ‘light’ 
intensity infections is not always possible. A similar level of diagnostic discord-
ance has been observed elsewhere  (Ignatius et al., 2014) which hopefully does 
not lead to a systematic bias in general reporting of each assemblage, as evi-
denced by Ct values in Figure 32, but rather than typing parasites with assem-
blage-specific primers is not possible when shedding cysts are too few in num-
ber.  
4.5.3 Associations between epidemiological information and assemblage 
Nonetheless, in this sample assemblage B dominates upon comparison to as-
semblage A. Notably this 1:2.7 ratio varied by school with Runga having a 
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greater proportion of assemblage A, as well as co-infection with assemblage B 
thereof, see Table 15, and more broadly, there appeared to be some interesting 
epidemiological associations by assemblage, see Table 16. Although there was 
no association with gender, younger children appeared to harbour a greater 
proportion of mixed assemblage infections than older counterparts (OR = 2.7 
[95% CI; 1.0, 7.3]). There was also an indication that FOBT was associated with 
assemblage B (OR = 2.2 [95% CI; 1.0, 5.2]) and in children being underweight 
(OR = 2.0 [95% CI; 1.0, 3.9]). These findings add to the general debate on the 
health consequences of giardiasis with particular emphasis on assemblage B, 
which also appears more genetically heterogeneous that assemblage A here 
(Thompson and Ash, 2016).  
4.5.4 Diversity within assemblages  
It is an interesting observation that of the six samples subjected to sequence 
analysis of β-giardin, the three samples selected from assemblage A were iden-
tical and could be further unequivocally assigned to sub-lineage AII, which has 
been reported in other studies (Cacciò and Ryan, 2008, Plutzer et al., 2010, 
Cacciò and Sprong, 2010, Ryan and Cacciò, 2013, Beck et al., 2012, Zhang et al., 
2012). By contrast, of the three samples selected from assemblage B, there 
were each different, see Table 17, and none matched exactly either BIII or BIV 
sub-assemblages. Most notable are the point mutations at positions 176, 188 
and 314, where split-peak chromatograms were observed (see Appendix 4 ). 
This is indicative of mixed amplicon templates inferring putative allelic varia-
tion within the TPI locus. The genomic complexity of Giardia is complex, being 
binucleate and sometimes aneuploid (Aguiar et al., 2016) which might infer 
sample 102 was either a mixed co-infection of two independent B lineages or 
contains a single infection lineage with an unusual genomic TPI variant. None-
theless, there is greater diversity within assemblage B and with further genetic 
profiling would reveal additional variants which might point towards currently 
unknown heterogeneities in local transmission cycles. For example, there is 
numerous livestock, e.g. cattle and goats, that regularly enter into the lake and 
while drinking openly defecate into the water which may add to raised zoonotic 
potential in such domestic water directly drawn from the lake. 
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4.5.5 Conclusion  
To conclude, additional sampling of school children would be worthwhile if pu-
tative associations between assemblage B and detrimental health outcomes re-
ported here are to be fully verified statistically. Furthermore, to better monitor 
local transmission cycles of Giardia, we encourage future studies that track 
each assemblage within local livestock and undertake environmental sampling 
of lake water where domestic water is drawn.  
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4.6 Appendix  
Appendix 4: Point mutations detected within assemblage B 
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5.1 Abstract 
Introduction: In 2016, an estimated 216 million cases of malaria were re-
ported, resulting in approximately 445,000 deaths. With increasing incidences 
of resistance to standard anti-malarial therapies and the unprecedented failure 
of RDTs in Sub-Saharan Africa, there is an onus on the scientific community to 
identify new mechanisms by which parasites of the Plasmodium genus can be 
detected and targeted for eradication. This study aimed to establish whether 
quantitative PCR (rtPCR) analysis of either dried blood spots (DBS) from fin-
ger-prick samples or ethanol preserved faces (EPF) samples collected as a part 
of surveillance programmes for schistosomiasis, could be used effectively as a 
highly sensitive and specific surveillance method for Plasmodium spp.  
Methods: 247 dried blood spots (DBS) and ethanol preserved faecal (EPF) 
samples were analysed using generic, genus-specific Plasmodium TaqMan™ as-
say methods, using a single primer/probe set for detecting Plasmodium spp., 
followed by species-specific probes targeting a conserved region of the small 
subunit 18S rRNA gene for species-specific Plasmodium detection. 7 of positive 
samples by species-specific TaqMan™ assay underwent sequencing for species-
specific confirmation. Prevalence, sensitivity, specificity, positive and NPVs 
were calculated to assess the efficacy of DNA from either blood or faecal sam-
ples using rtPCR as a diagnostic test for Plasmodium infection, compared to 
RDTs as the gold standard.  
Results: In Lake Albert, Uganda, of the 247 SAC  included in this study who 
were asymptomatic, 138 (55.8%; 95% CI: 49.6– 61.9) cases of malaria were 
diagnosed for P. falciparum (PfHRP-2-detecting RDTs), and 45 samples (18.2%; 
95% CI: 13.9–23.5) were positive for Plasmodium species ( PfHRP-2 and pan-
pLDH test lines). While rtPCR has detected 198 (80.1 %, 95% CI: 74.7–84.6) for 
any species of Plasmodium spp., whereas rtPCR-based assays for EPF were 158 
(63.9%; 95% CI: 57.8–69.7).  
Conclusions: rtPCR analysis of fDNA samples produced mainly similar preva-
lence estimates to RDT data when surveilling of genus-specific Plasmodium in-
fections. With the primer set used by this study, species-specific diagnosis of 
Plasmodium spp. was not possible. rtPCR using blood samples currently offers 
a superior surveillance method for species-specific Plasmodium detection.  
 
Keywords: Plasmodium; real-time PCR; surveillance; RDT; faecal samples;   
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5.2 Introduction  
With an estimated 216 million cases of malaria, resulting in 445,000 deaths, 
malaria remains a considerable cause of mortality and morbidity in 91 coun-
tries worldwide (WHO, 2016b). Approximately 90% of this malaria infection 
and deaths occurred in the WHO African Region, where ecological conditions 
are conducive to the transmission of Plasmodium spp. by their Anopheline in-
sect host (Christiansen-Jucht et al., 2014). Certain demographics are more 
vulnerable than others to malarial illness, such as children under 5 years of age 
in highly endemic areas,  while in areas of lower transmission, many cases 
occur in older children and adults (Nmadu et al., 2015, Roberts and Matthews, 
2016, Carneiro et al., 2010).  
Malaria is caused by a parasite of the Plasmodium genus, which in most cases is 
transmitted by the bite of a female Anopheles mosquito, though blood-borne 
transmission (through accidental nosocomial transmission via blood transfu-
sion or transplantation) and congenital transmission are also known to occur 
(Natama et al., 2017, Martín-Dávila et al., 2018). Upon inoculation of the human 
host with a motile Plasmodium sporozoite, the parasite spreads to the circula-
tory system via the liver, initiating a cytokine cascade which results in flu-like 
symptoms such as fever, malaise, myalgia, nausea and vomiting. Symptoms 
may progress quickly as parasites sequestrate in cerebral blood vessels, caus-
ing seizures, coma and eventually death (Bartoloni and Zammarchi, 2012). At 
present, five species of the Plasmodium genus are known to cause malaria in a 
human host: P. falciparum, P. vivax, P. ovale (now split into subspecies P. ovale 
curtisi and P. ovale wallikeri), P. malariae and P. knowlesi (Fuehrer and Noedl, 
2014). A sixth Plasmodium parasite, P. cynomolgi, has been reported in only one 
naturally-acquired case of human malaria (Ta et al., 2014).     
Poverty in sub-Saharan African countries, such as Uganda, create a favourable 
environment for mosquito breeding, with ample mosquito breeding grounds in 
stagnant water sources created by villagers living in poor conditions ((UBOS), 
2015, Kibret et al., 2018). Malaria prevalence has been previously reported 
here as between 55% and 96% (Betson et al., 2014, Al-Shehri et al., 2016). Com-
munities living near Lake Albert in Uganda have also been found to have an 
extensive burden of other parasitic diseases such as schistosomiasis and giar-
diasis (Al-Shehri et al., 2016), requiring treatment via MDA to school children 
in the area (Fenwick et al., 2009).  
Proper management lies mainly in the speed and accuracy of diagnosis, but also 
in an appropriate prescription (adapted antimalarial, dosage and appropriate 
duration of treatment) (Shah et al., 2016, Kabaghe et al., 2017). In Uganda, a 
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2009 health facility survey for monitoring quality of severe malaria case man-
agement showed that, of all patients assessed, only 27 % were correctly diag-
nosed with severe malaria and 30 % did not receive correct initial parenteral 
antimalarial medicine prescribed at the appropriate dose and frequency 
(Achan et al., 2011). The World Health Organisation (WHO) has emphasised 
diagnosis and surveillance as critical aspects of controlling and eventually elim-
inating malaria (WHO, 2012). Malaria is currently diagnosed either by micros-
copy,  RDT  or PCR of blood spots (Tangpukdee et al., 2009, Feleke et al., 2017, 
Doctor et al., 2016, Fancony et al., 2013, Golassa et al., 2013).  
Microscopy remains to this day the most commonly applied test for the diag-
nosis of malaria (Table 7). Not requiring sophisticated equipment or a perma-
nent source of electricity, the use of both ‘thick’ blood smears (also referred to 
as ‘thick blood films’) and ‘thin’ blood smears using Giemsa-stained blood are 
the diagnostics best suited for low-middle income countries such as Uganda. A 
‘thick’ blood film consists of several layers of red blood cells and can confirm 
the presence of a Plasmodium parasite, while the ‘thin’ blood film (a single layer 
of red blood cells) makes it easier to identify species-specific morphological 
features (Bejon et al., 2006). Correct diagnosis of a Plasmodium infection using 
microscopy is dependent upon the experience of the microscopist, with many 
Plasmodium spp. appearing indistinguishable under light microscopy, even to 
the trained eye (Lee et al., 2009). Light microscopy can only successfully detect 
a Plasmodium spp. infection (in approximately 0.025-0.0625 μl of blood) at a 
density of 50-100 parasites/μl, rendering this technique less effective for lower 
parasite densities, such as those occurring in patients following initial antima-
larial treatment (Koepfli et al., 2016).  
In the past two decades, new applications have become available for malaria 
diagnosis, such as the so-called "rapid" immunochromatographic tests (RDTs) 
(Table 7). These RDTs detect parasite-specific antigens, such as Plasmodium 
lactate dehydrogenase (pLDH) and P. falciparum histidine-rich protein II 
(PfHRP- II), with the former antigen being genus-specific, and the latter being 
specific only for the detection of a P. falciparum infection (Wongsrichanalai et 
al., 2007). In addition to their reliability in high endemic settings, RDTs are easy 
to use and interpret. However, some RDTs have a low sensitivity (ranging from 
50 to 1000 parasites /μl  (Huong et al., 2002, Makler et al., 1998) and a rela-
tively high cost, thus preventing their routine use in low-resourced field set-
tings of sub-Saharan Africa (Murray et al., 2003).  
It is currently recognised that PCR diagnosis of a Plasmodium infection is a 
more sensitive approach than the aforementioned techniques of light micros-
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copy and RDTs, but remains reserved for specialised laboratories given its ma-
terial and financial requirements. Nested PCR (nPCR) can detect up to 1 para-
site/μl (Snounou et al., 1993) and real-time PCR (also known as quantitative 
PCR or rtPCR), up to 0.2 parasite/μl  or even 0.02μl parasite/μl (Mangold et al., 
2005, Payne, 1988, Cnops et al., 2010). 
Diagnostics play a critical role in guiding both the deployment of existing NTDs 
program resources and the implementation and evaluation of intervention 
strategies. Currently, faecal samples are widely used for surveillance of dis-
eases such as schistosomiasis and STHs, but limited studies have been carried 
out in the detection of Plasmodium gDNA from human faecal samples (Jirků et 
al., 2012). In non-human primates, however, detection of Plasmodium spp. 
infections is routinely performed using DNA extracted from faecal samples, 
even providing evidence for the African origin of P. vivax (Liu et al., 2014, 
Martinsen et al., 2014, Plenderleith et al., 2018, Abkallo et al., 2014, Siregar et 
al., 2015, de Assis et al., 2016, Weimin et al., 2010, Kawai et al., 2014). As such, 
faecal samples from human patients could also be used to detect malaria 
infections in field surveys alongside a molecular diagnosis of schistosomiasis 
and STHs in order to monitor a program’s impact on transmission of these 
NTDs with minimal risk of recrudescence. The uses of such screening would 
range from mapping Plasmodium-endemic locations, monitoring and 
evaluation of malaria transmission, assessment of whether MDA could be 
ceased in favour of a targeted approach, and finally, as a means of post-MDA 
surveillance.   
We report here the development and implementation of quantitative PCR 
(rtPCR) for the diagnosis of Plasmodium species from faecal samples in Lake 
Albert, Uganda (Table 7). This study aimed to detect gDNA of Plasmodium 
species from either ethanol preserved faeces (EPF) or dried blood spot (DBS) 
samples previously collected by Hajri Al-Shehri et al., (Al-Shehri et al., 2016), 
and comparing the results with malaria RDTs as the gold standard. The aim of 
this study was to examine whether rtPCR of DNA from faecal samples could be 
used for the surveillance of species-specific Plasmodium infections in human 
populations, especially in countries such as Uganda where school-based con-
trol of these infections (Schistosomiasis, STHs, and Malaria) with MDA has 
taken place. 
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5.3 Materials and methods 
5.3.1 Study area 
In this cross-sectional survey, field sampling and examinations of children took 
place during May 2015 in five primary schools in Buliisa district located within 
the Lake Albert region. Three of these five schools have been visited previously 
as sentinel surveillance sites of the NCP (Kabatereine et al., 2007) and the 
global positioning system locations (GPS) for each school was recorded (Figure 
33). The schools Walakuba (GPS 01°50.323N, 031°22.740E), Bugoigo (GPS 
01°54.004N, 031°24.750E) and Runga (GPS 01°43.828N, 031°18.603E) were 
located on the immediate shoreline, while Biiso (GPS 01° 45.516N, 
031°25.236E) and Busingiro (GPS 01°44.090N, 031° 26.855E) were located 
over 10 km away inland with an altitude of 1,295 metres on average above sea 
level which aimed to represent the current control landscape across high- and 
low-endemic settings, respectively. 
 
Figure 33: Inset: sketch map of the study villages in Buliisa district, Lake Albert, Uganda. The 
grey area is Lake Albert while the grey hatched area is the lowland plain where inflowing and 
outflowing Victoria and Albert Nile rivers, respectively make their course. The northern village 
of Pakwach was where the NCP against bilharzia and intestinal worms was launched in 2003, 
and study area denoted (A). B. Schematic map of the five sampled primary schools inspected 
in the Lake Albert region. The primary schools of Bugoigo (1), Walakuba (2) and Runga (3) on 
the lakeshore plain (Low-Altitude), whereas Biiso (4) and Busingiro (5) are located on top of 
the escarpment (High-Altitude). Once part of Masindi District, the schools are now located 
within Buliisa District after administrative areas were revised.  
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5.3.2 Ethical approval 
The Ugandan Council for Science and Technology and the Liverpool School of 
Tropical Medicine granted approval for this study. Each child was examined by 
the project nurse and PZQ (40mg/Kg, Merck KGaA, Darmstadt, Germany) and 
Albendazole (400mg, GSK, Brentford, UK) treatment was administered by the 
attending nurse following WHO guidelines (Montresor et al., 1998) to all par-
ticipants irrespective of their infection status. Children with a positive malaria 
RDT were each offered a take-home, 3-day course of Artemether-lumefantrine 
(Coartem® Lonart; Cipla, Mumbai, India) with the ﬁrst and third administra-
tions directly overseen by the project nurse.  
5.3.3 Enrolment of participants 
After obtaining written informed consent and verbal assent, a pre-target 
enrolment of 60 children per school, of equal gender, randomly recruited from 
classes primary 1 to 3, were assessed for study eligibility and requested to 
provide two stool samples on consecutive days, a single urine sample and single 
finger-prick blood sample( Figure 18 Page-77). The inclusion criteria were: 
children aged between five- and ten-years-old presenting at selected school 
during the survey with a history of water contact activities in the previous 
months, and fever with measured axillary body temperature >37.5 °C at 
presentation. However, the absence of fever in a child did not exclude from ma-
laria diagnosis, and treatment. Exclusion criteria included severe and chronic 
illnesses, trauma/injury, and intake of anti-malarial medication within the pre-
vious weeks.  
5.3.4 Clinical examination and demographic information 
In liaison with the headmaster and class teachers, medical history and clinical 
examination were performed on each child by the study clinician and infor-
mation was entered into a standardised questionnaire form (Appendix 3 Page 
-95). This included demographic information, clinical and treatment history, 
vital signs, body weight, and epidemiological data pertinent to intestinal schis-
tosomiasis, and malaria. Schistosome-eggs were detected by microscopy (×100 
magnification) after duplicate KK thick smear slides (41.7 mg templates) were 
prepared from each stool. The eggs were then quantified and expressed as EPG 
of faeces with the intensity of infection classified as: light (1–99 EPG), medium 
(100–399 EPG) and heavy (⩾ 400 EPG) following the WHO guidelines 
(Montresor et al., 1998). Clinical diagnosis of malaria was made according to 
national guidelines. A maximum of 3 µL Finger-Prick blood was drawn from 
every child for RDTs, as well as one drop of blood, was spotted onto filter paper 
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(Whatman 3 MM, Whatman International, Maidstone, England). Spots were 
then dried at ambient temperature before storage in individual plastic bags 
with silica gel to preserve DNA integrity, and then transported to LSTM. Here, 
they were stored at −20 °C for molecular analysis with Malaria species-specific 
TaqMan™ Assay. 
5.3.5 Malaria RDTs detect specific antigens (proteins)   
At the study site, Finger-Prick blood was collected from each child, and all 
whole blood specimens were tested in singlet using the SD Bioline Malaria Ag 
P.f/Pan test (RDTs) (SD Diagnostics, Korea) (Figure 34). The tests were 
performed and interpreted following the manufacturer’s instructions. Briefly, 
the RDT were stored and used at room temperature, and approx. 2 µL of whole 
blood was transferred by provided plastic pipette to the round specimen well, 
followed by the addition of two drops of diluent into the square well. The test 
results were read at 15 minutes. The results were interpreted as invalid (no 
control line), positive (control line and test line present), mixed infection (con-
trol line and two test lines), or negative (control line present, no test line). The 
malaria RDT test results were provided directly to the on-site nurse and as-
sisted the clinician on the clinical decision for treatment. 
 
Figure 34: Malaria RDTs showing results from Biiso SAC 
5.3.6 DNA extraction from biological samples (EPF and DBS)  
Upon arrival, gDNA extraction, from ethanol preserved faeces (EPF) was 
performed by Al-Shehri et al. (Al-Shehri et al., 2016). In brief, approximately 
0.2 g of faecal sample preserved in ethanol was vigorously shaken, centrifuged 
and the pellet was washed twice with 1000 µl of Phosphate-buffered saline 
(abbreviated PBS). The sample then was suspended in 250 µl of 2% 
polyvinylpolypyrrolidone (PVPP; Cat-77627-25G, Sigma) before frozen 
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overnight at – 20 °C in a MagNA Lyser Green Beads (Product No. 03358941001, 
Roche). After tissue lysis treatment with proteinase K (Supplier No, BIO-37037, 
Bioline) for two hours at 55°C, DNA was then extracted from the pellet using 
the commercial QIAamp® DNA Mini Kit spin columns (QI gen, Hilden, Germany) 
following to the manufacturer's instructions. In each sample, 103 plaque-
forming units (PFU)/ml phocine herpesvirus-1 (PhHV-1) was added to the 
isolation lysis buffer, to serve as an internal control for the isolation using the 
method of Verweij et al.(Verweij et al., 2004). 
The blood gDNA was extracted from Dried Blood Spots (DBS) collected with a 
finger stick (FS-DBS) using Chelex Resin (Chelex® 100 sodium form 50-100 
mesh dry, No 11139-85-8, Sigma) (Strøm et al., 2014). A standard hole punch 
was used to cut hole 2-mm diameter circular from stored blood samples onto 
filter paper (Whatman 3 MM, England), and placed into a labelled 1.5 mL Ep-
pendorf tube (2.0 ml Crystal Clear Microcentrifuge Tube, No. E1420-2000, Star-
lab). The filter paper punches were then manually pushed towards the bottom 
of the tube several times with a pipette tip before one mL distilled water being 
added to each sample, and then incubating for 30 minutes at 55C. All superna-
tant was removed, before adding another 1 mL of distilled water and incubating 
in the same conditions for 15 minutes. After removing all supernatant, 200 L 
of adjusted 10% Chelex-100 concentration with distilled water, 100 L TE 
buffer (Tris-EDTA (TE) buffer solution, pH 8.0, 93283-100ML, Sigma), and 1 L 
sodium dodecyl proteinase K (Proteinase K, recombinant, PCR Grade, Sigma) 
was added, vortexed and centrifuged for 15 seconds at 14500 RPM, before in-
cubating in the same conditions for one hour. A further vortex and centrifuge 
took place as above, before incubating in a VWR incubator (VWR® Ovens and 
Incubators) at 300 RPM at 93C for 30 minutes. Samples were agitated and cen-
trifuged at 10000 RPM for one minute. 100 L of supernatant was removed, 
with taking care not to disturb the Chelex particles and added to another la-
belled 1.5 mL Eppendorf tube, before being stored at -20C.  
5.3.7 Malaria detection using malaria species-specific TaqMan™ Assay 
Extracted DNA was analysed using TaqMan™ Assay targeting mitochondrial ge-
nome 18S gene as previously described by Shokoples et al. (Shokoples et al., 
2009). A singleplex real-time RT-PCR assay was initially performed to detect a 
region of the Plasmodium 18S gene that is conserved across all ﬁve species P. 
falciparum, P. vivax, P. ovale, and P. malariae (Rougemont et al., 2004). Generic 
Plasmodium DNA was detected from DBS and EPF with the malaria-specific pri-
mers of Plasmo-1 F primer (5'GTT AAG GGA GTG AAG ACG ATC AGA'3) and 
Plasmo-2 R primer (5'AAC CCA AAG ACT TTG ATT TCT CAT AA'3), and Plasprobe 
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(FAM-ACC GTC GTA ATC TTA ACC ATA AAC TAT GCC GAC TAG-BHQ-1), supplied 
by Eurofins scientific (Eurofins Genomics Anzinger Str. 7a 85560 Ebersberg, 
Germany). The reaction was performed with a ﬁnal volume of 25 L containing 
12.5 L of iQ Supermix ((iQ™ Supermix, 100 x 50 µl reactions, 2x real-time PCR 
mix, contains dNTPs, 6 mM MgCl2, 50 U/ml hot-start iTaq™ DNA polymerase, 
Bio-Rad Laboratories Ltd.uk), 5 L DNA, 0.4 L (10 pmol/ul) - of each Plasmo-
1 F primer / Plasmo-2 R primer, 0.2 L (10 pmol/ul)-of Plasprobe, and 6.5L 
of nuclease-free H20 (Ambion® RT-PCR Grade Water).  
 Samples were conﬁrmed Plasmodium spp. positive with genus-speciﬁc pri-
mers, and the 6-carboxyﬂuorescein (FAM)-Labelled “Plasprobe” were 
subjected to species differentiation using TaqMan™ Assays. Plasmodium 
species were determined with species-speciﬁc forward primers, Plasmo-2 R 
primer and species-speciﬁc probes using multiplex rtPCR of the primers and 
probes listed in Table 18 with the respective concentrations for each reaction, 
as published by Shokoples et al. (Shokoples et al., 2009). 
Table 18: Primers and probes used for screening and identiﬁcation of Plasmodium speciesa 
 
 In total of 25 L in each reaction, consisting of 12.5 L IQ supermix, 5 L of 
DNA template, species-speciﬁc forward primers, Plasmo-2 R primer, species-
speciﬁc probes, and the reaction was completed with nuclease-free H20 (Ster-
ile, RNase and DNase Free, 3098-2ML, UK) until a final volume of 25 μl was 
reached. Extracted DNA-DBS and DNA-EPF for each school were run on 
different plates, included a number of controls: extraction of TE (10 mM Tris-
HCl [pH 8], 1 mM EDTA) as a negative control, and four positive controls, using 
DNA extracted from heavily infected samples diagnosed under microscope, 
with either P. falciparum, P. vivax, P. ovale or P. malariae, provided by diagnostic 
LAB at LSTM, as well as 10% experimental results repeated to ensure 
reliability. DNA-TaqMan® assays were performed in a Chromo-4 with Opticon 
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monitor Version 3.1. (Biorad, Hemel Hempstead, UK) with Biorad iQ™ Super-
mix and thermal cycling conditions of an initial denaturation of 3 minutes at 
95C, followed by 50 cycles of 15 seconds at 95C, 20 seconds at 60C and 15 
seconds at 72C.  Infected children were identified according to Ct values: either 
positive (10 > Ct ⩽ 45) or negative (Ct > 45), see Figure 35  
 
Figure 35: rtPCR quantitation as performed  by Opticon Monitor 3 software (Biorad), showing 
the 4 positive samples with malaria infection detected by bDNA in comparison with fDNA using 
samples collected from school A (Bugoigo). It can be observed  that, bDNA often gives lower Ct 
values and higher fluorescence  in opposition to fDNA, for example, school A, sample code- B20, 
diagnosed by blood has a Ct value of ~27 and fluorescence of ~0.225 nm, whereas diagnosed 
by fDNA has a Ct value of ~40 and fluorescence of ~0.1 nm  
5.3.8 Sequencing-based species-specific 18s gene for species 
confirmation 
In order to confirm the species present and assess the genetic variability of the 
Plasmodium 18S gene, the positive products of multiplex rtPCR for each species 
(P. falciparum, P. ovale and P. malariae), and one mixed infection (P. falciparum, 
and P. ovale) were performed by PCR-sequencing-based on marker 18s gene. 
Seven samples of PCR products from positive DNA-DBS samples (and a mini-
mum of 500 ng total DNA) were purified with the QIAquick® PCR Puriﬁcation 
kit (QIAGEN Ltd.) according to the manufacturer's instructions, and 5 L of pu-
rified PCR product was sequenced externally in forwarding direction by Source 
Bioscience (Nottingham, UK) with their specific primers (1 ng/L per 100 bp). 
Sequence reads were either 54 bp or 76 bp long, aligned using Geneious v9.1.5 
software (Biomatters Limited) package, then compared with gene sequences of 
Plasmodium available from the NCBI server, using the basic local alignment 
search tool (BLAST) (http://blast.ncbi.nlm.nih.gov/Blast.cgi) to determine the 
malaria species. Only sequences which mapped uniquely within the Plasmo-
dium spp. reference genome and map to the human reference genome were 
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included in our analyses. Plasmodium 18S gene reference sequences used for 
Plasmodium species were P. falciparum: M19172.1, P. ovale: L48987.1, P. 
malariae: AF488000.1, and P.vivax: XR_003001206.1.  
5.3.9 Statistical analysis 
Statistical analysis was performed using Minitab Ltd® (Brandon Court, Unit 
E1-E2 Coventry CV3 2TE UK), calculating prevalence, sensitivity, specificity, 
PPV and NPV of each of the diagnostic methods. Logistic regression tests were 
performed using risk variables as an independent indicator to assess any asso-
ciations with diseases based on diagnostic tools. For sequencing analysis, it was 
performed using the essential local alignment search tool (BLAST) 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi), and using the Geneious v9.1.5 soft-
ware (Biomatters Limited) package to find matching gene fragments, followed 
by checking the specificity of pre-existing primers and probes.  
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5.4 Results 
5.4.1 General characteristics 
A total of 271 children participating in this cross-sectional survey from May to 
June 2015 were screened; 247/271 (91.1%) met the inclusion criteria and 
were enrolled, mean age of 6.8 years (95% CI 6.6–6.9) with males accounting 
for 124/247 (50.2 %), and females 123/247 (49.7 %). Samples from 24/271 
(8.8 %) children were not available for data analysis; 4/271 (1.4 %) children 
did not provide sufficient blood samples, 6 /271 (2.2 %) children refused to be 
tested on site with RDTs, 7 /271 (2.5 %) children had inhibitors in their faeces, 
2/271 (0.7 %) had low yield DNA extracted from dried blood spots (DBS) on 
filter paper, and 5/271 (1.8%) of children demographic information was miss-
ing. The complete flow of the performed diagnostic tests and results are 
outlined in Figure 29.  
 
Figure 36: Flow Chart of Study Process, demonstrates various stages being taken for analysing 
Plasmodium spp. assay 
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5.4.2 Prevalence of malaria infection 
Of 247 SAC were tested for malaria infection using malaria Ag P.f/Pan test 
(RDTs), 138 (55.8%; 95% CI: 49.6– 61.9) were positive for P. falciparum 
(PfHRP-2-detecting RDTs). Forty-five samples (18.2%; 95% CI: 13.9–23.5) 
were positive for Plasmodium species ( PfHRP-II and pan-pLDH test lines). 
A singleplex rtPCR-based assay for DBS on filter paper was prepared and per-
formed, of which 198 (80.1 %, 95% CI: 74.7–84.6) were positive for any species 
of Plasmodium spp., whereas a singleplex rtPCR-based assay for EPF were 158 
(63.9%; 95% CI: 57.8–69.7). Co-infections among schoolchildren tested deter-
mined by the singleplex Real-Time TaqMan™ assays using eDNA-DBS and eggs 
for S. mansoni detected by two KK thick smears from each a single stool sample 
of two consecutive days were 88 (44.5%; 95% CI: 37.6–51.4) as shown in Table 
19  
Table 19: Prevalence and influence of diagnostic tests for detecting Plasmodium infection in 
primary school children 
 
5.4.3 Geographical distribution of malaria infection  
The trends of malaria prevalence by “Low-High Altitude” and “distance from 
Lake Albert” were mostly similar between the three diagnostic methods, and 
the rate of being diagnosed positive increased significantly by variation in dis-
tance from the Lake within the study sites (p < 0.001 for all three diagnostic 
tools), Figure 5.4.3. The highest rates of malaria infection detection by using 
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Real-Time TaqMan™ assays for eDNA-DBS targeting generic Plasmodium (18S 
gene) was 47 (95.9%; 95% CI: 86.2–98.8) at Busingiro SAC, and for eDNA-EPF 
was 45 (91.8%; 95% CI: 80.8 – 96.7) at Biiso school children. In Low Altitude, 
closest schools to the shoreline, Walukba and Runga , the rate of prevalence 
was low by A RDT 14 (32.5%; 95% CI: 20.4-47.4), 29 (58.0%; 95% CI: 44.2-
70.6), respectively, and by Real-Time TaqMan™ Assays for eDNA-EPF 15 
(34.8%; 95% CI: 22.4-49.8), 19 (38.0%; 95% CI: 25.8-51.8 ), compared to Real-
Time TaqMan™ Assays for eDNA-DBS  33 (76.7%; 95% CI: 62.2-86.8), 42 
(84.0%; 95% CI: 71.4-91.6). In Bugoigo school, the prevalence of malaria by 
Real-Time TaqMan™ Assays for eDNA-EPF was increased 43 (76.7%; 95% CI: 
64.2-85.9), compared to the other two diagnostic tools, see Figure 37. 
 
Figure 37: Estimated prevalence of Malaria infection by altitude and school distance from the 
shoreline. (A) Schematic map of the five sampled primary schools in the Lake Albert region, the 
blue area indicates Lake Albert. (B) Estimated prevalence of Malaria infection by altitude and 
school distance from the shoreline for each examined diagnostic test; prevalence by any 
positive test criterion is also illustrated. 
5.4.4 Correlation between Ct values and the presence of malaria DNA 
The relationship between Ct value of rtPCR-based assays for DBS and Ct value 
of rtPCR-based assays for EPF in diagnosing generic Plasmodium (18S rRNA 
gene), is DBS (Ct) = 26.93 + 0.1763 EPF (Ct) and is statistically significant (P = 
0.01), with R-squared 4.14 % (P < 0.005), and positive correlation as shown is 
r = 0.2 (Figure 38), indicating that when EPF (Ct) increase, the DBS (Ct) also 
tends to increase (p-value <  0.05). 
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Figure 38: Showing the regression between rtPCR-based assays for DBS (Ct) and rtPCR-based 
assays for EPF (Ct) for the singleplex assay to detect generic Plasmodium (18S rRNA gene). The 
red fitted line shows the predicted value and cross line is the cut off 45 Ct. The blue dashed lines 
show the 95% prediction interval. The mean Ct value of EPF (Ct) is 36.3, and DBS (Ct) is 33.3, 
and the actual difference between DBS (Ct) and EPD (Ct) is 2.3 (95 Cl; 1.1-3.5). 
5.4.5 Evaluating diagnostic accuracy in the face of RDT as ‘gold standard’ 
Using RDT as ‘gold standard’ Table 20, the estimated sensitivity of rtPCR-based 
assays for DBS targeting generic plasmodium is 94.2% (95% CI: 88.9-97.0), 
with diagnostic odds 9.7 (95% CI; 4.3 - 22.0), while rtPCR-based assays for EPF 
is 73.1% (95% CI: 65.2-79.8), and diagnostic odds 2.4 (95% CI: 1.4 - 4.2). The 
specificity for DBS was 37.6% (95% CI: 29.0-46.9), and the PPV of 65.6% (95% 
CI: 58.8-71.9) and NPV of 83.6 % (95% CI: 70.9-91.4), with agreement (Cohen’s 
kappa) was 0.3 (95% CI: 0.2- 0.4). rtPCR-based assays for EPF had specificity 
of 47.7 % (95% CI: 38.5-57.0), PPV of 63.9 % (95% CI: 56.1-71.0) and NPV of 
58.4 % (95% CI: 48.0-68.1), with agreement (Cohen’s kappa) was 0.2 (95% CI: 
0.1-0.3).  
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Table 20: Empirical estimates of sensitivity (SS), specificity (SP), negative predictive value 
(NPV) and positive predictive value (PPV), Cohen’s kappa for each diagnostic test against ma-
laria by RDT as ‘gold standard.’ 
 
 5.4.6 Geographical distribution of Plasmodium species   
Multiplex PCR that detects the four most common human Plasmodium species 
(P. falciparum, P. vivax, P. ovale, and P. malariae) using four different specific 
probes for Real-Time TaqMan™ Assay (Table 21).  
Table 21: Distribution of Plasmodium species across study sites using TaqMan® probe-based 
assays 
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5.5 Discussion 
5.5.1 Non-invasive surveillance for Plasmodium in non-human primates 
Owing to the difficulty of obtaining blood samples from great apes and other 
non-human primates, mapping the diversity of Plasmodium parasite infections 
from this group has relied almost solely on PCR-based detection of DNA ex-
tracted from faeces (Kaiser et al., 2010, Liu et al., 2010a, Liu et al., 2014, 
Boundenga et al., 2015, Plenderleith et al., 2018). Extraction of Plasmodium 
DNA from whole blood was only necessitated when whole genome sequencing 
(WGS) was to be carried out, and must be done so under sedation and with eth-
ical approval (Otto et al., 2014, Otto et al., 2018, Sundararaman et al., 2016, 
Pasini et al., 2017, Rutledge et al., 2017).  
In general, monitoring Plasmodium spp. infections in non-human primates 
from faecal samples is carried out using single genome amplification (SGA), fol-
lowed by direct sequencing of SGA amplicons; a procedure developed to elimi-
nate Taq polymerase template-switching which can result in recombinants that 
do not exist naturally (Liu et al., 2010b). Initial bulk PCR of fDNA samples first 
identifies samples with amplifiable Plasmodium spp. mitochondrial, apicoplast, 
and nuclear sequences. Bulk PCR-positive faecal samples are then selected for 
SGA analyses, with the original faecal sample diluted beforehand in nuclease-
free water, again to avoid Taq polymerase artefacts and the possibility of skew-
ing PCR results in favour of a predominant Plasmodium species infection (in 
cases where multiple species may be present)(Liu et al., 2010b). Using this SGA 
approach, in combination with primers specific for Plasmodium mitochondrial 
cytochrome B (cytB) sequences, nuclear gene sequences (such as erythrocyte-
binding antigen 165 (eba165) and gametocyte surface protein p47 (p47)), or 
apicoplast gene sequences (such as Clp chaperone M (clpM)), analyses of nearly 
3,500 SGA-derived sequences from both faecal and blood samples have been 
used to confirm the existence of six Laverania spp. (a Plasmodium subgenus) 
among non-human primates (Liu et al., 2016, Loy et al., 2017). 
5.5.2 Validation of a PCR-Based Test for the detection of Plasmodium spp 
In the present study, DNA samples derived from both faecal (EPF) and dried 
blood spot (DBS) samples were subject to real-time PCR as described in Sho-
koples et al., 2009 (a non-SGA approach) (Shokoples et al., 2009). Initially, ge-
nus-specific Plasmodium 18S rRNA sequence primers were used to detect the 
presence of a Plasmodium spp. infection, with Plasmodium spp.-positive sam-
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ples subject to further species-specific rtPCR analyses to determine the pres-
ence of either P. falciparum, P. vivax, P. malariae, P. ovale (both subspecies) or 
a mixed infection (Rougemont et al., 2004) (Table 18).   
Using these criteria, 198 of 247 children (80.1%; 95% CI: 74.7-84.6) tested pos-
itive for a Plasmodium spp. infection from DBS samples, with 158 of 247 chil-
dren (63.9%; 95% CI: 57.8-69.7) testing positive for a Plasmodium spp. 
infection using EPF-derived DNA (Error! Reference source not found.). Tak-
ing these data alone, both DBS- and EPF-derived DNA, followed by rtPCR diag-
nosis, identified more cases of Plasmodium spp. infection compared to the Ag 
P.f/Pan RDT, which tested positive for a P. falciparum infection (taking PfHRP-
II as a proxy) in only 138 children (55.8%; 95% CI: 49.6-61.9), with a pan Plas-
modium spp. lactate dehydrogenase (pLDH) detected in only 45 cases (18.2%; 
95% CI: 13.9-23.5). Assuming rtPCR data to be correct (no false positive 
results), discrepancies between these numbers may be accounted for by one of 
two reasons: (i) the increased sensitivity of PCR diagnosis compared to even 
the most sensitive of RDTs (Britton et al., 2016); or (ii) the failure of the Ag 
P.f/Pan RDT (detecting PfHRP-2/pan HRP-2) to detect the target antigen due 
to variation in, or deletion of, the histidine-rich repeat region of the hrp2 gene, 
an issue that has been documented in P. falciparum  (Koita et al., 2012, Deme et 
al., 2014, Okoth et al., 2015). Diagnosis of a Plasmodium spp. infection by a 
pLDH-positive result was an even less reliable method of detecting malaria, de-
spite the observed low genetic diversity of the P. falciparum ldh gene 
(Simpalipan et al., 2018).  
5.5.3 Altitude-variations in Plasmodium spp. prevalence 
Taking altitude and distance from Lake Albert into account, the highest preva-
lence of Plasmodium spp. infection by any method was at Busingiro school, 
where 47 out of 49 pupils (95.9%; 95% CI: 86.2-98.8) tested positive by rtPCR-
based assay of DBS samples (Figure 37). In contrast, only 73.4% (95% CI: 65.2-
79.8) of the same pupils tested positive for a Plasmodium spp. infection by 
rtPCR-based assay of EPF samples. The highest result for rtPCR-based detec-
tion of Plasmodium spp. DNA from EPF samples was at Biiso school, where 
91.8% of pupils tested positive for a Plasmodium spp. infection, with a similar 
number (89.8% of pupils) testing positive using rtPCR-based assay of DBS sam-
ples. Strikingly, in all but one case (at the Runga school) both rtPCR-based as-
says using either DBS or EPF samples proved more sensitive in the diagnosis of 
a malaria parasite infection than an Ag P.f/Pan RDT. These findings confirm 
those previously seen by Jirků et al.(Jirků et al., 2012), in that this study showed 
that Plasmodium spp.-infected humans shed a detectable amount of Plasmo-
dium spp. DNA in their faeces for PCR-based amplification and diagnosis.   
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Unlike in previous studies where P. falciparum infection and parasite density 
was negatively associated with rising altitude (Drakeley et al., 2005, Chandler 
et al., 2006, Pothin et al., 2016, Omondi et al., 2017), our study found that the 
highest percentages of Plasmodium spp. detection by Real-Time TaqMan™ -
based assay of DBS samples and RDTs were at Busingiro (95.9% of pupils) and 
Biiso (91.8% of pupils) respectively, both regions being at higher altitudes and 
at a greater distance from Lake Albert compared to the three remaining sites 
(Figure 37B). In both cases, Real-Time TaqMan™ -based detection of Plasmo-
dium spp. from EPF samples detected a higher percentage of infection than 
RDTs; at Busingiro, 73.4% diagnosed by Real-Time TaqMan™ -based assay 
from EPF compared to 65.3% by RDTs, and at Biiso; 91.8% diagnosis by Real-
Time TaqMan™ -based assay from EPF samples, compared to 67.3% diagnosis 
by RDTs.  
At lower altitudes, and adjacent to Lake Albert, rtPCR-based assay of DBS sam-
ples demonstrated a greater detection of Plasmodium spp. infection when com-
pared to RDT detection at all sites (Figure 37B). However, rtPCR -based detec-
tion of Plasmodium spp. DNA from EPF samples were unpredictable. At 
Bugoigo, DNA extracted from EPF samples detected the greatest percentage of 
Plamodium spp. infection (76.7% of pupils) compared to both rtPCR-based as-
say from DBS samples or RDTs (57.1% and 53.5% respectively). At Runga, 
rtPCR-based assay of EPF samples detected the lowest percentage of Plasmo-
dium spp. infection (38.0%) compared to RDTs (58.0%) or rtPCR-based assay 
of DBS samples (84.0%). At the lowest altitude, and in closest proximity to the 
water’s edge at Lake Albert, Walukuba school pupils tested positive for a Plas-
modium spp. infection in 32.5% of cases using RDTs, with rtPCR analysis of 
EPF-extracted DNA faring better with 34.8% detection. At Walukuba, rtPCR-
based assay of DBS samples demonstrated the greatest percentage detection, 
at 76.7%. At all five sites, rtPCR-based detection of Plasmodium spp. DNA from 
DBS samples diagnosed more pupils than RDT-based diagnosis, with the rtPCR-
based assay of EPF samples detecting a greater percentage of Plasmodium in-
fections at 4 out of 5 sites.  
5.5.4 Analytical specificity and sensitivity of a rtPCR-Based assay  
When determining the sensitivity and specificity of rtPCR-based assays; an 
initial evaluation of cycle threshold (Ct) values showed that there was a positive 
correlation between DBS- and EPF-derived samples (r =0.2), with a mean EPF 
Ct value of 36.3, and a mean DBS Ct value of 33.3 (Figure 38). When correlating 
these results to RDT diagnosis as our ‘gold standard’, rtPCR-based assay of DBS 
samples showed a greater sensitivity than EPF samples (94.2% versus 73.1%), 
with rtPCR of DBS samples having a specificity of 37.6% and a PPV of 65.6%. In 
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contrast, the specificity of the rtPCR-based assay of EPF samples was 47.7%, 
with a PPV of 63.9% (Table 20). Overall, the diagnostic accuracy of a rtPCR-
based assay of DBS samples was 69.2% (95% CI: 63.2-74.6) and for EPF sam-
ples was 61.9% (95% CI: 55.7-67.7). Therefore, EPF samples in this study 
proved less diagnostically accurate and had lower sensitivity when compared 
to DBS samples when diagnosing infection of a parasite of the Plasmodium ge-
nus. However, one must take into consideration that PCR analysis and 
microscopy are generally considered more accurate in the diagnosis of a 
malaria infection in all cases besides a P. knowlesi infection, and so, without 
microscopy results in addition to RDT results, it is unknown in our case 
whether both rtPCR-based assays in fact detected a greater number of cases 
accurately (Figure 37) in incidences where RDTs failed to detect a Plasmodium 
antigen(Mahende et al., 2016, Han et al., 2017, Mogeni et al., 2017).   
5.5.5 DNA-based species-specific assays 
In the next phase of our examination, i.e. when attempting to determine Plas-
modium species using species-specific primers (Rougemont et al., 2004) for 
Real-Time TaqMan™ -based analyses of both DBS- and EPF-derived DNA, three 
species of Plasmodium (P. falciparum, P. malariae, and P. ovale (either subspe-
cies)) were identified from DBS samples (Table 21). The presence of P. vivax 
was not detected in this study, in keeping with findings from previous studies 
in the same region (Betson et al., 2018). When examining EPF samples, and us-
ing the same probe-based assays, the rtPCR analysis failed to detect the pres-
ence of either P. vivax or P. ovale subspecies (though a total of 16 pupils tested 
positive for P. ovale DNA from DBSs). In the case of P. malariae, rtPCR-based 
assays from both DBS and EPF samples detected 9 cases (3.6% of the total num-
ber of pupils). However, when testing for P. falciparum DNA, rtPCR of EPF sam-
ples identified only 18 cases, though 111 cases were identified using DBS sam-
ples (Table 21). When using the same primers, Shokoples et al. (Shokoples et 
al., 2009) demonstrated a sensitivity and specificity of 100% in 91 single infec-
tions, with 13/16 mixed infections successfully identified. Assuming 100% sen-
sitivity and specificity of these Real-Time TaqMan™ probe-based assays, spe-
cies-specific multiplex PCR using DNA extracted from EPF samples was not suf-
ficient to accurately identify species-specific Plasmodium spp. infections. 
Analysis of the target sequence in the 18S rRNA gene using reference gene for 
each species revealed flaws in species-specific TaqMan™ Assay as for three spe-
cies (P. falciparum, P. malariae, and P. ovale) were correctly identified by using 
DNA extracted from DBS samples. However, the infections with these species 
(P. malariae, and P. ovale ) may be missed by the 18S rRNA-based PCR diagnos-
tic method in the presence of deletions and mutations in the 18S rRNA-based 
157 | P a g e  
 
target sequences (Appendix 5 Page-160). Thus, it can be concluded that in ad-
dition to molecular biological methods for the detection and characterisation 
of Plasmodium spp, careful microscopic examination of stained thin blood films 
is still essential in high-prevalence malaria regions, including sub-Saharan Af-
rica for identifying different malaria species (Kawamoto et al., 1996, Zhou et al., 
1998).  
Despite these results, the sensitivity and specificity of a rtPCR-based assay us-
ing EPF samples, with Plasmodium spp. genus-specific primers were similar to 
those seen when using DBS samples (using the P.f/Pan RDT as a ‘gold stand-
ard’) (Table 20). In addition, Plasmodium spp. identification from faeces could 
be carried out in tandem with tests for schistosomiasis and STHs, and is a less 
invasive (and possibly more accurate (Figure 37B) method of determining ma-
laria status when compared to DBS samples and RDTs, especially in small chil-
dren who are most at risk when infected with a Plasmodium parasite(Jirků et 
al., 2012)  
In addition, in both this study and that of Jirků et al., 2012 carried out, PCR-
based analysis of Plasmodium spp. DNA using an initial ‘bulk’ PCR approach, in 
contrast to the limiting dilution and SGA procedure that has become a mainstay 
in the identification of Plasmodium spp. DNA from the faeces of non-human 
primates (Liu et al., 2010b, Liu et al., 2016, Loy et al., 2017). Future 
examinations using this protocol, alone or in combination with more sensitive 
rtPCR probes (Dormond et al., 2011, Gavina et al., 2017), may prove more 
sensitive in both genus-specific and species-specific Plasmodium spp. detection 
and identification from human faecal samples. Advances in handheld rtPCR 
equipment may also provide an avenue by which these diagnostics can become 
more portable and affordable in field conditions (Ahrberg et al., 2016, Li et al., 
2016). What is evident from our results is that, in accordance with the findings 
of Jirků et al., human faecal samples, even those transported as EPF samples for 
diagnosis of schistosome or STH infections, contain sufficient Plasmodium spp. 
DNA to enable Real-Time TaqMan™ -based identification of malaria parasite 
infection.         
5.6 Conclusions  
According to the studies, the sensitivity thresholds of the different PCRs 
targeting the Plasmodium genes vary from 0.001 to 30 parasites / μl, whereas 
microscopy when correctly performed at a detection threshold of 50-100 
parasites / μl, and RDTs ranging from 50 to 1000 parasites / μl. In addition, 
microscopic diagnostic performance is closely related to the microbiologist 's 
experience, reading time, and intensity of parasitaemia so that microscopic 
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examination may be negative in pauciparasitic forms. Hence the introduction 
of molecular biology techniques should be explored which are more sensitive 
and more specific. It should be noted that internal control of inhibition was 
used for all the samples of our study to detect the false negative results by the 
rtPCR. This discordant results would probably be related to an error of 
identification of Plasmodium spp by RDTs, compared to DBS or EPF that the 
level of parasitaemia was low and under the threshold of detection. Multiplex 
PCR has demonstrated the existence of a mixed P. falciparum, P.ovale and P. 
malariae infection among SAC, the RDTs of which only allowed the diagnosis of 
P. falciparum and mixed infection. In this sense, different studies have shown 
that PCR is more sensitive and more specific than RDTs examination for the 
detection of mixed infections (Siwal et al., 2018). The multiplexed PCR used 
saves time and reagents by using multiple primer pairs; allowing the detection 
of the four malaria species in a single stage. In addition, this technique is 
suitable for a large number of blood samples, which would allow it to be applied 
to malaria screening in subjects from endemic areas. Nevertheless, although 
the introduction of PCR in malaria screening is fascinating, the cost of this 
molecular technique remains high compared to the microscopic examination 
which represents the reference technique for malaria, schistosomiasis and 
STHs. Also, PCR requires equipment that is only available in undoubtedly 
specialised laboratories.  
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6.1 Abstract 
Background: Schistosomiasis, a well-known disease in the Kingdom of Saudi 
Arabia, is a major public health challenge in the Middle East regions, especially 
in Asir Province, the southwestern part of Saudi Arabia. Within the WHO 2012-
2020 Roadmap on NTDs has set control and elimination of schistosomiasis by 
the scale-up of MDA with PZQ, snail control using chemical molluscicides, and 
early detection and treatment of infected cases, which has led to change the 
epidemiological landscape across the Kingdom of Saudi Arabia.  
Methods: To develop better monitoring protocols, two commercially available 
diagnostic tests –Urine- CCA strip and SEA-ELISA – were evaluated for detec-
tion of Schistosoma infections in 163 schoolchildren from two primary schools 
(Huzaifa Ibn al-Yaman and Ibn al-Athir schools) representative of disease 
endemicity at Al-Majardah District in Saudi Arabia. DNA analysis using the 
COX1 gene combined with the morphological identification of snail species was 
also implemented in this study. In an attempt to characterise infection status 
further, urine filtration assessment with microscopy and CCA-testing was also 
used in a follow-up survey for children being positive in the baseline.  
Results: DNA analysis using the COX1 gene combined with the morphological 
identification of snail species demonstrated the presence of Bulinus forskalii in 
the selected study area and absence of Biomphalaria during malacological sur-
veys. Using urine-CCA strip assessment and SEA-ELISA, the prevalence of S. 
mansoni was 15.3% and combined S.mansoni/haematobium 34.3%, 
respectively. Using the CCA-urine as a reference test, the diagnostic scores of 
the SEA-ELISA using sera from fingerprick blood were not satisfactory; a 
sensitivity of 60.0%, a specificity of 70.2 %, a PPV of 26.7 %  and a NPV of 90.6 
%. At the unit of the school, statistical tests were performed, which showed no 
apparent relationship between age and inferred from CCA or ELISA tests (P > 
0.05). In the following up, one year later, standard urine filtration assessment 
with microscopy and CCA-testing did not reveal active infections, pointing 
toward the importance of past infection and prior treatment status.  
Conclusions: The SEA-ELISA test holds promise as a complementary field-
based test for monitoring the effectiveness of preventive and infection control 
programs in schoolchildren over and above standard examined methods 
especially when current and previous infection status is considered negative. 
Keywords: schistosomiasis, elimination, a freshwater snail, point-of-contact, 
urine-CCA strip, SEA-ELISA, Kingdom of Saudi Arabia  
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6.2 Introduction 
Schistosomiasis is a parasitic disease, caused by platyhelminth worms, schisto-
somes, o more commonly known as  ‘blood flukes’ (Hotez et al., 2008, Colley et 
al., 2014). Over 66.5 million people were treated for the disease in 2015 (WHO, 
2016a).  It is the second most common parasitic disease globally after malaria,  
and is listed in the WHO portfolio of NTDs (WHO, 2015c, WHO, 2016a). World-
wide, the number of people thought to be infected with S. haematobium is ap-
proximately 112 million and for S. mansoni 54 million (Koukounari et al., 2007). 
It can cause various symptoms, depending on the chronicity of infection, the 
level of infection and the individual. Chronic infections can lead to anaemia, 
learning difficulties and in severe cases even death (Helmy et al., 2017, Colley 
et al., 2014). Urogenital and gastrointestinal pathology can also occur, the 
symptoms of which may include haematuria, genital lesions, abdominal pain 
and diarrhoea (Gray et al., 2011a). Bladder cancer has also been reported in the 
late stages of infection (Mostafa et al., 1999, Marbjerg et al., 2015).  
Schistosoma mansoni and S.  haematobium are commonly found in Africa as well 
as the Middle East, and both species being detected in the Kingdom of Saudi 
Arabia (KSA) (Lotfy and Alsaqabi, 2010, El-Shahawy et al., 2016, Barakat et al., 
2014). Schistosomiasis has been reported in Saudi Arabia since the first S. 
haematobium case was confirmed in 1887, but it is believed that the disease in 
Saudi Arabia has been endemic since the 10th century (Barakat et al., 2014, 
WHO, 1993). When the first national survey was carried out for 
comprehensively tracking schistosomiasis and its intermediate host 
distribution (s) across countrywide in Saudi Arabia, estimated overall 
prevalence was 17%. However, it was thought by other surveyors that this 
statistic was an over-estimate owing to geographical complexity of the disease 
due to the relative risks associated with a unsafe water source in urban centres 
and the Eastern region, and the focal nature of the disease in rural areas, which 
should be better delineated for better strategic control and prevention at local 
levels (Lotfy and Alsaqabi, 2010). 
There are different specific types of freshwater snails serving as intermediate 
hosts for Schistosoma spp. in Saudi Arabia: (1) Biomphalaria pfeifferi– 
presented  in perennial and intermittent streams, rivers, lakes, reservoirs, and 
ponds  in Northern, Northwestern, Southwestern, Mid-northern, and Mid-
southern areas; (2) Bulinus beccarii – found in shallow slow running perennial 
and intermittent streams, and created bodies of water, including ponds in 
Western and Southern provinces; (3) Bulinus truncatus – is abundant on stones 
and masonry surroundings small pools practically lacking water plants, and 
more common species  in the Mid-western and Southern areas; (4) Bulinus 
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wrighti – present in most common on clean rock surfaces in the shade far from 
human settlement, and  according to Brown and Gallagher (1985), this species 
of snail appears less ecologically specialised and restricted to pristine habitats, 
and therefore, unlikely important in human disease transmission in general, 
although it is a permissive intermediate host for S. haematobium and widely 
used in the experimental laboratory (Lotfy and Alsaqabi, 2010, Brown et al., 
1985, Arfaa et al., 1989, Amr and Alshammari, 2012, Mostafa et al., 2012, Bin, 
2009); (5) Bulinus forskalii  is one of Bulinus species that has  complex genetic 
variations, and is typically responsible for the transmission of non-human 
Schistosoma in Africa and adjacent endemic areas (Jones et al., 2001), and its 
distribution remains unclear due to insufficient data of many parts of the 
Arabian Peninsula, particularly in KSA (Jones et al., 2001, Neubert, 1998, Amr 
and Alshammari, 2012).   
The national programme to control schistosomiasis (bilharzia) in KSA is 
focused on the detection and PZQ treatment of infected cases, snail control, and 
health education which led to a considerable decrease in the prevalence of the 
disease  in most regions of Saudi Arabia (Ashi et al., 1989, WHO, 1993, Ageel 
and Amin, 1997, Fenwick et al., 2006, Hotez et al., 2012). Earlier in environ-
mental control, copper sulphate was the first substance used to control snails. 
Also, the available drugs being used to treat infected people included antimo-
nials, niridazole and then later metrifonate; however, when PZQ was 
introduced in 1982 (Ashi et al., 1989), it replaced all these drugs, and from that 
point onward being used in mass control, the prevalence of schistosomiasis in  
Saudi Arabia declined significantly (Hotez et al., 2012). The prevalence in 1983 
was 9.8% which reduced to  0.6% in 2004, because of regular treatment of all 
risk groups with PZQ alongside treating identifiable sites of frequent human 
contact with snail-infested waters (Lotfy and Alsaqabi, 2010). In 2005, the 
elimination control program for schistosomiasis was launched in KSA, 
targeting 12 remaining focal transmission sites (Lotfy and Alsaqabi, 2010). 
The strategy for elimination included: active case detection and treat-
ment of 80–100% of the endemic population; biannual-directed treatment of 
80-100% children of school-age; availability of adequate water supply and 
sanitation as well as good hygiene to endemic communities; snails control 
with chemical molluscicides; and finally, health promotion and ill-health pre-
vention by health education (Kloos, 1995, McCullough, 1986, Fenwick, 1987, 
WHO, 1993).  In 2008,  the WHO Department of Control of NTDs convened up 
to 30 global experts and country representatives  where schistosomiasis has 
been under control for a long time which could contribute to the future expan-
sion of strategies for monitoring schistosomiasis in very low-transmission re-
gion as well as criteria for examining and evaluating  disease elimination (WHO, 
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2009a). As of 2010, the estimated country prevalence (%) of schistosomiasis in 
2010 dropped quickly to <0.01%  in Saudi Arabia (Rollinson et al., 2013). Areas 
within Saudi Arabia today are classed as a) disease free; b) transmission inter-
rupted; c) low transmission (Figure 39) (Stothard et al., 2014).  
 
Figure 39: An outline map of the KSA with capital Riyadh depicted. Major administrative 
boundaries are shown, and the associated status of Schistosomiasis therein is indicated by 
shaded circles. (A) Al-Jouf; (B) Tabuk; (C) Hail; (D) Al-Madena and Al Monawarah; (E) Al Qasim; 
(F) Riyadh; (G) Najran; (H) Tardif, Makkah, Jeddah, Al Qunfudhah and Alith; (I) Bishah and Asir 
(J); Jazan (K) (Stothard et al., 2014)  
Asir Province (see J in Figure 39) is in the southwestern part of KSA, bordering 
Yemen in a very limited area. Topographical classification of this Region has 
led to difficulties in controlling schistosomiasis as it is comprising of vast and 
steep rocky mountains, Asir Plateau which is very suitable for ﬂourishing of 
snail breeding sites, and the coastal plain is known as Tihama (Figure 40A). 
This topography leads to disseminating the snails from the high -lower areas 
(Al-Madani, 1991). In this scenario, there is a requirement for more sensitive 
and field-based methods for the detection of Schistosoma infection in people as 
well as in snails. Unfortunately, parasitological diagnosis, which lacks sensitiv-
ity, within a community is still one of the mainstays in planning, implementa-
tion and sustainability of MDA, and guidelines for evaluating the schistosomia-
sis control in subject areas (Bergquist et al., 2009, Cavalcanti et al., 2013, Knopp 
et al., 2013). Importantly, there is no one generic diagnostic tool for monitoring 
and evaluating the current status of infection prevalence that can be entirely 
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accurate or reliable to detect any infected person for achieving elimination 
stages (Bergquist et al., 2009). 
As KSA has started moving from schistosomiasis control towards elimina-
tion and eradication, careful consideration and planning are essential 
(Rollinson et al., 2013, Barakat et al., 2014). As an alternative to replace time-
consuming parasitological examinations is presently available, the point-of-
contact (POC)-tests, urine-CCA and SEA-ELISA  seem to be appropriate tests for 
implementation in low-transmission settings (Stothard, 2009, Stothard et al., 
2009, Grenfell et al., 2014).  
Without such a reliable test, future monitoring and evaluation of the 
performance of control programmes involves assessing the different 
transmission settings,  characterised by ‘light’ egg-patent infections have 
become ever more required as several hundreds of children are needed to be 
screened quickly and easily in this manner to draw a conclusion about whether 
or not intensive or more preventive control actions are needed (Stothard et al., 
2014). In the present context of control, there is also a need for better 
documentation of snail species in such a country like KSA, where there is a lack 
of information about contemporary snail’s distribution. This work, therefore, 
sought to employ morphological and molecular characterisation of snails 
targeting the mitochondrial  COX1 gene for identification of encountered snails 
and their distribution alongside the main river at Al-Majardah district in South-
Western Saudi Arabia. Also, contemporary disease surveillance data to assess 
putative transmission of schistosomiasis was explored by assessing the preva-
lence of schistosomiasis in two selected school’s locations, and comparing the 
results of different diagnostic tests: CCA-urine test and SEA- ELISA, using the 
CCA-urine as a reference test. 
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6.3 Methodology  
6.3.1 Study site 
Saudi Arabia is in the south-west of the Asian continent and is the largest coun-
try in the Middle East. It occupies four-fifths of the Arabian Peninsula covering 
an area of 2.25 million km2. According to the system of regions issued, this 
country has been divided into 13 administrative regions. The schistosomiasis 
control programme is operating across all primary schools in 11 regions (Fig-
ure 40), including Asir region (J). For this study, two primary schools at Al-
Majardah district (Huzaifa ibn al-Yaman Primary School, and Ibn al-Athir Pri-
mary School) were purposively selected based on previous S. haematobium 
prevalence data, and their geographical locations to the known disease-trans-
mission zone. Huzaifa ibn al-Yaman represented a low/non-transmission zone; 
Ibn al-Athir represented a suspected- transmission zone (Figure 40 B). The 
study was carried out in early December  2016, approximately one month after 
the last round of vector control teams with annual diagnostic and monitoring 
in both schools. 
 
Figure 40: A map of administrative boundaries for Asir province with pointing study sites. A,  
a map of administrative boundaries for Asir province with red dots indicating three capital 
cities (Abha, Khamis Mushayt, and Bishah) (Alshahrani et al., 2016), and study area (Al-
Majardah district) highlighted with red circular (GPS co-ordinates: 19°06'18.2"N, 
41°55'46.2"E). B: An outline map of a total number of snails collected at each monitoring site, 
and a map of the two schools inspected with an arrow showing water flow from mountains 
down to the coastal plain known as Tihama. The primary schools of Huzaifa ibn al-Yaman are 
located around 17 Km away from Al-Majardah town (GPS co-ordinates: 19°02'57.8"N, 
41°46'38.6"E), and Ibn al-Athir is around 4 Km (GPS co-ordinates:19°05'22.1"N, 
41°57'25.9"E). The distance between two schools approximately 20 Km, and both schools lo-
cated close to the main river at Al-Majardah district. 
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6.3.2 Surveys for freshwater snail populations  
It is during the warm and wet season of the year (a period of local people 
frequently contact with rivers and other natural water resources which are 
abundant) that shoreline of the main river at Al-Majardah district is considered 
a space of at-risk status. The malacological surveys were conducted in the mid-
dle of the season in December 2016 on a diverse set of sampled locations within 
this river to identify the potential transmission sites. 17 sites were prospected, 
each of these sites being likely to be used or frequented by the local human 
populace. As such, each site can be a favourable site for the transmission of 
schistosomiasis as intermediate hosts (i.e. Bulinus) were present ( 
Figure 41). A standard snail scoop was used at each location, water pH and 
conductivity (µs) were measured as well in each site using a hand-held water 
meter (Hanna pH environmental combo-meter). Potential aquatic and difficult 
access sites were sampled by hand. All molluscs present were systematically 
collected, identified and kept for morphological analysis. All snails stored later 
in pure ethanol according to collection location within a labelled Conical Cen-
trifuge Tubes (Thermo Scientific Nunc 339653 Conical Centrifuge Tubes 
300/CS, RACKED 50 mL) for later species identification (Figure 41 D). 
.  
Figure 41: A - Photographed representing one study site nearby Huzaifa ibn al-Yaman primary 
school (GPS co-ordinates: 19°01'08.5"N 41°46'12.8"E), around 4Km away from school. B: 
Measuring surface-water chemistry and collecting snails around this site (500 square meters). 
C: Snails found on the stones which are common in these areas (148-Freshwater gastropods of 
the genus Bulinus collected from this site). D: Alive snails kept for morphological analysis to 
identify snail species and cercariae by using the dissecting microscope in the Vector Control 
Laboratory at Al-Majardah District 
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6.3.3 Selected schools and participants 
After explaining the objectives of this study with the vector control division at 
Asir region, two schools were chosen based on their location, and prior infor-
mation on schistosomiasis infection status. First, written informed consent was 
obtained from the headteacher of selected schools (Figure 42). Informed oral 
consent was obtained from the children attending grade 1-6 (typically aged be-
tween 7 and 12 years) before randomly screening all eligible children from 
each school (112 boys from Huzaifa Ibn al-Yaman primary school, and 51 boys 
from Ibn al-Athir primary School), following guidelines released by the WHO 
(Montresor et al., 1998). Each child then gave a mid-morning urine specimen 
in a 250-ml plastic container (Thermo Scientific™ Urine Specimen Container) 
(Figure 42C), and a finger-prick blood sample was taken using a disposable 
safety lancet (Haemolance Plus® Safety Lancets (PACK OF 50)) and Gilson pi-
pette (Gilson® P10, STARLAB) (Figure 42D). Finally, each child was asked four 
questions; full name (i) data of birth, (ii) location of living, (iii) duration of 
attendance at this school, and (iv) previous anthelminthic treatment (s).  
 
Figure 42: Enrollment and participation in research at the study sites. A: participating children 
in the survey, and discussing any concerns with oral health staff, and the headteacher at Hu-
zaifa Ibn al-Yaman school, following school-based survey protocol for NTDs control (Montresor 
et al., 1998). B: setting up the equipment for data collection and sampling. C:  participants pro-
vided a mid-morning urine specimen in a 250-ml plastic container. D: is taking a finger-prick 
blood sample using a disposable safety lancet 
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6.3.4 Field-based evaluation of POC-CCA urine test  
The urine-CCA strip tests were used according to the protocol supplied by man-
ufacturer’s Rapid Medical Diagnostics, Pretoria, South Africa. In brief, a total of 
163 individual urine samples were each tested by mixing with two drops of 
provided hydration buffer then dropped onto the plastic cassette containing 
labelled antibodies, and then the strip was incubated at room temperature. Af-
ter an incubation period of 20min, the test line for each urine-CCA strip was 
compared against that of the ﬁve quality control standards (Figure 6.3.4E); a 
negative test criterion was based upon a test line either not visible or weaker 
than standard, while the internal control line was visible (Figure 6.3.4 C, D). 
An antigen-antibody complex forms as the liquid moves along the cassette and 
fixes to another monoclonal antibody. If positive, a pink line appears on the 
strip. The strength of the pink line correlates to the intensity of schistosome 
infection. So, The test result was classified by visual inspection against a colour 
chart as used previously (Sousa-Figueiredo et al., 2013), by two individuals as 
negative, trace (±), light positive (+), medium positive (++) and heavy positive 
(+++).  
 
Figure 43: A- Urine and blood sample examination at Primary Health Care (PHC) public ser-
vices in Tharban (GPS co-ordinates:19°03'20.9"N 41°47'09.6"E), around 3,708.64 ft away from 
Huzaifa Ibn al-Yaman primary school, where urine sample examination was performed. B: 
checking all labelled and the turbidity of the collected urine samples from participants. 
Detailed photograph of POC-CCA cassettes with control and result bands. To the left (C), POC-
CCA shows the results for some infected SAC with schistosomiasis at Huzaifa Ibn al-Yaman 
school. To the right (D), POC-CCA shows the results for SAC at Ibn al-Athir school. E: POC-CCA 
shows classified visually into four infection status groups.  
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6.3.5 Finger-prick blood SEA-ELISA 
A commercially available ELISA kit (IVD Inc.; Carlsbad, USA) was evaluated to 
detect host antibodies (IgG/M) againts soluble egg antigens (SEA) using a field-
based ELISA test following manufacturer’s instructions (Check chapter 2 for 
assay protocol, (Appendix 1 Page-92). A disposable lancet was used to 
withdraw approximately 100 µl of a finger-prick blood sample from each child 
and stored in a 1.5ml Eppendorf tube at room temperature (Figure 44 A). After 
2 hours, the samples were centrifuged for 3 minutes at 9,000 rpm, and serum 
from each child was harvested. 2 µl of harvested serum was then collected and 
diluted in 2:80 with specimen dilution buffer before loading a total of 100 µl 
into each ELISA micro-well. Upon completion,the micro-titre plate was placed 
on a white card to view the visual colour of each reaction as graded into pale 
yellow (light positive), yellow (medium positive) and dark yellow (heavy 
positive) (Figure 44 C),  upon visual comparison with the control sera as 
recorded previously (Stothard et al., 2009). Two laboratory technicians 
analysed the colour change to improve reliability.  
 
Figure 44: A field-based ELISA test using the treated SEA to detect specific antibodies to SEA 
in the sera of eligible children. A: Withdraw approximately 100 µl of a finger-prick blood 
sample from each child and stored in a 1.5 ml Eppendorf tube for performing a field-based 
ELISA test following the manufacturer’s instructions by Hajri Al-Shehri. B: shows the schools 
sites alongside the bank river (1; Huzaifa ibn al-Yaman, and 2-Ibn al-Athir schools). C: ELISA 
plate is demonstrating colour change (apparent to yellow), indicating schistosome antibody 
detection in SAC study at Huzaifa ibn al-Yaman, including two positives and two negatives 
control 
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6.3.6 DNA Methods  
gDNA was extracted from 21 snails (one snail from each site including identi-
fying snails for control) using the CTAB method as described by Stothard & Rol-
linson et al. (Stothard and Rollinson, 1997) (see Appendix 6 Page-190). Ex-
tracted DNA was re-dissolved in 0.1TE buffer (TE Buffer contains 1M Tris-HCl 
(pH approximately 8.0), containing 0.1M EDTA, Cat. 12090015, Thermo Fisher 
Scientific), and stored at 4oC until being used. Fragment of the gene CO1 was 
amplified from nucleic acid extraction by PCR. A co1 region was amplified using 
forward primer CO1-LC1490 (5'GGT CAA CAA ATC ATA AAG ATA TTG G 3'), and 
reverse primer CO2-HCO2198 (5'TAA ACT TCA GGG TGA CCA AAA AAT CA 
3')(Kane et al., 2008). The PCR conditions were: initial denaturing step at 95◦C 
(3 min) followed by 50 cycles of denaturing, annealing and extension of 95◦C 
(15 s), 60◦C (20 s), 72◦C (25 s), with a final extension step at 72◦C (2 min).  
A master mix was made up with 1.6 μL of each a 10 μM primer working solu-
tion, and 21.4 μL of Nuclease-Free water (Sterile, RNase and DNase Free, 3098-
2ML, UK) dissolving in PuReTaq Ready-To-Go PCR Beads (GE Healthcare, 
27955702, solid, Sigma), and 2 μL of DNA was finally being added to each PCR 
tubes. The PCR was run on one plate, included a number of controls: extraction 
of TE (10 mM Tris-HCl [pH 8], 1 mM EDTA) as a negative control, and tow 
positive controls, using DNA extracted from characterised Biomphalaria 
pfeifferi  (N= 2) and Bulinus truncatus  (N= 2) collected by Professor Stothard 
in 2014 from Abha city, around 200Km in the distance from the study site. The 
tubes were briefly centrifuged, and placed in a thermocycler using Bio-Rad 
Thermal Cyclers (T100™ Thermal Cycler / a 96-well block format). The DNA 
was then purified using the QIA quick® PCR Purification Kit (Qiagen, for direct 
purification of double-single stranded PCR products >100 bp), following the 
manufacturer's Protocol. Purified PCR products were labelled with the sample 
name and coded, were sent for sequencing at Source Bioscience. Additional 
tubes of Forward and Reverse primers were sent at concentrations of 10ng/ul 
for PCR samples. 
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6.3.7 Inclusion criteria 
To be included in the study participants had to meet following general criteria: 
1) should not have received anti-helminthic treatment prior to the study (as-
sessed by asked each participant with his headteacher individually, and their 
parents if they are around, 2) be healthy as assessed by a clinical examination 
conducted by the local nurse working with NTDs control teams at Al-Majardah 
District. Children were excluded from the cross-checking analysis for the fol-
lowing up in December 2017 if their results of either CCA-ve or SEA-ELISA-ve. 
A total of 56 children met these criteria and were included in the following up 
study.  
6.3.8 Data handling and statistical analysis 
All data collected in the field and processed in the laboratory were recorded on 
proforma data sheets. These were then double entered in Microsoft Excel prior 
to the generation of summary tables for prevalence and intensity of infection. 
Empirical estimates of prevalence were calculated in the Minitab statistical 
package.18 (Minitab Ltd for Statistical Computing, Coventry CV3 2TE, UK), 
assuming the urine-CCA as the diagnostic ‘gold standard’ against the SEA-
ELISA, as alternate urinary schistosomiasis diagnosis diagnostic tests. For 
percentage values, 95% confidence intervals (95% CI) were estimated using 
the exact method (Armitage et al., 1994). We have decided to assume the urine-
CCA as the gold standard for our descriptive analyses (i.e. empirical estimates 
of diagnostic performance), since there have been extensive evaluations of 
urine-CCA dipsticks (Colley et al., 2013) and WHO recommendation of its use 
in surveillance mapping (Danso-Appiah et al., 2016). We calculated sensitivity 
(SS), speciﬁcity (SP), PPV and NPV for the SEA-ELISA diagnostic approach.  
6.3.9 Ethical considerations and anthelminthic treatments 
The Research Council of the Saudi Arabia Ministry of Health and the Liverpool 
School of Tropical Medicine granted approval for this study by Professor Luis 
Cuevas, Chair of Review panel at LSTM in April 2015, and ethical approval 
granted by Dr Mohammed H Alzahrani, Supervisor of Disease Vector Units & 
Director of Malaria Program at the Ministry of Health, Saudi Arabia in October 
2016 (Appendix 7 Page-192). The local NTDs control teams were given the 
full results for enrolling, children, and any infected children or even being sus-
pected to have Schistosomiasis infection, and then being referred to local pri-
mary health care for treatment. Case-reported were also taking place according 
to vector control and NTDs control at Asir region.  
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6.4 Results  
6.4.1 Morphometric analysis   
An overview of freshwater snail distribution and abundance, as well as water 
pH reading and conductivity levels (µs), was taken at all sample sites (Table 
22). Biomphalaria was not encountered at all visited sites, while a species of 
the genus Bulinus was often found in this river in large numbers. Out of 851 
snails collected from 17 locations (Figure 40B), five snails from each sample 
site (85 snails in total) were selected randomly with taking into account for a 
different size (from the biggest snail shell to smallest). All these chosen snails 
then underwent morphological measurement of the mean (x̅) and the standard 
deviation (σx̅) for Shell Width (SW), Shell Height (SH), Aperture Height (AH), 
Aperture Width (AW), Shell Length (SL) (see Figure 45A). Also, water-quality 
(water pH and conductivity (µs)) was measured at least twice at each sam-
pling site (Table 22).  
Table 22: Morphometric data gathered from Bulinus snails at 17 different sites in Saudi Arabia. 
The standard deviation of the mean values (σx̅) for the shell width (SW), shell height (SH), ap-
erture height (AH), aperture width (AW), and shell length (SL) of each 5 snails collected from 
each site are shown. All measurements are in mm. Also, water pH and conductivity (µs) values 
measured at all sample sites, and a total number of snail specimens collected with GPS Co-or-
dinates on Google Maps for highlighting the risk sites based on the distance from selected 
schools. 
 
During morphological measurements, the five snails were placed under a light 
microscope next to a known scale at LSTM (Figure 45 A) and were photo-
graphed using Motic Images Plus 2.0 software (www.motic.com). The five mor-
phometric parameters were plotted based on the mean (x̅) of each 5 snails at 
each site individually. A scatter plot with regression line predicting the varia-
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tion of the mean morphometric parameters (x̅) was generated for Bulinus: Ap-
erture Height (AH) against Aperture Width (AW), Shell Height (SH) against 
Shell Width (SW), and Shell Length (SL) against Shell Height (SH). See Figure 
45 B, C, D.   
 
Figure 45: Regression analysis of Mean morphometric measurements of 5 snails at each coding 
site (1-17) are presented with predicating lines for determining the correlation of the mean 
shell parameter. The tree red fitted lines show the predicted Y for any X value. The blue dashed 
lines show the 95% prediction interval. A: photo taken at LSTM lab shows dimensions of the 
177 | P a g e  
 
shell illustrated for a specimen of Bulinus spp. Aperture Height (AH), Aperture Width (AW), 
Shell Hight (SH), Shell Width (SW), and Shell length (SL) were measured in scale bar= 5mm. 
AW was taken at the point equidistant between the top and bottom of the aperture. Following 
this morphometric analysis, the mean morphometric measurements of each 5 Bulinus snails at 
each site was calculated and plotted using a linear regression model, so the variation between 
the measurements can be visualised. Measuring snails were to give the experience of morpho-
logical variation. Tree lines were added to show how intimately connected (or unconnected) of 
the snails based on mean morphometrics. In the right-hand graphs. B: A statistically significant 
relationship between Mean AH and Mean AW (P Value < 0.01, R=0.83, R-sq 95.73%). C: The 
relationship between Mean SH and Mean SW is statistically significant (P Value < 0.05, R=0.98, 
R-sq 68.44%). D: The regression variant in the mean measurement of Mean SL against Mean 
SH is not statistically similar (P Value= 0.051, R=0.4, R-sq 23.11%) 
6.4.2 Environmental parameters and snail distribution 
A significant positive relationship was found between a number of freshwater 
snails collected at each site and water pH (R = 0.72, P = 0.001) (Figure 46). In 
addition, a significant negative relationship was found between the number of 
freshwater snails collected and water conductivity (µs) (R = -0.12, P = 0.65) 
 
Figure 46: Showing the predicted Y (water pH or conductivity (µs)) for the number (X) of fresh-
water snails collected from 17 sites at Al-Majardah District. The blue dashed lines show the 
95% prediction interval. The fitted equation for the linear model that describes the relationship 
between water pH and the number of freshwater snails is: pH = 7.032 + 0.01566 number of 
snails, with R-sq=52.33%, while the relationship between water conductivity (µs) and the num-
ber of freshwater snails is:  µs= 640.4 - 0.1335 number of snails, with R-sq=1.33%  
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6.4.3 DNA sequencing 
Random 17 snails identified using morphological characteristics of the shells, 
geographic distribution Table 22, was subjected to sequencing analysis for 
COI. From 1-85 individuals of each snail from each of the 17 sites were ana-
lysed, including known snails as controls. The sequences from all selected 
snails loaded onto BLASTn confirmed that the species found is Bulinus forskalii. 
The sequence showed a 99% identity score with B. forskalii collected in the 
study sites (Appendix 8: Analysis and sequence alignment for Bulinus forskalii).    
6.4.4 Prevalence of schistosomiasis by an ELISA and CCA  
A total data set was assembled from 163 children with a prevalence of schisto-
somiasis by each diagnostic test presented, see Table 23. All male children, 
between the ages of 7 and 12, were tested for schistosomiasis using CCA-Urine 
dipstick and SEA-ELISA tests. The overall percentage of the prevalence from 
both tests were different (P Value < 0.05), by Urine-CCA, was 25/163 [15.3%; 
95CI %, 10.6-21.6] and SEA-ELISA 56/163 [ 34.3%; 95CI %, 27.5-41.9], with chil-
dren at Huzaifa Ibn al-Yaman school, has the higher infected children (P Value 
< 0.05). Statistical tests were performed, which showed no apparent relation-
ship between age and CCA or ELISA result (P Value < 0.05). The prevalence of 
schistosomiasis was: 18/112 [16.0%; 95CI %, 10.4-23.9] by urine-CCA dipstick 
at Huzaifa Ibn al-Yaman school and 7/51 [11.7 %; 95CI %, 5.5-23.3] at Ibn al-
Athir school. By SEA-ELISA, the rate of infection was quite higher at Huzaifa Ibn 
al-Yaman school, 40/112 [35.7%; 95CI %, 27.4-44.9], while lower at Ibn al-Athir 
school 16/51 [31.3%; 95CI %, 20.3-45.0]. The intensity of infection was only 
detected at Huzaifa Ibn al-Yaman school, with only 2/112 [1.7%; 95CI %,0.4-
6.2], being heavy infected with schistosomiasis determined by SEA-ELISA.   
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Table 23: Showing results of CCA and ELISA from school Huzaifa ibn al-Yaman and Ibn al-Athir 
school as well as the intensity of infection based on each diagnostic method with 95% confi-
dence interval. The majority of schoolchildren from both schools had a negative result for schis-
tosomiasis with both CCA and ELISA tests (P Value < 0.05). Huzaifa ibn al-Yaman School had 
more children with an ELISA result of either moderate or light infection compared with school 
Ibn al-Athir. However, two children from school Huzaifa ibn al-Yaman have a heavy infection 
by the SEA- ELISA, while school Ibn al-Athir, where no heavy infected children detected by both 
methods.  
 
6.4.5 Evaluation of an ELISA for combined with CCA as a standard gold 
test 
Assuming the urine-CCA as an arbitrary diagnostic ‘gold’ standard, the diagnos-
tic performance for SEA-ELISA tests is shown along with diagnostic accuracy 
and Cohen’s kappa statistic, Table 24. The sensitivity of SEA-ELISA is (60.0 %), 
also the specificity (70.2 %), with the PPV (26.7%), and a higher percentage for 
NPV (90.6%).  
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Table 24: Diagnostic comparison of sensitivity (SS), specificity (SP), negative predictive value 
(NPV) and positive predictive value (PPV) of SEA-ELIZA against urine-CCA dipstick as ‘gold 
standard’ 
 
6.4.6 Urine filtration assessment with microscopy (Following–up)  
A total of 56 children with results of either CCA+ ve or SEA-ELISA +ve were re-
tested by using the urine-CCA strip as well as urine filtration in the following 
up study. All specimens were processed and filtered in the field. The urine sam-
ple was taken between the hours of 10:00 and 14:00 for optimum egg passage. 
The urine of egg-positive specimens was used as the template. All tested chil-
dren were negative with urine-CCA and no Schistosoma-eggs being seen with 
urine filtration method.  
 
6.5 Discussion  
6.5.1 Schistosomiasis in Saudi Arabia 
Schistosomiasis remains a life-threatening public health problem in many developing 
countries particularly in rural communities (Rollinson et al., 2013, Stothard et al., 
2017a, Stothard et al., 2014). The transmission of this parasitic infection relies on the 
three disease levels (human, parasite and intermediate host) and surface waters 
(Ponce-Terashima et al., 2014). Both S. haematobium and S. mansoni has been 
documented in Saudi Arabia, and their distribution in KSA is focal because of the scat-
tered nature of the population (Lotfy and Alsaqabi, 2010). Saudi Arabia has imple-
mented schistosomiasis control and elimination programs resulting in a reduced prev-
alence of the disease throughout the country to very low levels. Since schistosomes are 
transmitted by freshwater snails; each schistosome species has its characteristic in-
termediate-host snails then combined snail investigations are important (Ashi et al., 
1989, Ageel and Amin, 1997, WHO, 1993). The intermediate hosts of S. mansoni and S. 
haematobium, while belonging to the same pulmonate family: Planorbidae differ by 
snail genus. Schistosoma mansoni is transmitted by the genus Biomphalaria, while S. 
haematobium is transmitted by the genus Bulinus (Brant and Loker, 2013). Thus, 
Bulinus serves as an intermediate-host for S. haematobium in Saudi Arabia, but not all 
species are thought to be permissive hosts (Al-Zanbagi, 2013).  
To capture the environmental heterogeneities and biological discontinuities of the 
epidemiological landscape of schistosomiasis in the KSA, this field survey was 
conducted to be reflective of an area of low endemicity within Al-Majardah District, in 
Asir region. A total of 851 genus Bulinus snails were collected from the 17 sites along 
the shoreline of the main river at Al-Majardah District in south-western Saudi Arabia 
through this species was identified by morphology (Figure 45) and molecular 
methods as B. forskalii (Appendix 8), typically considered a refractory host for S. hae-
matobium (Abe et al., 2018, Labbo et al., 2007). Biomphalaria was not encountered in 
any of the selected sites indicative of the absence of transmission potential for S. 
mansoni.  
6.5.2 Spatial distribution of identified Bulinus snails 
 Out of the 17 sites sampled (Figure 40), the spatial distribution of Bulinus snails was 
higher in the different sites ( from 1 to 8 sites), which is around Huzaifa Ibn al-Yaman 
(n= 542 in total )  with average distance from school 0.1 -6 Km in comparison  to other 
sites ( from 9 to 17 sites) that are around  Ibn al-Athir (n= 117 in total ) with an average 
distance of 0.1 -10 km  (P Value < 0.05) (Table 22). The highest number of  Bulinus 
snails (n= 148)  were collected from site-7 (GPS co-ordinates:19°05'02.0"N 
42°00'23.8"E), approx. 3.56 km in the distance from Huzaifa Ibn al-Yaman, while 62 
Bulinus snails were the highest sampled site-10 (GPS co-ordinates: 19°05'02.0"N 
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42°00'23.8"E), around  5.18 km in the distance from  Ibn al-Athir school. Indeed,  wa-
ter-level fluctuations and summer draught negatively affect the population dynamics 
of the freshwater snails as well as the transmission of schistosomiasis in KSA (Al-Akel, 
2012). From the outset, some features emerge as a tropical climate or temperate, the 
presence of surface waters, a modest socio-economic level and a specific population 
density (Barbosa et al., 2013, Mari et al., 2017).  
6.5.3 Environmental effects on snail population density 
In considering environmental factors and ecological drivers, however, it needs to be 
remembered that the variability of environmental conditions has many effects on snail 
populations through time and can limit overall freshwater snail abundance (Monde et 
al., 2016). Intriguingly, despite apparently favourable water pH and conductivity 
readings, not all sites were found to be inhabited by many freshwater snails (see Table 
22), however; likely due to unsuitable environmental conditions, indicating perhaps 
that negatively charged ions in the water known to disrupt  snail development, such 
as chloride, nitrate, sulfate, and phosphate anions (ions that carry a negative charge), 
whereas positively charged inorganic dissolved solids required for snail growth, such 
as calcium, magnesium, potassium, and sodium (Utzinger et al., 1997). Also, few snails 
(n=7) was collected from Site-17 (GPS co-ordinates: 19°05'01.1"N 41°56'11.6"E), 
which had a water conductivity reading of 667.2 µs, suggesting that other 
environmental conditions, such as water flow rate or temperature, may be preventing 
snail colonisation (McCreesh and Booth, 2014). For example, site- 1  had much fewer 
freshwater snails (n=34), possibly due to such low water pH readings (Spyra, 2017).  
6.5.4 Employed five morphological parameters for snail shells 
Mollusca is the most extensive and diverse phylum of invertebrate animals, which are 
found in a wide range of freshwater habitats and have various life-history strategies 
(Strong et al., 2007, Benkendorff, 2010). Thus, characterisation of snail species in the 
concerned area is of value not only to malacologists but also parasitologists because 
of the role they perform as intermediate hosts for a variety of parasitic infections  
(Aguiar-Silva et al., 2014, Oso and Odaibo, 2018). The most characteristic feature of 
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molluscs is their shell, the shape of which varies among taxa, partly reflecting their 
phylogenetic history and relationship between species where they are living (Bogan, 
2008, Perez and Minton, 2008, Falade and Otarigho, 2015). Therefore, an analysis of 
collecting 85 Bulinus snail’s morphological parameters with the standard division is 
presented in Table 22. The snails collected around Ibn al-Athir school, as an example, 
(Site-15, GPS co-ordinates: 19°04'60.0"N 42°00'22.2"E) had the highest Mean SW 
(7.18±1.98), Mean SH (11.08±3.81), Mean AH (7.53±3.14), Mean AW (4.98±1.92), with 
comparable Mean SL (3.20±0.31) with other sites, and site-9 (GPS co-ordinates: 
19°05'15.4"N 41°58'23.3"E) had the lowest Mean SW (2.58±0.32), Mean SH 
(5.50±0.72), and comparable Mean AH (2.86±0.30), Mean AW (1.70±0.24), Mean SL 
(2.48±0.48) with other sites. But, those nearby Huzaifa Ibn al-Yaman, few snails col-
lected had low-morphological parameters, with site-5 (GPS co-ordinates: 
19°02'48.4"N 41°46'22.1"E) had the lowest Mean SW (2.80±0.48), Mean SH 
(5.30±0.74), Mean AH (2.70±0.30), Mean AW (1.50±0.18), and Mean SL (2.50±0.51). 
Indeed, a variation of shell morphology have seen can be explained on the basis of ge-
netic factors and/or environmental influences, and the interaction between them (Hill, 
2004). In Low-transmission zone, particularly in rural communities in Saudia Arabia, 
human-made habitats, such as irrigation canals, serving as aquaria for the intermedi-
ate snail hosts have been frequently attributed to the disease transmission (Al-
Madani, 1991, Kloos, 1995).  
Although no report exists of human schistosomiasis around Al-Majardah District re-
cently, the general presence of Bulinus and other potential intermediate hosts in the 
main river may pose the risk of the disease being introduced to the surrounding com-
munities in the future. This is because agricultural activities are being carried out 
daily, which are allowing human water contact. Thus, the epidemiological study  of 
molluscan-borne diseases through, e.g., shell morphology represents a significant 
advance tool for identifying different snail species of medical importance, and can be 
critical steps for making public health-control decisions in order to  take a step for-
ward  to control these snail vectors by molluscicide (Ibikounlé et al., 2008, Falade and 
Otarigho, 2015).  
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6.5.5 Relationship of snail’s morphological parameters 
In an analysis of five mean morphological parameters of 85 Bulinus snails (5 snails 
from each site), the relationship of snail’s morphological parameters showed linearity 
for Mean AH against Mean AW, and Mean SH against Mean SW (Figure 45).  Also, the 
highest and lowest coefficient of the determinant (R-square) was observed, respec-
tively (Figure 45  B, C, D). A linear relationship for Mean AH when compared to Mean 
AW (P Value < 0.01, R=0.83, R-sq 95.73%), and the relationship of Mean SH when com-
pared to Mean SW (P Value < 0.05, R=0.98, R-sq 68.44%) was observed, while the 
linear relationship of Mean SL against Mean SH is not statistically significant (P Value= 
0.051, R=0.4, R-sq 23.11%). This pattern of association has been observed in many 
studies, among freshwater (Ismail and Elkarmi, 2006, Falade and Otarigho, 2015). 
Morphological differences may also be due to several factors of particular populations 
(e.g., by geographic distance); shell morphology may also be shaped mainly by the en-
vironment (Vergara et al., 2017).  
6.5.7 Morphological and genetic analysis of Bulinus snails 
Besides, morphological shell characterisation of snail populations and species within 
the genus from different geographical locations, the molecular evolutionary genetics 
analysis can significantly contribute to the taxonomy and systematics of species 
groups by correlating identified morphological parameters with the one-step molecu-
lar analyses of the mitochondria 1gene cytochrome oxidase I (COI) (Jones et al., 1999). 
Consequently, sequencing and analysis of the complete I gene (COI) from 17 collecting 
snails undertaken here, indicated the presence of Bulinus forskalii  (Appendix 8). This 
study has proven that this species is abundant at all sites (17- Sites), where their role 
as intermediate hosts in the transmission of S. haematobium are well known (Abe et 
al., 2018, Labbo et al., 2007). Nevertheless, the implementation of unambiguous and 
reliable DNA-based approaches for species identification seems to be an essential aim 
for schistosomiasis control in Saudi Arabia. Particular analyses of Random Amplified 
Polymorphic DNA (RAPDs) and the I (COX)  has been recommended for effectively 
differentiating B. forskalii group (Jones et al., 1999), and more generally have been 
documented as a useful tool in an evaluation of the stability of the derived 
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phylogenetic relationships within the genus Bulinus, either by a direct comparison of 
genetic variation within and between species of Bulinus profiles (Langand et al., 1993, 
Kane et al., 2008, Rollinson et al., 1998), or by cluster analysis of genetically derived 
distance estimates (Stothard et al., 1996).  
6.5.8 Immunological detection  of schistosomiasis  
Various studies have shown that the presence of an intermediate snail host may de-
termine the prevalence and explain the transmission of infection in the subject area 
(Abe et al., 2018). So, developing better diagnostic protocols with increased sensitivity 
and specificity is central for the monitoring and surveillance programme of schistoso-
miasis in KSA Since traditional parasitological approaches become more unreliable as 
both infection prevalence and intensity diminish through control (Stothard et al., 
2014). Recently, urine-CCA strip test (POC-CCA®) and finger-prick blood SEA-ELISA 
tests have become commercially available and evaluating their diagnostic accuracy in 
high-low prevalence settings for schistosomiasis was performed recently (Al-Shehri et 
al., 2018, Knopp et al., 2015). These tests can potentially indicate the occurrence of 
disease transmission locally and also providing cost-effective strategies to ensue from 
chemotherapy-based control in comparison with traditional methods (Stothard et al., 
2014, Weerakoon et al., 2018, Al-Shehri et al., 2018).  
As was expected (see Table 23), the prevalence of infection at Huzaifa ibn al-Yaman 
school was observed to be highest locally 18/112 [16.0%;95CI %, 10.4-23.9] by urine-
CCA dipstick, and 40/112 [35.7%;95CI %, 27.4-44.9] by SEA-ELISA, exceeding 16.0 % 
in all methods, whereas the prevalence of infection at Ibn al-Athir school was lowest 
7/51 [11.7 %;95CI %, 5.5-23.3] by urine-CCA dipstick and 16/51 [31.3%;95CI %, 20.3-
45.0] by SEA-ELISA. However, pooling infection status by being positive by any test 
revealed that just above half of the children attending both schools could be consid-
ered ‘free’ from infection. For the total data set only just a 65.6 % of children, 107/163 
[95CI %, 58.0-72.5] could be considered to have no evidence of schistosomiasis infec-
tion demonstrating the low-transmission of schistosomiasis at Al-Majardah District in 
the Asir region. Presently, the CCA assay has been further developed and became es-
tablished as part of WHO guidelines as a point of care (POC) urine-dipstick (van Dam 
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et al., 2004, Utzinger et al., 2015). Unexpectedly,  in field evaluation studies, the test 
has showed some limitations in detecting  S. haematobium infections (Stothard et al., 
2006, Stothard et al., 2009, Ayele et al., 2008), but performed well for S. mansoni infec-
tion (Legesse and Erko, 2007, Stothard et al., 2006).  Also, the correlation between the 
intensity of infection, as measured by egg counts against CCA concentration can be 
applicable and reliable in field-based research (Stothard et al., 2006) . Another hurdle 
limiting further use of the CCA test in such poor resource settings, even within an area 
mono-endemic for schistosomiasis is the cost of the dipsticks, currently more than 
US$2 per test (Stothard et al., 2009). On another hand, the ELISA technique, using SEA 
as the target, is the most widely used technique for its high sensitivity and stability 
(McLaren et al., 1978, Mott and Dixon, 1982, Mott et al., 1987, Doenhoff et al., 2004).  
However, this serodiagnosis of schistosomiasis has few drawbacks which are common 
to antibody detection techniques for parasite infection (Wu and Halim, 2000, Doenhoff 
et al., 2004). For example, antibody-detection tests are often criticised for lacking its 
specificity, including the difficulty in accurately differentiating between active from 
past infection, with parasite-specific antibodies remaining a long time after cure 
(Doenhoff et al., 2004, Hinz et al., 2017). Antibody false-positive result is of course also 
possible due to overlapping in heterologous immunity between infectious agents 
(Smith et al., 2012). Despite its instability in schistosome detection, immunodiagnostic 
techniques remain the best available methods for diagnosis in areas of low intensity 
of infection where the sensitivity and specificity of these methods appear to be satis-
factory (Goncalves et al., 2006, McCarthy et al., 2012, Bergquist et al., 2009). 
Comparing urine-CCA strip to SEA-ELISA gives a more accurate estimate of the relia-
bility of using SEA-ELISA as a diagnostic method (Table 24). The sensitivity of SEA-
ELISA compared to urine-CCA strip was shown as 60.0 % (95CI %; 40.7%-76.6%). Un-
derstandably, compared to the sensitivity established using the urine-CCA strip as a 
reference test, this is lower due to the higher prevalence obtained using SEA-ELISA 
test. The specificity was calculated to be 70.2 % (95CI %; 62.2%-77.2%), again lower 
when compared to urine-CCA as the gold standard. The PPV was determined to be 26.7 
% (95CI %;16.9%-39.5%). The NPV was estimated at 90.6 % (95CI %; 83.6%-94.8%), 
and Cohen's kappa 0.2% (95CI %;0.0%-0.3%). As for many other helminth infections, 
the implementation of parasitological diagnosis as the ‘gold standard’ leads to other 
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diagnostic test results (incorrectly) appear as inaccurate and unreliable tests for the 
monitoring and surveillance programme of parasitic infections (Doenhoff et al., 2004).  
6.5.9 Following up examination for positive cases  with urine filteration 
included 
In the following up in December 2017 for children with results of either CCA+ Ve or 
SEA-ELISA+Ve. A total of 56 children met these criteria and were tested by using the 
urine-CCA strip as well as urine filtration.  Upon follow-up of children who were 
considered to have an infection, a re-examination of cases appeared negative with the 
urine-CCA strip, and no eggs were seen by using urine filtration under the microscope 
in this study. This is probably due to PZQ treatment in between, so a follow-up in a 
year or two might reveal new infections. It has been suggested to succeed in dealing 
with the known limitation of this parasitological detection method in low- endemic 
settings, replicate specimens or the number of preparing slides from a single sample 
needs to be increased.  However, this increases costs may hamper the survey for the 
need of repeated samples and would complicate control strategies based on screen 
and treat (Wu and Halim, 2000). In China, where the target of some control pro-
grammes is the elimination of S. japonicum, a two-step diagnostic approach has been 
used, entailing initial serodiagnostic screening, followed by stool examination using 
the KK technique in seropositive individuals (Zhu, 2005). So, further evaluations are 
required in a region where schistosomiasis is non-endemic to determine whether 
there is cross-reactivity with antibodies against other infections. 
6.5.10 Aspect of future works  
In Asir Region, however,  the infection with schistosomiasis has been documented to 
be endemic within this area and age group as the age group of 15-35 showed the high-
est infection rate, as well as the incidence in males, was higher than females, providing 
evidence about the endogenous source of infection (Shati, 2009). So, evaluations these 
test’s diagnostic accuracy should now be expanded with using larger sample sizes, 
including more diverse age groups and in this areas and others with lower endemicity 
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for S. haematobium. A range of approaches to improving the accuracy of immunodiag-
nostic assays has been described. More sensitive assays (such as antibody-detection 
techniques) could be employed in future studies to confirm this to be true. More 
accurate reference standard tests, such as an increased number of parasitological 
examinations and the use of DNA screening of urine and stool with the Dra 1 PCR 
technique (Ibironke et al., 2011) or using  a TaqMan™ real-time PCR assay 
using specific primer-probe as s described in Uganda study for S. mansoni (Al-Shehri 
et al., 2018), should also be employed for more realistic estimates of both sensitivity 
and specificity. Also, a sensitive diagnostic tool that can also distinguish between past 
and present infections will be most useful for monitoring and evaluate control pro-
grammes with the ultimate goal of elimination (Bergquist et al., 2009).  
6.6 Conclusion  
Both intestinal and urinary schistosomiasis have been previously documented in this 
province, S. mansoni is mainly prevalent in the Asir Range, while S. haematobium oc-
curs on the Asir Plateau and in the Tihama area (Lotfy and Alsaqabi, 2010). The inter-
mediate hosts of the latter species are B. truncatus and B. beccarii. A total of 851 snails 
found in the 17 sites along the shoreline of the main river at Al-Majardah District, only 
Bulinus species found during this survey and confirmed the present of B. forskalii by 
morphological and molecular tools. However, this species is not typically associated 
with S. haematobium infection (Labbo et al., 2007). There were not cercariae shed by 
B. forskalii were observed from 17 sites, and none of them was not of medical im-
portance. That could be due to the opportunistic sampling that might have missed the 
transmission spots. DNA COX1 of collecting snails confirmed its identity 99% (497/ 
501) with the closest sample on GenBank of HQ121585.1. No Biomphalaria pfeifferi 
(intermediate host snail of S. mansoni) were encountered despite repeated and inten-
sive searching, which is suggestive of limited local transmission potential of S. mansoni 
during this time or have been a couple of years before. From screening children, there 
was evidence of past infection by SEA-ELISA and active S mansoni infection by CCA 
test. However, upon parasitological-serological follow-up a year later no further infec-
tion was seen presumably due to PZQ treatment in intervening at time point (Tchuenté 
et al., 2013). Further surveillance of S mansoni needed and broadened snail habitat 
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sampling to see if Biomphalaria can be encountered in future as well as increasing 
number of samples with including different age groups and gender alongside molecu-
lar tools such as rtPCR could help in highlighting the actual prevalence of 
schistosomiasis in rural communities sitting in KSA. 
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6.7 Appendices  
Appendix 6: CTAB extraction 
REAGENTS 
⚫ CTAB solution 
➢ For 200ml 
• 2.42g Tris 
• 16.4g NaCl 
• 1.2g EDTA 
• 4g CTAB (Hexadecyltrimethylammonium bromide) 
• 0.4ml 2-Mercapto Ethanol 
• Mess up to 200ml with sterilized water 
⚫ Protease K 
⚫ Chloroform + Isoamyl alcohol (Chloroform: isoamyl alcohol = 24: 1 (v/v), CIA)  
⚫ Absolute Ethanol 
⚫ 70% Ethanol 
⚫ 0.1 x TE 
⚫ Control samples 
PROCEDURES 
1. Prepare CTAB + ProK solution. 
i)  Heat up CTAB solution at 65ºC in water bath (or incubator). 
ii) Add 10µl of Protease K into each 600 µl of CTAB solution for each sample and 
mix. 
2. Put each filter sample into a NEW 2ml tube with screw cap (use a tube with sealed 
cap to prevent leaking). 
3. Add 600µl of CTAB + ProK solution MIX into each tube. 
4. Add virus solution in all tubes to confirm success of DNA extraction. Add 10µl of 
PHPV solution for all prepared samples. 
5. Keep at 65ºC for 3 h with mixing using a rotary. 
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6. Add 600µl of CIA to each tube, and centrifuge at 14000~15000rpm (8000g) for 
3min. 
7. Pick up 450µl of supernatant and transfer it into a new microtube. Do not pick up 
white debris at liquid border. 
8. Add 1ml of absolute Ethanol into each tube and mix by inverting tubes. After mix-
ing well, centrifuge at 14000~15000rpm (8000g) for 20min at 4ºC. If much DNA 
is collected, you can see fibrous thing in the liquid when you add ethanol. 
* This is usual ethanol precipitation procedure. So if you want, keep tubes at -20ºC for 
a while before centrifuge. 
9. Decant liquid carefully. 
10. Add 1ml of 70% ethanol to wash out salt. After mixing by inverting tubes, centri-
fuge for 5min at 14000~15000rpm (8000g), 4ºC. 
11. Decant ethanol and remove remained liquid using a micropipette. 
12. Dry with a heat block at 80ºC for few minutes (keep open the top of tube). 
* Be careful not to dry too much and not to leave liquid. 
13. Add 25~50µl of 0.1 x TE and rotate for 15min at 35ºC using a rotary. 
14. Centrifuge for 3min at 14000~15000rpm (8000g). 
15. Check by electrophoresis and PCR 
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Appendix 7: Ethical approval (KSA)  
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Appendix 8: Analysis and sequence alignment for Bulinus forskalii 
 
Controls 
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Chapter 7. General discussion  
             The present thesis has contributed to obtaining better appraisal and knowledge 
about the current epidemiology of key parasitic and communicable diseases in Uganda 
and Saudi Arabia. It has sought to provide evidence-based information for the health 
authorities to guide the respective national programmes to move forward in achieving 
their programmatic goals. To do so, we have carried out cross-sectional studies and 
assessed the prevalence of schistosomiasis, giardiasis and malaria using a combina-
tion of novel and traditional diagnostic tools. This has linked standard microscopic 
examination of collected samples with rapid antigen diagnostic tests. Furthermore, 
DNA based molecular techniques, for detecting Schistosoma spp. (with the 
characterisation of intermediate snail hosts), giardiasis and genotyping assemblages 
of Giardia, and generic 18S DNA Plasmodium detection following Plasmodium species-
specific real-time PCR for differing between species. On top of the epidemiological pro-
files of these parasites, we also identified factors associated with their infections and 
negative impacts upon on child health. Also, the thesis has provided actual examples 
of how the national programmes could evidence-based programmatic decisions based 
on the information obtained from these surveys, in order to help meet their control or 
elimination goals.  
The thesis consists of diagnostic and detection studies that were based on parasitolog-
ical- and serological-based methods alongside real-time PCR assays (Table 7), and fo-
cused upon examination of children of school-age as access opportunities for monitor-
ing and evaluation of the national control or elimination programmes. In particular, 
the thesis has 
a) Explored the geographical distribution of the most common parasitic infections 
among SAC by assessing the infection prevalence of the target species and con-
ducting spatial analysis;  
b) Assessed the extent and geographical distribution of schistosomiasis infections 
among school children in Uganda and Saudi Arabia using advanced diagnostic 
tools for documenting the effectiveness and cost-effectiveness of nation-wide 
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preventive chemotherapy via MDA campaigns with rising the impact of target 
different diseases; in specific,  
• Assessed the impact of the MDA in Uganda, in order to provide evidence 
to intensify drug administration decisions along the lake shoreline or as 
a critical part of post-MDA surveillance activities away from the lake; 
• Explored the prevalence levels of schistosomiasis in Saudi Arabia, as 
well as the accuracy of immunologic tools being evaluated among SAC, 
where the NCP was taking place for elimination of transmission;  
• Expolred the distribution of intermediate snail hosts in the different 
settings in Uganda and Saudi Arabia, and documented the impact of 
physico-chemical parameters of the water body including pH, conduc-
tivity on an abundance of intermediate snails; 
• Performed molecular characterisation of collected intermediate snail 
hosts using a DNA-based molecular technique as an advanced-tool for 
species-specific identification; 
•  Explored the impact of school location and household conditions, as 
well as behavioural components, on schistosomiasis transmission and 
infection intensity among schoolchildren, to be served as evidence-
based information to guide future schistosomiasis infection control 
strategies; 
• Investigated factors associated with schistosomiasis infections in 
critical districts  in Uganda and Saudi Arabia, not only limited to 
sanitation, and hygiene, but also environmental and socioeconomic 
characteristics, and assessed the distribution pattern of infection at the 
school-level  using spatial analysis; and  
c) Determined the prevalence of giardiasis infection using rapid antigen detection 
and TaqMan@ assay to determine the diagnostic accuracy as well as the distri-
bution patterns of assemblages of Giardia as evaluated by using assemblage-
specific TaqMan®TPI probes with confirming their presence by sequence anal-
ysis of β-giardin gene, to identify potential coinfections, risk factors and pathol-
ogies associated with differing assemblages; 
d) Highlighted the interactions between giardiasis, intestinal schistosomiasis and 
anaemia in theses school children; 
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e) Recorded the prevalence of malaria infections at at the district-level in Uganda, 
to evaluate the impact of the malaria control programme and assess future op-
tions for DNA-based surveillance to detect Plasmodium spp. making use of 
samples typically collected by schistosomiasis control programme. 
f)  Explored the possibility of the implementation of the TaqMan® assay as a plat-
form for monitoring and evaluation of of different public health interventions 
and assess the impact to control and eliminate critical communicable diseases. 
7.1. National control programme (NCP)  
7.1.1 Schistosomiasis Control Initiative (SCI) Programme, Uganda 
In recent years, several countries in sub-Saharan Africa have made significant pro-
gress in treating and reducing the spread of NTDs (WHO, 2017a).  Uganda, for exam-
ple, was one of the six countries initially selected by SCI to instigate a nationwide pre-
ventive chemotherapy intervention as implemented by the Vector Control Division, 
Ministry of Health  (Fenwick et al., 2009). In 2002, Uganda was the first country in sub-
Saharan Africa to start schistosomiasis MDA at scale. In April 2003, over 400,000 chil-
dren were treated with deworming medication, with SCI aiming to target three-quar-
ters of SAC (SAC: 5–14 years old) with preventive chemotherapy and reducing infec-
tion intensity and promoting the national and regional prevention programmes. The 
programme expanded to cover increasing numbers of schoolchildren and 
communities in only 23 of the 56 districts in Uganda over the six-year period (Fenwick 
et al., 2009), consequently highlighting the need for further surveys in the remaining 
districts, and include  communities that are poorly served by local health services 
(Tchuenté et al., 2017). In 2018, 46 districts will be received PZQ MDA through the 
NCP  (Adriko et al., 2018).  Although the higher rate of schistosomiasis infection among 
children, PSAC, i.e., those aged ≤5 years were considered to be at a low risk of infection 
for a long time (Adriko et al., 2018, Fenwick and Jourdan, 2016), and also this age 
group was not originally included within  the remit of the SCI (Fenwick et al., 2009). 
However, several studies have documented the burden of disease in this neglected 
population; a study carried out on the shoreline of Lakes Albert, and Victoria in Uganda 
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estimated the prevalence of S. mansoni at 62.3% in PSAC, further evidence these chil-
dren need to be treated (Sousa-Figueiredo et al., 2010b). In the absence of significant 
socio-economic development and environmental change, progress 
towards elimination remains elusive or at least a distant goal in most countries 
(French et al., 2018, Fenwick and Jourdan, 2016).   
7.1.2 Schistosomiasis Control Programme (SCP), Saudi Arabia 
 Primary health care centres have played a critical role in the comprehensive imple-
mentation of control activities targeting schistosomiasis which is launched by the 
MOH in 1971 (McDowell and Rafati, 2014). In 2003, the prevalence of this disease had 
significantly declined to 0.007%, and this is due to multiple activities imple-
mented and regular overseeing the effectiveness of intervention strategies (Barakat et 
al., 2014, Stothard et al., 2014, Lotfy and Alsaqabi, 2010). In addition to mass chemo-
therapy using PZQ, public health education focusing on behaviour changes towards 
risk factors, improving sanitation, provision of clean water supply, and snail control 
were applied (WHO, 2007). According to the annual MOH report, the outcome of the 
program was very optimistic; the rates of infection were 2.2, 2.9, and 2.78/100,000 in 
2000, 2004, and 2008 respectively. Also, from an examination of 34,305 water bodies, 
there were only 778 sites found to harbour intermediate snail hosts (McDowell and 
Rafati, 2014).   
Thereafter, a comprehensive review of the status of this disease and elimination ac-
tions were taken; accordingly, KSA can be categories into 3: (a) disease free, (b) trans-
mission interrupted; and (c) low transmission (general prevalence <1%) (Stothard et 
al., 2014). However, the overall effects of the control programme in South-East regions 
were not satisfactory when compare it to patterns reported from other regions (Al-
Madani, 1991, McDowell and Rafati, 2014, Shati, 2009, Stothard et al., 2014, Lotfy and 
Alsaqabi, 2010). In this context, appropriate diagnostics becomes a central role in 
providing accurate information for guiding the implementation strategies. It is clear 
that in high-endemic settings the number of diagnostic tests used to identify whether 
or not treatment is required is much less critical than that needed in elimination set-
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tings (Figure 47) (Stothard et al., 2014). Also, diagnostic methods used in near-elimi-
nation settings, e.g. serology, involve the use of more invasive methods such as capil-
lary blood rather than stool or urine specimens. 
 
Figure 47: (A) Idealized surface plot about showing the number of diagnostic tests performed increases 
as the rates of infection in the school decline. (B) Treatment and diagnosis areas are divided into hypo-
thetical project areas based on transitions from control to elimination interventions. Also, there will be 
a question mark  when the costs of the diagnostic tests vary in different settings; this may outweigh the 
costs  of MDA treatment(s) (Stothard et al., 2014) 
7.1.3 Giardia control programme in Uganda: current and future challenges 
 Relatively little is known about the epidemiology of giardiasis in African countries as 
this disease does not benefit from a disease-specific programme (Squire and Ryan, 
2017), although a recent review of giardiasis in Uganda focussed on the epidemiology 
and zoonotic transmission dynamics between primates, gorillas, cattle and humans 
living in close proximity or using similar water sources (Graczyk et al., 2002, Johnston 
et al., 2010). In Uganda, current prevalence estimates for humans varies from study to 
study primarily because of the age groups studied. The prevalence in children and in-
fants is usually higher than adults (Graczyk et al., 2002, Johnston et al., 2010, 
Ankarklev et al., 2012, McElligott et al., 2013). However, the majority of studies from 
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Uganda focus on the zoonotic potential of giardiasis and not the pathological effects 
on the human population.  
Our efforts in characterising the molecular epidemiology of giardiasis and the roles of 
various animals in the transmission of human giardiasis are hindered by the lack of 
case-control and longitudinal cohort studies. This sampling bias restricts the range of 
testing of humans and animals living in the same community. Nevertheless the 
frequent detection of infections with different genotypes and subtypes, and the link 
between heterozygosity and apparent mutation at some genetic loci for some G. 
duodenalis genotypes (Feng and Xiao, 2011). Therefore, the purpose of this study was 
to determine the prevalence and molecular epidemiology of Giardia assemblages 
around Lake Albert in Uganda, with a focus on current and future challenges and to 
develop recommendations for better control of this important parasite. At the very 
least, a high burden of infection and disease has been clearly presented which has 
drawn better attention to the importance of this disease locally. 
7.1.4 Malaria control programme in Uganda 
Despite a significant decline in the global malaria burden have been reported, declines 
were slower in the 15 highest -burden countries, the majority of which are located in 
sub-Saharan Africa (WHO, 2016b). Among the high-burden countries, Uganda has 
reported some of the highest levels of transmission intensity in the world and ranks 
fourth among these high malaria burden countries (Katureebe et al., 2016). Since 
2006, Roll Back Malaria (RBM) has involved in malaria prevention and control in 
the country and periodically funding the malaria indicator surveys (MIS) (Ssempiira 
et al., 2017). The MIS is standardised nationally-representative surveys for 
determining the prevalence of parasitaemia and its risk in children ≤ 5 years old and 
evaluating malaria control interventions coverage. To date, two studies have been car-
ried out by malaria indicator surveys (MIS) in Uganda; MIS 2009 and MIS 2014–2015 
(Ssempiira et al., 2017). The first study showed a high burden of malaria in different 
districts, with three regions had the prevalence between 50–75% and six were 10–
50%, and only one community < 10% ((UBOS), 2010). In the second survey of MIS, 
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there was a significant reduction of parasitaemia risk of 50%, and this is due to im-
provement in the coverage of Insecticide Treated Nets (ITNs) and ACTs intervention 
at all level of care. Additionally, parasitaemia prevalence has declined in the majority 
of districts to mesoendemic, 11%–50% ((UBOS), 2015, Ssempiira et al., 2017).  The 
actual effects of each intervention on parasitaemia reduction are not clear at na-
tional and subnational levels, but a new update national malaria control and elimina-
tion plans as a framework has been developed by the Ministry of Health (MoH) to ac-
celerate malaria control efforts (Ssempiira et al., 2017).  
In this framework known as Uganda Malaria Reduction Strategic Plan (UMRSP) 2014–
2020, clear aims have been establishing to reduce malaria mortality rates from very 
high levels to close to zero, morbidity to 30 cases per 1,000 persons per year, and the 
prevalence of  parasitic infections to less than 7% ((NMC), 2016). To achieve these 
targets and ensure from the more efficient use of scarce resources and an active 
surveillance programme, it is important to know the impact of each intervention on 
the prevalence. So, identifying diagnostic platforms seem to be important for accurate 
estimation of malaria prevalence in such this setting. The information presented in 
this thesis has shown that there remains a substantial burden of infection in school 
children in Buliisa District which would benefit from intensification of control inter-
ventions. 
7.2 Molecular diagnosis in clinical parasitology: current and future aspects 
Within the fields of molecular diagnostics, DNA-based detection has been established 
itself as a sensitive and specific qualitative and quantitative technique that has be-
come extensively used as diagnostic tools (Kralik and Ricchi, 2017, Chew et al., 2012, 
Craw and Balachandran, 2012, Schuurman et al., 2007, Melchers et al., 2014). In the 
field of parasitic diagnosis, several real-time PCR assays for the detection of intestinal 
parasites have been developed and shown to have excellent specificity and sensitivity; 
they have been accepted as objective tools for case confirmation and as gold standard 
in the development of alternative new diagnostic tools as they have been registered to 
ISO standards  (Verweij et al., 2004). Recent developments in improved and auto-
mated DNA extraction methodologies and a more comprehensive application of real-
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time PCR in molecular diagnostic laboratories for viral and bacterial diseases will al-
low DNA-based methods  to be used as an alternative tool for the detection and iden-
tification for a range of  different pathogens including parasitic infections (Verweij and 
Stensvold, 2014, Siwal et al., 2018, Ndao, 2009, Won et al., 2016). This thesis has de-
scribed different approaches on the implementation of real-time PCR for the detection 
and quantification of schistosomiasis, giardiasis and malaria using different biological 
samples to validate and optimise its use in future epidemiological surveys (Table 7). 
7.2.1 Schistosoma spp.  
In chapter 2, a real-time PCR approach targeting the internal transcribed spacer 2 
(ITS-2) has been developed and showed higher sensitivity for detecting schistosomia-
sis (Obeng et al., 2008). The ITS-2 PCR improved Schistosoma spp.  detection consid-
erably, in particular for the detection of S. mansoni (Table 8)(Weerakoon et al., 2018). 
A real-time PCR targeting the gene CO1of S. mansoni detected as similar as percent-
ages of S. mansoni-positives with standard microscopy in a Senegalese population 
(Ten Hove et al., 2008).  Unlike the cox1 gene, which can exhibit sequence variation 
between populations, the real-time PCR assay on ITS-2 does not discriminate between 
DNA of S. mansoni and DNA of S. haematobium and is less sensitive to reaction failures 
due to intra-specific variation (Ibironke et al., 2012, Meurs et al., 2015). In this thesis, 
the ITS-2 PCR was further evaluated using urine samples collected in different studies 
and compared with Urine- CCA strips and microscopy (Obeng et al., 2008, Melchers et 
al., 2014), which showed higher sensitive than CCA test. Also, ITS2-based 
schistosomiasis PCR on stool samples for the detection of S. mansoni and found that it 
outperforms standard microscopy on parasitological faecal smears, which makes it 
particularly useful in low–endemic setting areas, and consequently, in post-control 
settings (Meurs et al., 2015). Therefore, the outcome of results indicates that real-time 
PCR assay is a valuable tool for diagnosis, and could potentially serve as a gold stand-
ard to estimate the prevalence and intensity of Schistosoma infections in epidemiolog-
ical surveys (French et al., 2018). However, serology remains the best method to ex-
clude infection and have the highest NPV. 
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7.2.2 Giardia duodenalis 
Real-time PCR for this parasite has been already evaluated and shown 100% specific-
ity and a higher sensitivity as compared to conventional microscopy and antigen-
based detection (Verweij et al., 2004, Verweij et al., 2003, Stark et al., 2011, Laude et 
al., 2016). In chapter 3, Table 12 gives the results of the diagnostic tests for G. duode-
nalis in Lake Albert, Uganda where the schistosomiasis control is taking place since 
2002.  The results show that the real-time PCR assay has the highest sensitivity com-
pared to the antigen-based test for the detection of G. duodenalis. In this thesis, G. du-
odenalis real-time PCR was evaluated as part of an epidemiological study for intestinal 
schistosomiasis in LSTM research laboratory in Liverpool. In previous studies, G. 
duodenalis are very scant in Uganda (Ankarklev et al., 2012, McElligott et al., 2013, 
Fuhrimann et al., 2016). While the disease is zoonotic in livestock and an essential an-
thropozoonosis of the mountain gorilla (Hogan et al., 2014, Sak et al., 2014), the bur-
den of giardiasis in school children is mostly unknown across all country. A compara-
ble prevalence with antigen-based detection is reported in chapter 3 after screening 
eligible children with GIARDIA/CRYPTOSPORIDIUM QUIK CHEK™ test under field con-
dition. When real-time PCR was used on the same samples, the prevalence increased 
to 87.0 % which was graded into light (27.1%), medium (40.5%) and heavy (19.2%) 
categories upon comparison with Ct values. So, real-time PCR assay seems to be much 
more sensitive and beneficial for accurate detection of G. duodenalis in human stools 
and this finding is supported with those from other studies in different setting world-
wide (Beyhan and CENGİZ, 2017, Verweij et al., 2004). In chapter 3, all detected cases 
of G. duodenalis originated from SAC without previous data about the prevalence of 
this parasite in those communities, but these settings are well-known about 
endemicity of S. mansoni. The finding of the association between tow diseases, (see 
Table 13),  brought the importance for implementing effective controls targeting both 
or more of this water-borne diseases in this communities using real-time multiplex 
PCR assay as described in several studies (Verweij et al., 2004, Verweij et al., 2007, Ten 
Hove et al., 2008), and also creates opportunities for investigations of 
(sub)assemblage transmission dynamics (Thompson and Ash, 2016). 
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 In chapter 4, the G. duodenalis -positive samples were further characterised in an 
attempt to determine the geographic distribution of assemblages and identifying its 
risk factors. The data showed that assemblage B was dominant across the sample, 
which is supported by another study in Rwandan children (Ignatius et al., 2012), and 
assemblages A and B is varied by school sites and by the age of the child.  Mixed infec-
tions were so prevalent at Runga school in concordance with the highest rate of intes-
tinal schistosomiasis infections, translated as a co-morbidity and transmission-score 
(Table 15). Also, assemblage B revealed an association with underweight children in 
concordance with another study carried out in  Rwandan children (Ignatius et al., 
2012). Previous studies have suggested the epidemiological role of G. duodenalis as-
semblages in children as a factor associated with clinical manifestation (Ignatius et al., 
2012, Jerez Puebla et al., 2015, Kohli et al., 2008, Mahdy et al., 2009, Puebla et al., 2017, 
Puebla et al., 2014).  
Like most research subjects in chapters 3 and 4, and despite extensive attempts to 
associate symptoms with genotype in human infections, conflicting results have been 
obtained, and there is to date no clear correlation between assemblage and symptoms. 
However, it has been documented that genotype AI is more frequently detected in an-
imals, whereas genotype AII is mainly found in humans (Sprong et al., 2009, Cacciò 
and Ryan, 2008). It has been suggested that the presence of clinical presentation of 
infection depends on different factors such as the degree of host adaptation, 
nutritional and immunological status (Bartelt and Sartor, 2015). The results of studies 
on the association of G. duodenalis assemblages with epidemiological factors are 
summarised in Table 16. Future molecular studies on transmission patterns in these 
communities in combinations with a detailed description of underlying conditions 
might provide more insight into the source and impact of G. duodenalis assemblages 
on those children.   
7.2.3 Plasmodium spp. 
Measures of accuracy include sensitivity and specificity for malaria detection always 
rely on using the blood samples (Chotivanich et al., 2007), making several attempts to 
develop diagnostic tools using other biological samples from human to detect this 
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parasite unnecessary or impractical. Furthermore, It could not be expected that a 
blood parasite could shed detectable DNA amounts in faeces (Prugnolle et al., 2011, 
Jirků et al., 2012). However,  there is limited published data in this field, with only one 
past attempt of diagnosing malaria using human fDNA (Jirků et al., 2012), with another 
looking at diagnosis using human saliva and urine samples (Putaporntip et al., 2012). 
In the current attempt, chapter 5, quantitative PCR (rtPCR) assays have been 
optimised to detect and quantify malaria parasite from school-aged–children using 
generic primer-probe published by Shokoples et al. (Shokoples et al., 2009) for 
Plasmodium-DNA detection from either faeces and blood spots. The findings were 
promising to enhance assay used in malaria control sitting ,  which fits in with the 
objectives of the WHO global technical strategy for malaria (WHO, 2015a). 
 Despite a century of research, current knowledge of African great ape malaria and 
identifies gaps is limited, and future research for zoonotic transmission is 
currently unclear (Nys et al., 2017). However, several  molecular studies have 
shown surprisingly high genetic diversity and population of these species typically 
inspecting fDNA material (Duval et al., 2009, Krief et al., 2010, Liu et al., 2010a, Liu et 
al., 2010b, Liu et al., 2014, Liu et al., 2016, Rayner et al., 2011, Boundenga et al., 2015, 
Otto et al., 2014). Available evidence has been published for supporting P. falciparum 
from western gorillas can be transmitted to humans (Duval et al., 2009, Prugnolle et 
al., 2011). All data for identification of Plasmodium spp. were based on the molecular 
analysis using PCR-based amplification of faeces (Jirků et al., 2012). Because it is 
difficult to obtain their blood samples, which are used for detection of Plasmodium 
spp.,  the estimation of the prevalence of Plasmodium spp. is problematic (Jirků et al., 
2012). However, faecal-based diagnostics open new platform tools for addressing the 
questions regarding the prevalence, epidemiology, and clinical role of zoonotic 
malaria in such these setting. In addition, it could be used for other parasitic infection, 
which is detectable in faeces or blood from either humans and wildlife, and if so, this 
will have a high impact on malaria controls in recent future.   
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7.3. Key recommendations 
Control efforts for schistosomiasis and other NTDs, if followed, can reduce 
endemicities to levels that are no longer considered as public health problems. With 
the general success achieved by the schistosomiasis control and elimination 
programmes in Africa and Saudi Arabia (Bergquist et al., 2017, Stothard et al., 2014, 
French et al., 2018, Fenwick and Jourdan, 2016), there are few recommendations for 
improving the schistosomiasis control at national levels but at local levels where 
transmission can remain high, more specific revision of control tactics is needed 
(Figure 48) (Bergquist et al., 2017).  
 
Figure 48: Schematic figure is highlighting essential differences between the endemic areas and the 
appropriate control tools (Bergquist et al., 2017) 
Above all, using more sensitive diagnostics are now urgently needed since current 
methods (which are suitable for gaining control) are not sensitive enough in the longer 
term. When the goal is the elimination of the disease, active case detection can be a 
problem. The clinical and parasitological conditions commonly used are not 
  
 
 
206 | P a g e  
 
 
 
 
 
sufficiently sensitive. Approaches will need to be modified to incorporate more 
sensitive techniques. Currently available tests for antibodies and antigens may be used 
for the diagnosis of schistosomiasis in areas of low transmission (e.g. in Saudia Arabia), 
but new field-based antigenic or molecular tests will be needed (Figure 49).  
 
 
Figure 49: Modified figure about what expected diagnostic tools should be applied for future schisto-
somiasis surveillance based on endemicity and control achievements (Le and Hsieh, 2017) 
Whatever technology is available, it is essential that programme managers maintain 
staff interest in case finding and treatment. As the endemicity decreases, the 
sustainable control of transmission must become the major consideration; it should 
be based on improved hygiene and sanitation and the fight against molluscs (Figure 
48). These measures will help prevent a resurgence of schistosomiasis on the one 
hand, and on the other hand, consolidate the results already achieved in terms of 
improving health.  
In areas of low transmission, resources may be more effectively used if central 
authorities delegate the implementation of schistosomiasis control to regional 
authorities. This will require greater reliance on health resources and local education; 
training and skills transfer from the central to the peripheral level will be essential. 
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The integration of control activities into the health and hygiene-related services will 
further benefit health as a whole. In addition, the integration of schistosomiasis 
control and activities to control other diseases. Furthermore, the integration of control 
activities into existing health and school facilities on the one hand, and the 
development of intervention with other existing programs, such as lymphatic 
filariasis, malaria, nutritional programs, Immunization and other public health 
interventions, on the other hand, should be sought and encouraged, especially if new 
and more sensitive diagnostic tests are available. Staff motivation and retraining 
should also be strengthened by organising "cross-training" of laboratory staffs. 
Because asymptomatic cases are common and there are animal reservoirs for some 
species of these parasitic infections, the definition of elimination criteria would be 
particularly tricky to achieve. The risk of reintroduction of the disease in an area from 
which it had been eliminated, for example as a result of water resources development 
projects or population movements, further complicates the picture. By establishing a 
reliable surveillance system,  any new locally acquired infections can be detected 
within a suitable period of time, and this is essential. Similarly, the degree of the 
reliability of the surveillance system - the sensitivity of the diagnostic method used 
and the efficiency of the reporting system should be updated based on the endemicity 
of the diseases. When the endemicity of the disease has been reduced, thresholds and 
treatment strategies must be modified. When treatment has been administered 
repeatedly for many years, active surveillance is essential to detect any emergence of 
drug resistance.  
The results in this thesis reflect the role played by human activities in the transmission 
of schistosomiasis. The risk of infection with schistosomiasis is related to the presence 
or absence of the parasite, but also all the conditions necessary for the completion of 
the transmission cycle. So, the contact more or less frequent and sustainable with 
water, contaminated by stool and urine of infected persons constitute the main risk 
factor for infection with schistosomiasis (Stothard et al., 2017a). Thus, schistosomiasis 
is sensitive to the relationship between the human community and the aquatic 
environment. Typically streams, ponds and lakes remain significant sources of 
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infection in Uganda and Saudi Arabia, so investment in sustainable water-related in-
frastructure will be important for reducing schistosomiasis transmission through 
prevention  of new habitats.  
Discussions on the improvement of the molecular diagnostic tools and collecting 
samples for schistosomiasis, giardiasis and malaria control programme in Uganda and 
the findings of this thesis will help inform decisions on how best to improve the pro-
gramme outputs for these several diseases. Moreover, there is a need to focus on bet-
ter inter-sectoral approaches for the effective delivery of treatments. With levels of 
infection evidence in the total number of SAC in the study areas in Lake Albert in-
spected, several thousand children are likely infected Giardia spp. and are living with 
an unmet treatment need (Al-Shehri et al., 2016). Whilst not all the infected children 
would develop symptoms; it is likely that in these settings with these infections 
(giardiasis and schistosomiasis), children have been in regular contacting with 
infested water which is known to be a source of the disease (Adam, 2001, Colley et al., 
2014). Thus, we recommend establishing the overall public health importance for 
these infections in Uganda and what would be a core set for improving the case 
detection at the school level as a part of the integrated approach, reflecting this finding.  
Considering that the Giardia infection prevalence levels were even higher in several 
hotspots, attention should also be paid to waster, sanitation and hygiene (WASH), the 
sensitivity of diagnostic tests available, and zoonotic transmission as a significant risk 
for human infections. Enhanced surveillance efforts should be considered in these 
communities against Giardia infections. A close collaboration with the health promo-
tion programme under the environmental health programme for health education and 
access to improved water and sanitation would be useful as part of ‘inter-sectoral ap-
proaches’, which will shorten the duration of deworming required to interrupt para-
sitic infection transmission. WASH programmes should be implemented in these 
communities and actively advocated against water-borne diseases, by establishing 
this programme in a long run and the primary preventive measures such as personal 
hygiene (washing hands after defecation and defecating in the toilet) and sanitation 
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should be reinforced. Malaria infection screening should be considered in the schisto-
somiasis and STH infection surveillance activities in Uganda, employing molecular 
tools whenever possible.  
In Saudi Arabia, the contribution of genetic diversity of schistosomiasis and snails in 
Asir needs to be investigated. Several studies in KSA identified genetic variability 
within the same species collected from different regions at different periods (Mostafa 
et al., 2012, Shalaby et al., 2011). Schistosomiasis was detected in Hamadryas baboons, 
which live near local human settlements in the Saudi-Yemeni border areas (Yamane et 
al., 2003), so the role of animal reservoir hosts for schistosomiasis in KSA should also 
be considered. Other factors that might affect the successful implementation of such 
control programs are illegal immigration from the highly endemic countries and the 
creation of multiple water bodies, which can be suitable for breeding of snails (Lotfy 
and Alsaqabi, 2010, McDowell and Rafati, 2014).  
7.4. Suggestions for future work 
Real-time PCR, hereafter abbreviated RT PCR, is becoming a common tool for diagno-
sis of several pathogens including intestinal parasites. Nevertheless, there is 
ongoing research for improving diagnostic applicability in different resource settings. 
It is evident that real-time PCR platforms will improve substantially, including faster 
thermocycling times, flexibility, multiplexed amplification of multiple targets, speed-
ing up of the assay, processing and generating multi well-plates for a larger number of 
samples. Indeed, a real-time PCR technique has already been implemented for the de-
tection of several diseases, such as Schistosoma spp. (Melchers et al., 2014, Ten Hove 
et al., 2008), Giardia spp. (David et al., 2011, Verweij et al., 2004), Plasmodium spp.  
(Shokoples et al., 2009, Chew et al., 2012, Gavina et al., 2017, Siwal et al., 2018), viral 
pathogens  (Mirza et al., 2018). So, it is scale-up of implementation, therefore, that will 
allow early disease detection and control methods. Moreover, diagnostic technologies, 
such as DNA microarray and biosensor technologies are rapidly advancing (Peña-
Bahamonde et al., 2018). Also, recombinase polymerase amplification (RPA) has 
shown great potential, as evidenced by different studied (Daher et al., 2016, Poulton 
and Webster, 2018, Kosack et al., 2017).  
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The present thesis highlights that real-time PCR provides a feasible and cost-effective 
alternative diagnostic method for the detection of different parasitic infections in the 
presented epidemiological studies. The initial implementation of real-time PCR in a 
laboratory requires the substantial monetary investment required for “real-
time” PCR instrumentation as well as investing in rather costly reagents are 
major stumbling blocks for its routine use in most epidemiological settings. On the 
other hand, real-time PCR could be cost-effectiveness when its diagnostic applications 
are expanded for detecting multiple targets such as bacteria, viruses, protozoa, fungi, 
and parasites. Nevertheless, it needs to be considered that despite cost efficiency re-
garding cost component for most molecular genetic assays, real-time PCR-based de-
tection can still favour when using multiple primers directed at multiple templates 
within a single reaction. This is where the most significant advantage lies. For future 
work there are several components that need to be considered outlined as follows: 
• To adapt real-time PCR assays into more field-applicable platforms that 
allow closer-to-patient diagnosis and low-cost community disease sur-
veillance. 
  
• To explore the performance of these real-time PCR assays on other non-
invasive sampling specimens e.g. urine and saliva, for co-detection of par-
asites. 
 
  
• To embed these clinical diagnostics into wider environmental surveil-
lance of parasites screening of water or intermediate hosts in high-
through-put formats. 
Altogether these advances have the potential to provide a mechanism for the broader 
application of more accurate and convenient DNA detection methods that will be in-
valuable in future NTDs control and elimination efforts.  A significant challenge that 
remains to be addressed is the implementation of highly sensitive and specific molec-
ular diagnostic tools in several resource-poor settings. Although the real-time PCR 
method has brought forward new interesting prospects for molecular diagnosis of 
most common intestinal parasites in different endemic settings, it has little application 
for epidemiological surveys in most of these settings. However, real-time PCR can be 
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currently used as a gold standard for the evaluation of new rapid and inexpen-
sive tests for field diagnostics. Ultimately, field- PCR platform (such as RPA) has re-
cently become promising tools with equipment and processing times being further 
miniaturised with integrated processing of DNA extraction, which could apply to re-
source-poor settings (Crannell et al., 2015, Daher et al., 2016, Weerakoon et al., 2018). 
Such advanced diagnostic tools would have a significant impact on controls of these 
NTDs in resource-poor settings, particularly in early case detection and monitoring 
treatment efficacies.  
As a general rule, sensitivity is an essential factor in diagnosis. It is important for a 
clinician to know the specifications of the PCR methods used by the laboratory con-
ducting the analysis and/or to have a result accompanied by a specific comment in 
order to interpret the results correctly. The most important factors influencing the 
sensitivity of PCR methods are the choice of primers (to the genetic locus selected), 
the quality and the quantity of the extracted sample for analysis. The delays and the 
conditions of transport influence the reliability of the results. The commercialised 
techniques allow, when they exist, a level of standardisation of these results and an 
easy comparison from one laboratory to another, but there remain difficulties in co-
ordination. In all other cases, the developed techniques must be validated with maxi-
mum sensitivity. Adequate controls for contamination and inhibition should be 
included. Participation in external quality controls is also essential. A positive PCR re-
sult ensures the presence of the desired pathogen, while in some cases a negative re-
sult may be related to sensitivity problems. During a strong clinical suspicion, a repe-
tition of the exam a few days is often useful. In the context of certain chronic infections, 
a positive PCR is not synonymous with disease, the development and the 
standardisation of the quantitative PCR will make it possible to define thresholds.  
In view of the continuous development of new diagnostic methods, it becomes all the 
more essential that the clinician or researchers are able to choose the right test, based 
on its characteristics and clinical applicability in a given clinical situation or public 
health setting. For this purpose, as part of a series of recommendations for critical 
reading published and recently updated in “A guide to aid the selection of diagnostic 
tests” (Kosack et al., 2017), the ASSURED (Affordable, Sensitive, Specific, User-friendly, 
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Rapid and robust, Equipment-free and Deliverable to end-users) criteria can be 
considered  as a benchmark for deciding which diagnostic tests could be used in  
different resource-constrained settings (Appendix 9) (Kosack et al., 2017). However, 
these criteria are generic and are required to be adapted to the needs of each of the 
diagnostic tests and the manuscripts reported in this thesis hope to direct and stimu-
late this debate. 
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7.5 Appendix  
Appendix 9: A guide to aid the selection of diagnostic tests 
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